PROGRAMME BOOK

CINP 31st World Congress 16th – 19th June 2018 Austria Centre Vienna

www.cinp.org/vienna [email protected]

[Type text]

CONTENTS Contents

Contents Congress Programme ...... 3 Welcome Address ...... 6 About CINP ...... 6 Committees ...... 8 Ambassadors ...... 9 CINP Awards and Award Winners ...... 10

Scientific Information ...... 15

Plenary Speakers ...... 16

Ceremonies and Welcome Reception ...... 19

Scientific Programme ...... 20

Poster Presentations ...... 33

Congress Information ...... 65

Exhibition Floorplan ...... 74

Sponsor and Exhibitor Guide ...... 75

Sponsored Satellite Symposia ...... 78

Index of Authors ...... 81

2

Saturday 16th June 2018 Hall E Room 0.14 (x120) Auditorium

09.00- PCW1 10.30 TMS

11.00- PCW2 12.30 Bipolar

14.30- PCW3 16.00 PTSD Welcome and Awards Ceremony 16.45- 18.00 Special Lecture by Josh Gordon, NIMH Director Sunday 17th June 2018 Hall E Hall F1 Hall F2 Room 0.96&0.97 Room 0.14 Hall M1 Hall M2 Auditorium 08.30- Opening Address 08.45

PL01 Andreas Meyer 08.45- Lindenberg, Germany 09.30 The environment and resilience against mental illness 09.30- Tea and Coffee Break 09.45 Post Traumatic Attention Deficit OTHERS Schizophrenia OTHERS Stress Disorders Disorders WS01 S4 Bipolar Disorders S5 S3 ADHD across the CP01 The place of CINP 09.45- S1 S2 CINP initiative for PTSD Genetics in lifespan - biological Addiction treatment guidelines 11.30 GABA regulation: from The use of technology in public private a military context mechanisms underlying for bipolar disorder mechanisms to novel mental illness and partnerships (PPPs) disease onset and in clinical practice: therapeutic targets mental wellbeing for innovative CNS persistence, implications controversies and drug development for treatment consensus 11.30- Poster Session and Lunch Women’s Symposium 13.00

Satellite Symposia 1 Satellite Symposia 2 Lundbeck Janssen

The place of long-acting 13.00- Treating depression 14.30 injectables in severe today and tomorrow mental health disorders - bipolar disorder and schizophrenia

14.30- Afternoon Break 14.45 14.45- Depression Others Bipolar Disorders Addictive Disorders Depression 16.30

S6 S7 S8 S9 S10 CP02 WS02 New approaches in New insights into the Strategies to Cannabis shapes the Glutamate and mood Schizophrenia Childhood and transcranial magnetic role of orbitofrontal prevent morophologfical and disorders: All is not Adolescent stimulation for cortex in compulsive neurobehavioral epigenetic trajectory of explained by NMDA Disorders

depression behavior progression and mesocorticolimbic brain Advances in the psychopathology and its suicide in bipolar development relevant to diagnosis of treatment disorder psychiatric vulnerability paediatric mood disorders

PL02 Maria A Oqendo, USA Suicidal subtypes: 16.45- 17.30 improving phenotypes to uncover underlying biosignatures

Hall N

Satellite Symposia 3 AsCNP/ Sumitomo Dainippon 18.00- 19.30 Schizophrenia Today: Review of pharmacology, metabolics and cognition across the lifespan

Monday 18th June 2018 Hall E Hall F1 Hall F2 (x500) Room 0.96&0.97 Room 0.14 Hall M1 Hall M2 Auditorium

PL03 Elisabeth Binder, Germany Molecular mechanisms 08.45- of gene x environment 09.30 interactions - implications for diagnosis and treatment of psychiatric disorders

09.30- Tea and Coffee Break 09.45 Presidential Addictive Obsessive-Compulsive Depression Depression Schizophrenia symposium Disorders Disorders

S11 S12 S13 S14 S15 WS03 Prediction of disease Translational research Transformative A translational Translational Schizophrenia: From Progress of the vulnerability and on etiopathogenesis of Treatments for approach to neuroscience of genes to changed neuroscience-based treatment response in late-life cognitive Psychiatry reducing drug- obsessive-compulsive brain function nomenclature (NbN) 09.45- 11.30 mood and anxiety impairment and related memories disorders for Psychotropic disorders depression: four and enhancing drugs different approaches self-control in drug toward the common addiction goal

Corresponding Organisations 11.30- Poster Session and Lunch 13.00 Addiction problems in Asia

Satellite Symposia 4 Satellite Symposia 5 Lundbeck AsCNP/ Sumitomo Dainippon Why do we need new 13.00- treatments for major Neuropsychopharma- 14.30 depressive disorder and cology to the next schizophrenia? generation: New wave from Asia

14.30- Afternoon Break 14.45 Addictive Depression Depression Schizophrenia LATE BREAKING Disorders

S16 S17 S18 S19 S20 CP03 Special Lecture by The antidepressant It's all in the wiring: Behavioural Dopamine signal D-lysergic acid Treatment Resistant Josh Gordon, 14.45- controversy: what do Brain circuits involved in addiction: a intensity in diethylamide (LSD) and Depression NIMH Director 16.30 reanalyses of controlled depression and research and neuropsychiatric classical hallucinogens: Siegfried Kasper, trials reveal regarding antidepressant actions clinical update disorders: etiology preclinical and clinical Austria From gene to the true efficacy of and therapy studies in psychiatric behavior; analysis antidepressants? disorders of the 22q11 microdeletion

PL04 Noboru Hiroi, USA 16.45- Modeling and predicting 17.30 developmental trajectories of neuropsychiatric dimensions

4

Tuesday 19th June 2018 Hall E Hall F1 Hall F2 Room 0.96&0.97 Room 0.14 Hall M1 Hall M2 Auditorium

PL05 Amit Etkin, USA

08.45- The Arvid Carlsson 09.30 Lecture

A circuits-first approach to mental illness

09.30- Tea and Coffee Break 09.45 Obsessive-Compulsive Depression Schizophrenia Depression Schizophrenia CP04 Disorders WS05 S21 S22 S23 S24 S25 Neuropsychopharm Understanding the Deep brain stimulation Recent updates on Neuroimaging in NMDAR dysfunction, The Paul Kielhotz acology of the 09.45- mechanism of action of for severe OCD: effect controversial the treatment of neuromodulatory Lecture endocannabinoido 11.30 ketamine-like drugs in and mechanisms of STN issues in the depression - acute dysfunction and me mood disorders and and nucleus accumbens management of neuronal response, glutathione deficit in Rapid acting their implementation in targets schizophrenia treatment effects schizophrenia antidepressants the clinic and recurrence pathogenesis John Krystal, USA prediction

11.30- Poster Session and Lunch Business Meeting 13.00

PL06 Birte Glenthoej, Denmark

Glutamatergic GABAergic and dopaminergic 13.00- 13.45 abnormalities in antipsychotic-naive first- episode schizophrenia patients: connected disturbances or independent biomarkers for outcome?

13.45- Others Others Schizophrenia Depression LATE BREAKING CP05 LATE BREAKING 15.30

S26 S27 S28 S29 S30 S31 Microbiome and Psychedelic medicine: Developing new Genes epigenome Clinical, genetic, and Advances in non- neuropsychiatry - the therapeutic potential medications for the and environment in molecular determinants invasive brain moving towards of mind-altering treatment of pathophysiology of of mood fluctuations in Anxiety Disorders stimulation mechanisms substances schizophrenia: brain illness bipolar disorder: focus on and OCD approaches

failures and hopes circadian rhythms. Naomi Fineberg, UK targeting prefrontal, cingulate and insular cortices for treatment of OCD and addictions

PL07 Tibor Harkany, Austria

Differential influence of 15.30- 16.15 pre- and early postnatal cannabis exposure on the developing brain

16.15- Closing ceremony 16.30

5

About CINP

Dear Colleagues,

Welcome to the CINP World Congress! The theme of this meeting is “Neuropsychopharmacology: Meeting Global Challenges with Global Innovation.” The theme of this meeting articulates the essence of the uniqueness of CINP. On the one hand, this meeting will be a venue for transformative science aimed at alleviating the burden of neuropsychiatric disorders. On the other hand, our theme recognizes that the challenges and opportunities to make progress are of a global nature. All countries, in fact nearly all families, struggle in some way with the burden of mental illness. Similarly, exciting science is “breaking out” all over the world. I have witnessed this explosion first hand. Over the past two years, I have represented CINP at continental and national Colleges of Neuropsychopharmacology and visits to universities in Europe, Asia, and South America. Further, I have been in communication with the leadership of the African College of Neuropsychopharmacology, one of the newest Colleges in our global community of Colleges of Neuropsychopharmacology.

It is my hope to capture the global energy and excitement in our Vienna Congress. I have worked closely with our International Scientific Program Committee Co-chairs, Professors Barbara Sahakian (University of Cambridge, UK) and Marina Picciotto (Yale University, USA) and the rest of the Program Committee to select an extraordinary array of outstanding scientific presentations. I am confident that it will be a great conference. However, what would make this a unique World Congress would be to have the greatest global diversity of participants possible. The breadth and diversity of our community is a source of excitement and inspiration.

The CINP World Congress is also an opportunity to tour historic Vienna, the home of our CINP President-Elect, Prof. Dr. Siegfried Kasper. I look forward to sampling its pleasures including a visit to the renowned Opera House, a trip to the Sacher hotel to sample its famous pastry, an excursion to the spectacular Schönbrunn Palace, a tour of Vienna’s wonderful Kunsthistorisches Museum of art, and a “must see” for all CINP members, an outing to the restored former home of that neuroscientist-turned-psychologist, Sigmund Freud.

I look forward to the World Congress in Vienna with great anticipation. I hope that you will join me there.

Sincerely,

John H. Krystal, M.D. President, CINP

Siegfried Kasper Barbara Sahakian Marina Picciotto Chair, Local Organising Chair, International Scientific Co-Chair, International Scientific Committee Programme Committee (ISPC) Programme Committee (ISPC)

6

About CINP

The International College of Neuropsychopharmacology (CINP) is a truly worldwide organisation established over 50 years ago in Zurich, Switzerland. CINP hold meetings all over the world with the aim to promote research and education on a worldwide basis. These meetings mainly cover one of the four types below:

• Thematic Meetings • Regional Meetings • Training/Educational Programmes • Biennial World Congress

Any member of CINP is able to submit a proposal to the Executive Committee via the CINP Central Office should you wish to hold a Thematic or Regional Meeting in your area.

The Executive Committee and Councillors of CINP are nominated by the membership and serve as an officer of the College for a minimum of 4 years. These individuals cover a wide range of disciplines within the field, from psychiatrists, psychopharmacologists, basic and clinical researchers to clinical psychologists. CINP also relies on its many subcommittees who undertake a variety of activities for the College.

Membership of the College is available to any individual to apply for and we offer members the opportunity to become part of this knowledgeable group of scientists who work at an international level. The membership application is reviewed by a dedicated committee on a regular basis and applications can be made online. As a member of CINP you may have the opportunity to be invited to one of the smaller meetings or invited to participate in the running of the College by sitting on a subcommittee.

The International Journal of Neuropsychopharmacology (IJNP)

Oxford University Press has a rich history dating back to 1478; today OUP has 6,000 employees in offices in 50 countries and is the largest university press in the world. OUP has an incredibly diverse publishing program; publishing in more than 40 languages and in a variety of formats–print and digital, for all audiences–from pre-school to secondary level schoolchildren; students to academics; general readers to researchers and clinicians; individuals to institutions. As a department of the University of Oxford, our worldwide publishing furthers the University's objectives of excellence in scholarship, research, and education. For more information about the College visit www.cinp.org

7

Committees

CINP COMMITTEES AND ORGANISERS 2016 – 2018

International Scientific Local Organising Executive Committee Programme Committee Committee (All from Austria) (ISPC) President Chair Chair John Krystal, USA Barbara Sahakian, UK Siegfried Kasper Past President Co-Chair Members Shigeto Yamawaki, Japan Marina Picciotto, USA Jahannes Berger Vice Presidents Members Andreas Erfurth Pierre Blier, Canada Alan Frazer, USA Richard Frey Toshikazu Saito, Japan Kenji Hashimoto, Japan Marcus Hacker President Elect Noboru Hiroi USA Reinhard Haller Siegfried Kasper, Austria Yasmin Hurd, USA Tibor Harkany Secretary John Joska, South Africa Hans-Peter Kapfhammer Elias Eriksson, Sweden Siegfried Kasper, Austria Thomas Klausberger Treasurer John Krystal, USA Georg Kranz Brian Dean, Australia Jun Soo Kwon, Korea Rupert Lanzenberger Philip McGuire, UK Michael Lehofer Councillors Trevor Robbins, UK Markus Mitterhauser Francesc Artigas, Spain Toshikazu Saito, Japan Lukas Pezawas Helena Calil, Brazil Akira Sawa, USA Daniela Pollak Maurizio Fava, USA Simone Shamay-Tsoory, Israel Nicole Praschak-Rieder Kazutaka Ikeda, Japan Etienne Sibille, Canada Christa Rados Jun Soo Kwon, Korea Carol Tamminga, USA Michael Rainer Carol Tamminga, USA Shigeto Yamawaki, Japan Gabriele Sachs Gustavo Turecki, Canada Harald Sitte Allan Young, UK Wolfgang Wadsak Matthäus Willeit Elmar Windhager Dietmar Winkler Markus Zeitlinger

8

AmbassadorsCONTENTS

AMBASSADORS

Anissa Abi-Dargham, USA Sidney Kennedy, Canada Giorgio Racagni, Italy Huda Akil, USA Raymond Lam, Canada Mark Rapaport, USA Robert H. Belmaker, Israel Stephen Lawrie, UK Scott Rauch, USA Michael Berk, Australia Jeffrey Lieberman, USA Akira Sawa, U.S.A. Yuan-Hwa Chou, Taiwan Shih-Ku Lin, Taiwan Alessandro Serretti, Italy Euripides Constantino Miguel, Brazil Donatella Marazzitti, Italy Gwenn Smith, U.S.A

Angel Moríñigo Dominguez, Spain Eduard Maron, Estonia Dan Stein, South Africa

Peter Falkai, Germany Hans-Jürgen Möller, Germany Alexandra Sulcova, Czech Republic Konstantinos Fountoulakis, Greece Toshitaka Nabeshima, Japan Andi Jayalangkara Tanra, Indonesia Tony George, Canada Rao Naren, India Si Tianmei, China Anthony Grace, U.S.A. Charles Nemeroff, U.S.A. Jari Tiihonen, Sweden Yanling He, China John O'Brien, UK Ganesan Venkatasubramanian, India Noboru Hiroi, U.S.A. Maria Oquendo, USA Eduard Vieta, Spain Oliver Howes, UK Norio Ozaki, Japan Xin Yu, China Shitij Kapur, Australia Anthony Phillips, Canada

The Ambassadors of CINP are a group of eminent scientists within the psychiatric and neuropsychopharmacological fields in their country or region who strive to promote the 31st CINP World Congress in Vienna, Austria, 16th – 19th June 2018. In doing so, Ambassadors have also promoted CINP at the international level. CINP Ambassadors are greatly respected throughout the field; both nationally and internationally. We are very fortunate to have such an outstanding group of Ambassadors for Vienna 2018. We would like to thank all of our Ambassadors for their valuable contribution.

9

CINP Awards

CINP 2018 AWARDS The following awards will be presented during a special Reception at the Austria Centre on Saturday 16th June 2018 from 16.45 – 18.00 in the Auditorium (Hall E).

CINP Pioneers in Psychopharmacology Award

The Award is given at each Congress honour those individuals who have made major contributions to the field as it has developed. The contributions may be in research, clinical, or administrative areas but must be internationally recognized as significant to the growth of the field.

The Pioneer Awardees for 2018 are:

Kjell Fuxe, Hans Jürgen Möller, Robert Post, Sweden Germany USA

Previous Pioneers

2016: George Aghajanian, (USA), Sung Kil Min, (Republic of Korea) Herbert Meltzer, (USA), Stuart Montgomery, (UK) 2014: Julien Mendlewicz (Belgium), Thomas Südhof (USA), Solomon Snyder (USA) 2012: William Bunney (USA), Karl Rickels (USA), Moussa L. Youdim (Israel) 2010: Per Bech (Denmark), Salomon Langer (Israel), Teruo Okuma (Japan) 2008: Jean-Pierre Changeux (France), Samuel Gershon (USA), Hannah Steinberg (UK) 2006: Leonard Cook (USA), Fridolin Sulser (USA), Merton Sandler (UK) 2004: Hanns Hippius (Germany), Alfred Pletscher (Switzerland), Herman M. van Praag (The Netherlands)

10

CINP Awards

CINP Presidential Medal

The CINP is proud to present Professor Susan Iversen with the Presidential Medal. The Presidential Medal is presented to an individual who has had a transformative impact on the field of neuropsychopharmacology research. This award is presented in recognition of her fundamental contributions to psychopharmacology, neuropsychyology, and neuropsychopharmacology. Professor Iversen initially helped to define the role of the cerebral cortex in memory and cognition in non-human primates, first with Professor Larry Weskrantz at the University of Cambridge and then with Mortimer Mishkin at NIMH. These studies had broad implications, including implicating the lateral prefrontal cortex in cognitive control. Following a stint at Harvard Medical School, she began to use pharmacologic approaches to study the role of dopamine signaling in behavior. Her studies were among the first to focus on the role of dopamine in the nucleus accumbens, paving the way for generations of research. Professor Iversen left Cambridge in 1983 to become Director of Behavioral Pharmacology at Merck, Sharp, and Dohme. Ten years later, she assumed the Chair of the Department of Experimental Psychology at Oxford University and as a Fellow of Magdalene College. . Professor Iversen also has made a lasting contribution to the field as a mentor and role model, with prominent mentees including Trevor Robbins, George Koob, and Amy Arnsten. She is the recipient of numerous honors including Fellowship in the Academy of Medical Sciences and, in 2005, she became a Commander of the Most Excellent Order of the British Empire.

11

CINP Awards Max Hamilton Memorial Prize

Max Hamilton, M.D., F.R.C.P., F.R.C.Psych., D.P.M. (1912-1988) is best known for his assessment of depressive illness through psychometrics. The Hamilton Rating Scale for Depression is widely used throughout the world, and his 1960 paper on the problem of measuring the severity of depression is probably the most cited medical publication in the second half of the twentieth century.

The Max Hamilton Memorial Prize is given to a young scientist in recognition of an outstanding contribution to psychopharmacology. The recipient of the 2018 award has been chosen by an international scientific jury.

The Max Hamilton Awardee is:

Gwyneth Zai, Centre for Addiction and Mental Health (CAMH), Canada

Previous Max Hamilton Awardees:

2016: Nikolaos Koutsouleris, Ludwig Maximilian University of Munich, Germany 2014: Rudolph Uher, Dalhousie University, Canada 2012: Elizabeth Binder, Max-Planck Institute of Psychiatry, Germany 2010: Jean-Martin Beaulieu, Université Laval, Canada 2008: George Papakostas, Harvard Medical School, USA 2006: Alexander Neumeister, Yale University School of Medicine, USA 2004: Sarah H. Lisanby, New York State Psychiatric Institute at Columbia University, USA.

12

CINP Awards

Rafaelsen Young Investigators Travel Award

In 1986 Ole Rafaelsen and William Bunney were instrumental in establishing a CINP programme supporting the attendance of young scientists at the XVth CINP Congress in 1986. That programme was posthumously named the Rafaelsen Fellowship Award to honour Dr. Rafaelsen, who died in 1987.

The Rafaelsen Travel Awards enable young researchers to attend the CINP 2018 World Congress of Neuropsychopharmacology in Vienna and mark a step in a future rising career. The recipients of the 31st Congress Awards are chosen by an international scientific jury. The selected recipients also have the opportunity to present their poster as part of a Rafaelsen Young Investigators Travel Award Winners session under a new initiative within CINP.

Please come and see our Rafaelsen Winners posters which will be displayed throughout the whole Congress.

The Rafaelsen Awardees and their poster numbers are:

Poster Name Title Number

Value-Based Decision-Making of Cigarettes and Non-Drug Rewards in RAF1 Will Lawn, UK Dependent and Occasional smokers: An fMRI Study The development of dissociable and common aspects of RAF2 Giovanni Salum, Brazil psychopathology from childhood to adolescence and their brain structural correlates Therapeutic Drug Monitoring in quantifying in vivo fetus/infant drug RAF3 Georgios Schoretsanitis, Switzerland exposure to psychotropic agents Higher interleukin 17 is associated with greater severity of anhedonia in RAF4 Manish Jha, USA male, but not female, depressed outpatients: Findings from CO-MED trial Chie Shimamoto – Mitsuyama, Altered fatty acid composition of phospholipids in the corpus callosum RAF5 Japan of patients with schizophrenia Targeting microRNAs to screen new compounds to treat bipolar RAF6 Chiara Bortolasci, Australia disorder. RAF7 Ji-Seon Seo, USA Elevation of p11 in Lateral Habenula Mediates Depression-Like Behavior

The impact of stress during adolescence or adulthood is dependent on RAF8 Felipe Gomes, USA the state of the critical period

Peripheral methylome analysis in bipolar disorder patients suggests RAF9 Gabriel Fries, USA brain-relevant alterations in the glutathione system Maternal prenatal psychological distress and the early infant gut RAF10 Petrus Naude, South Africa microbiome in a South African birth cohort

13

CINP Awards

CINP 2018 Poster Awards

Clinical, translational and basic neuroscience research awards are given. Those presenting the best posters receive a certificate. These awards serve to encourage scientists who are actively involved in clinical and preclinical research. The final selection of Poster Awards will be made on the basis of the study’s scientific excellence during the Congress. The awards will be presented during the closing ceremony on Tuesday 19th July 2018.

14

Scientific Information

Plenary Lectures Clinical Perspectives Plenary lecturers present 45 minute talks at the Clinical Perspective sessions typically involve beginning of each morning and afternoon brief presentations from individual panel session Sunday to Tuesday. A plenary lecture members from a clinical perspective, followed will close the Congress on Thursday. These by the opportunity for lively and informative speakers are chosen in recognition of their discussion. This format provides substantial exceptional achievements in basic or clinical audience participation in education and research and the talks will include material of science and should be highly interactive. interest to both basic science and clinical audiences. All Plenary Lectures will take place Poster Sessions in the Auditorium (Hall E). These sessions offer an effective forum for the exchange of information and a means to Symposia communicate ideas, research, and Symposia of two-hour duration cover latest programmes. Poster authors will present and advances in basic and clinical discuss their results in these highly interactive Neuropsychopharmacology, biological sessions in various fields. psychiatry, drug development, public policy issues relevant to the field, mental health, mental illness and treatment outcome. Each symposium is scheduled for 120 minutes and consists of four speakers.

Educational Workshops Educational Workshops are sessions, which typically involve brief presentations from individual panel members, followed by the opportunity for lively and informative discussion on educational goals in the field of Neuropsychopharmacology. This format provides substantial audience participation in education and science and should be highly interactive.

15

Plenary Speakers

Sunday 17th June 2018 08.45 – 09.30 PL01 Auditorium (Hall E)

The environment and resilience against mental illness Speaker: Andreas Meyer-Lindenberg, Germany Chair: John Krystal, USA

Prof. Meyer-Lindenberg is Director of the Central Institute of Mental Health, as well as the Medical Director of the Department of Psychiatry and Psychotherapy at the Institute, based in Mannheim, Germany, and Professor and Chairman of Psychiatry and Psychotherapy at the University of Heidelberg in Heidelberg, Germany. He is board certified in psychiatry, psychotherapy, and neurology. Before coming to Mannheim in 2007, he spent ten years as a scientist at the National Institutes of Mental Health, Bethesda, USA.

His research interests focus on the development of novel treatments for severe psychiatric disorders through an application of multimodal neuroimaging, genetics and enviromics to characterize brain circuits underlying the risk for mental illness

Sunday 17th June 2018 16.45 – 17.30 PL02 Auditorium (Hall E)

Suicidal subtypes: improving phenotypes to uncover underlying biosignatures Speaker: Maria Oqendo, USA Chair: Siegfried Kasper, Austria

Maria A. Oquendo, M.D. is Professor and Chairman of the Department of Psychiatry at the Perelman School of Medicine, University of Pennsylvania. Her posts include: American Psychiatric Association, Immediate Past President; International Academy of Suicide Research, President; American Foundation for Suicide Prevention’s Board of Directors, Vice President; American College of Neuropsychopharmacology Council, member; National Institute of Mental Health Advisory Council, member. Her expertise spans from pharmacology and neurobiology of mood disorders and suicidal behavior to Global Mental Health (GMH). With over 350 peer-reviewed articles, she has received multiple awards, including Honorary Professor at Universidad Peruana Cayetano Heredia, Peru (2011), Stengel Award, International Academy of Suicide Research (2013) and the Virginia Kneeland Frantz Award for Distinguished Women in Medicine (2016).

16

Plenary Speakers

Monday, 18th June 2018 08.45 – 09.30 PL03 Auditorium (Hall E)

Molecular mechanisms of gene x environment interactions - implications for diagnosis and treatment of psychiatric disorders Speaker: Elisabeth Binder, Germany Chair: Elias Eriksson, Sweden

Elisabeth Binder has studied Medicine at the University of Vienna, Austria and Neuroscience at Emory University in Atlanta, GA, USA. Following a postdoctoral training at the Max-Planck Institute of Psychiatry in Munich, Germany, she returned to Emory University as an Assistant Professor in the Departments of Psychiatry and Behavioral Sciences and Human Genetics. In 2007, she was appointed as research group leader at the Max-Planck Institute of Psychiatry within the Minerva Program of the Max-Planck Society.

Since August 2013, Elisabeth Binder is the director of the Department of Translational Research in Psychiatry at the Max-Planck Institute of Psychiatry. She also holds an appointment as an Associate Professor in the Dept. of Psychiatry and Behavioral Sciences at Emory University School of Medicine. Her main research interests are the identification of molecular moderators of the response to environmental factors, with a focus on early trauma and gene x environment interactions. She studies how such factors influence trajectories to psychiatric disease or well- being to ultimately use this information for novel prevention and treatment strategies.

Monday, 18th June 2018 16.45 – 17.30 PL04 Auditorium (Hall E)

Modeling and predicting developmental trajectories of neuropsychiatric dimensions Speaker: Noboru Hiroi, USA Chair: Shigeto Yamawaki, Japan

Noboru Hiroi, PhD, is interested in the genetic, cellular and molecular mechanisms underlying developmental neuropsychiatric disorders. He is currently identifying specific genes responsible for dimensional aspects of schizophrenia and autism using mouse and cell models of copy number variants at human chromosome 22q11.2. His recent findings have identified Tbx1 and COMT as two 22q11.2 genes that contribute to the developmental trajectories of social communication and working memory, respectively.

Dr. Hiroi completed his undergraduate education at Waseda University, Japan, in 1985 and earned his PhD at McGill University (Dean's honor list), Canada, isn 1991. His background in behavioral neuroscience has grown and diversified over the years with experience in the laboratories of Dr. Ann M. Graybiel at MIT and of Dr. Eric J. Nestler at Yale University School of Medicine. Dr. Hiroi started his own laboratory in 1998 as an Assistant Professor at Albert Einstein College of Medicine, New York, became Associate Professor in 2005 and Professor in 2011. He was awarded an NARSAD Young Investigator Award in 1998, a NARSAD Independent Investigator Award in 2006, and the Lilly Basic Neuroscience Award in 2016. He serves on the editorial boards of Biological Psychiatry and Neuropsychopharmacology.

17

Plenary Speakers

Tuesday, 19th June 2018 08.45 -09.30 PL05: The Arvid Carlsson Lecture Auditorium (Hall E)

A circuits-first approach to mental Illness Speaker: Amit Etkin, USA Chair: Pierre Blier, Canada

Amit Etkin, MD, PhD is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Stanford, a member of the Stanford Neurosciences Institute, and an Investigator at the Palo Alto VA. He is trained as both as a neuroscientist and psychiatrist. The overarching aim of the Etkin lab is to understand the neural basis of emotional disorders and their treatment, and to leverage this knowledge to better understand how the brain works and to develop novel treatment interventions. In support of this goal, Dr. Etkin also collaborates with neuroscientists, engineers, psychologists, physicians and others to establish a new intellectual, scientific and clinical paradigm for understanding and manipulating human brain circuits in healthy individuals and for treating psychiatric disease.

Tuesday, 19th June 2018 13.00-13.45 PL06 Auditorium (Hall E)

Glutamatergic, GABAergic and dopaminergic abnormalities in antipsychotic-naive first-episode schizophrenia patients: Connected disturbances or independent biomarkers for outcome? Speaker: Birte Glenthøj, Denmark Chair: Barbara Sahakian, UK

Birte Glenthøj, MD, DMSc, is professor and leader of the Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Centre Glostrup, University of Copenhagen. Her research focuses on pathogenetic and pathophysiological disturbances in schizophrenia. The goal is to develop a scientific basis for an optimized and individualized treatment of schizophrenia and prevent progressive brain changes and loss of functions. To accomplish this, her group has, among others, collected multimodal data from a large number of antipsychotic-naïve first-episode schizophrenia patients and matched controls. The cohorts have been examined before and after the patient’s first antipsychotic treatment and followed for up till 16 years. Her presentation will focus on neurochemical disturbances in these cohorts and how they relate to outcome.

Tuesday, 19th June 2018 15.30-16.15 PL07 Auditorium (Hall E) Differential influence of pre- and early postnatal cannabis exposure on the developing brain Speaker: Tibor Harkany, Austria Chair: Toshikazu Saito, Japan

Tibor Harkany was born in Hungary and graduated as molecular neurobiologist at the University of Szeged. He then went on to complete his PhD in medical sciences at the Semmelweis University in Budapest. After successive post-doctoral training periods in the Netherlands and Sweden, he was appointed as independent group leader at Karolinska Institutet in 2005. In 2007, he was recruited as SULSA professor of cell biology to the University of Aberdeen (United Kingdom). Since 2013, he is chair of the Department of Molecular Neurosciences of the Medical University of Vienna, Austria, and simultaneously professor of neurobiology at Karolinska Institutet. His major research interests include the interrogation of cellular diversity in the nervous system and life-long effects of prenatal and neonatal substance exposure on brain development.

18

Ceremonies and Welcome Reception

Welcome Reception and Awards Ceremony

Master of Ceremonies: Professor Rupert Lanzenberger, Austria Local Organising Committee

Saturday 16th June 2018 Austria Centre Vienna 16.45 – 18.00 Auditorium (Hall E)

Welcome Addresses will be given by: Dr John Krystal, USA (10 mins) CINP President

Professor Siegfried Kasper, Austria (10 mins) CINP President-Elect, Chair of the LOC

Professor Barbara Sahakian, UK (10 mins) Chair of the International Scientific Programme Committee

Award Presentations Awards will be presented to the recipients of:

 Presidential Medal Award  The Pioneers Awards  Max Hamilton Award  Rafaelsen Winners (Announced)

Dr Alan Frazer, Editor-in-chief of the CINP Journal, the International Journal of Neuropsychopharmacology (IJNP) will announce the winners of the most cited papers.

Opening Plenary Introduction of Dr Joshua Gordon, Director of the NIMH. USA

Invitation from the President to a drinks reception

Closing Ceremony Tuesday 19th June 2018 Austria Centre Vienna 16.15 – 16.30 Auditorium (Hall E)

Closing Address by Siegfried Kasper, Austria CINP President Elect

Closing Address by John Krystal, USA CINP President

Poster Awards Awards will be given to the recipients of the poster awards.

19 Scientific Programme Saturday 16th June 2018

PCW01 WORKSHOP 09.00-10.30 Room 0.14 Topic: TMS Speakers: Georg Kranz, Austria Katharine Dunlop, Canada Jonathan Downar, Canada Mark George, USA Frank Padberg, Germany Nolan Williams, USA

PCW02 WORKSHOP 11.00-12.30 Room 0.14 Topic: Bipolar Speaker: Eduard Vieta, Spain

PCW03 WORKSHOP 14.30-16.00 Room 0.14 Topic: PTSD Speaker: Joseph Zohar, Israel

OPENING PLENARY Hall E (Auditorium) Speaker Joshua Gordon, USA

20 th ScientificCONTENTS Programme Sunday 17 June 2018

PL01 PLENARY LECTURE S2-03 08.45 – 09.30 Auditorium (Hall E) Wrist-worn activity measurement as a potential The environment and resilience against biomarker for late life depression mental illness John O’Brien, UK Chair: John Krystal, USA S2-04 Speaker: Andreas Meyer-Lindenberg, Germany Real life monitoring for mental health 09.30 – 09.45 Coffee Break Ellen Frank, USA

S1 SYMPOSIA S3 SYMPOSIA 09.45 – 11.30 Auditorium (Hall E) 09.45 –11.30 Hall F2 Topic: Others Topic: Post-Traumatic Stress Disorders GABA regulation: from mechanisms to novel PTSD Genetics in a Military Context therapeutic targets Chair: Joel Gelernter, USA Chair: Oliver Howes, UK Co-Chair: Joseph Zohar, Israel Co-Chair: Thomas Klausberger, Austria S3-01 S1-01 Dissecting the genetics of PTSD-related GABA and stress resilience- The role of GABA B phenotypes using an extensively phenotyped, John Cryan, Ireland longitudinal dataset of Dutch military personnel

Jurjen Luykx, Netherlands S1-02 Human cortical GABA systems in alcohol S3-02 response and alcohol dependence. Results Informative for PTSD-related traits from John Krystal, USA the Army Study to Assess Risk and Resilience in Service members (STARRS) S1-03 Murray Stein, USA The role of GABA in schizophrenia Oliver Howes, UK S3-03 Results from the USVA MVP PTSD Cooperative S1-04 Study GWAS. The role of GABA in autism spectrum disorders Joel Gelernter, USA Jackie Borg, Sweden S4 SYMPOSIA S2 SYMPOSIA 09.45 – 11.30 Room 0.96 & 0.97 09.45 – 11.30 Hall F1 Topic: Attention Deficit Disorders Topic: Schizophrenia ADHD across the lifespan - biological The use of technology in mental illness and mechanisms underlying disease onset and mental wellbeing persistence, implications for treatment Chair: Barbara Sahakian, UK Chair: Barbara Franke, Netherlands Co-Chair: Katharina Domschke, Germany Co-Chair: Thomas Vanicek, Austria

S2-01 S4-01 Cognitive training using a game on an iPad How ADHD changes its presentation across the in Schizophrenia and mild cognitive impairment lifespan Barbara Sahakian, UK Andreas Reif, Germany

S2-02 S4-02 New technologies: application to mental health Brain imaging of ADHD across the lifespan – and resilience results of the largest study worldwide from the Andreas Meyer-Lindenberg, Germany ENIGMA ADHD Working Group

Martine Hoogman, Netherlands

21 th ScientificCONTENTS Programme Sunday 17 June 2018

S4-03 Genome-wide association studies of ADHD WS01 WORKSHOP across the lifespan - differences between the 09.45-11.30 Hall M2 genetics of disease onset and persistence? The place of CINP treatment guidelines for Marta Ribases, Spain bipolar disorder in clinical practice: Controversies and consensus S4-04 Speakers: Hans Jurgen Mӧller, Germany Epigenetic DNA-methylation in humans with Eduard Vieta, Spain ADHD: biomarker or more? Lakshmi Yatham, Canada Barbara Franke, Netherlands 11.30 – 13.00 S5 SYMPOSIA Poster Session and Lunch 09.45 – 11.30 Room 0.14 Topic: Others CINP initiative for public private partnerships 11.45 – 12.45 WOMEN’S SYMPOSIA (PPPs) for innovative CNS drug development Chair: Barbara Sahakian, UK Chair: Shigeto Yamawaki, Japan Panel Speakers: Co-Chair: Peter Falkai, Germany Rita Goldstein, USA Eileen Joyce, UK S5-01 Fei Li, China CINP initiative for public private partnerships Barbara Sahakian UK (PPPs) for innovative CNS drug development Gwenn Smith, USA Shigeto Yamawaki, Japan Gwyneth Zai, Canada

S5-02 13.00 – 14.30 The role of imaging biomarker in the drug SATELLITE SYMPOSIA development process See page 78 for details Tetsuya Suhara, Japan

S5-03 S6 SYMPOSIA Translational PET Neuroimaging for Drug 14.45 – 16.30 Auditorium (Hall E) Development Topic: Depression Christer Halldin, Sweden New approaches in transcranial magnetic stimulation for depression S5-04 Chair: Siegfried Kasper, Austria Role of Public-Private Partnerships for Imaging Co-Chair: Georg Kranz, Austria biomarker development and sharing from the Pharmaceutical Industry perspective S6-01 Johannes Tauscher, USA Clinical insights to TMS therapy in depression

Linda Carpenter, USA CP01 CLINICAL PERSPECTIVES 09.45-11.30 Hall M1 S6-02 Topic: Addiction Optimizing rTMS for accelerated antidepressant Chair Helena Calil, Brazil response Co-Chair Konstantinos Papageorgiou, Austria Katharine Dunlop, Canada Speakers: Toshikazu Saito, Japan S6-03 Hisatsugu Miyata, Japan rTMS, monoaminergic neurotransmission and

neuroplasticity

George Kranz, Austria

22 th ScientificCONTENTS Programme Sunday 17 June 2018

S6-04 S8-03 Refining the region stimulated and Enhancing Resilience and Preventing Allostatic coordinating treatment with the brain state Overload in Bipolar Disorder Mark George, USA Eduard Vieta, Spain

S7 SYMPOSIA S8-04 14.45 – 16.30 Hall F1 Biomarkers of Lithium Response in Bipolar Topic: Others Disorder New insights into the role of orbitofrontal cortex Frank Bellivier, France

in compulsive behavior, psychopathology and its treatment S9 SYMPOSIA Chair: David Morilak, USA 14.45 – 16.30 Room 0.96 & 0.97 Co-Chair: Andreas Reif, Germany Topic: Addictive disorders S7-01 Cannabis shapes the morphological and Deciphering decision making: when to bet on the epigenetic trajectory of mesocorticolimbic brain orbitofrontal cortex development relevant to psychiatric Catherine Winstanley, Canada vulnerability Chair: Yasmin Hurd, USA S7-02 Co-Chair: Tibor Harkany, Austria Orbitofrontal cortex mediates choice behavior guided by taste memory S9-01 Francisco Sotres-Bayon, Mexico Neuronal and Molecular Effects of Adolescent Cannabinoid Exposure on Prefrontal Cortical S7-03 Function: Implications for Schizophrenia A novel role for JAK-STAT signaling in reversal Steven Laviolette, Canada learning in the orbitofrontal cortex: Implications S9-02 for new therapeutic mechanisms Cannabinoids shape prefrontal development: David Morilak, USA Multiple scale visualization

Olivier Manzoni, France S7-04 The role of the orbitofrontal cortex in compulsive S9-03 behaviour The epigenetic trajectory of developmental Trevor Robbins, UK cannabis exposure Yasmin Hurd, USA S8 SYMPOSIA 14.45 – 16.30 Hall F2 S9-04 Topic: Bipolar Disorers Epigenetic signatures of cannabinoids in the Strategies to Prevent Neurobehavioral developing brain Progression and Suicide in Bipolar Disorder Francesca Telese, USA Chair: Hilary Blumberg, USA Co-Chair: Andreas Erfurth, Austria S10 SYMPOSIA 14.45 – 16.30 Room 0.14 S8-01 Topic: Depression Neurobehavioral Progression in Adolescents and Glutamate and Mood Disorders: All is not Young Adults with Bipolar: Implications for Explained by NMDA Treatment and Suicide Prevention Chair: Mark Rasenick, USA Hilary Blumberg, USA Co-Chair: Harald Sitte, Austria

S8-02 Cognitive Dysfunction in Bipolar Disorder Allan Young, UK

23 th ScientificCONTENTS Programme Sunday 17 June 2018

S10-01 Comparison of (R)-ketamine and enantiomers of ketamine metabolites as rapid-onset and sustained antidepressants Kenji Hashimoto, Japan

S10-02 Restoration by ketamine of maladaptive plasticity induced by acute and chronic stress Maurizio Popoli, Italy

S10-03 A rapid, Ketamine-induced antidepressant biosignature in primary and cultured glia reveals NMDA-Receptor independent increases in cAMP and BDNF Mark Rasenick, USA

S10-04 Optimizing Full and Partial mGlu5 Negative Allosteric Modulators for the Treatment of Depression, Anhedonia, and co-morbid Addiction Use Disorders Carrie Jones, USA

CP02 CLINICAL PERSPECTIVES 14.45-16.30 Hall M1 Topic: Schizophrenia Chair Eileen Joyce, UK Co-Chair Ana Weidenauer, Austria Speaker: Carol Tamminga, USA

WS02 WORKSHOP 14.45-16.30 Hall M2 Advances in the diagnosis of pediatric mood disorders Speakers: Janet Wozniak, USA Joseph Biederman,USA Giulia Serra, Italy Jeffrey Newcorn, USA

PL02 PLENARY LECTURE 16.45-17.30 Auditorium (Hall E) Suicidal subtypes: improving phenotypes to uncover underlying biosignatures Chair: Siegfried Kasper, Austria Speaker: Maria Oqendo, USA

18.00-19.30 SATELLITE SYMPOSIA See page 78 for details

24 Scientific Programme Monday 18th June 2018 CONTENTS

PL03 PLENARY LECTURE S12-01 08.45-09.30 Auditorium (Hall E) Multi-Modality Imaging of Neurodegeneration Molecular mechanisms of gene x environment in Late Life Cognitive Decline and Depression interactions - implications for diagnosis and Gwenn Smith, USA treatment of psychiatric disorders S12-02 Chair: Elias Eriksson, Sweden PET imaging of tau and neuroinflammation in Speaker: Elisabeth Binder, Germany dementia

John O’Brien, UK 09.30–09.45 Coffee Break

S11 SYMPOSIA S12-03 09.45 – 11.30 Auditorium (Hall E) Bench to bedside: using mouse models to Topic: Depression identify new treatment approaches for dementia Prediction of disease vulnerability and treatment Masafumi Ihara, Japan response in mood and anxiety disorders Chair: Charles Nemeroff, USA S12-04 Co-Chair: Nicole Praschak-Rieder, Austria Cardiovascular surgery as an experimental model to test Vascular Depression Hypothesis and S11-01 CATCH hypothesis Childhood Adversity and Biological Hochang Ben Lee, USA Predictors of Mood Disorder Vulnerability and Treatment Response PRESIDENTIAL SYMPOSIUM Charles Nemeroff, USA 09.45-11.30 Hall F2 Transformative Treatments for Psychiatry S11-02 Chair: Barbara Sahakian, UK Using multi-levels of biomarkers for prediction of Co-Chair: Marina Picciotto, USA depression outcome Discussant John Krystal, USA Elisabeth Binder, Germany Speakers David Nutt, UK Matthew State, USA S11-03 Hayriye Cagnan, UK Cortisol Response to a Neuroendocrine Test for Predicting Future Onset of Depression and Anxiety Speaker 1 Disorders Drugs of abuse as novel therapeutics for the Linda Carpenter, USA upcoming century David Nutt, UK S11-04 MicroRNAs 146a/b-5p, 425-3p and 24-3p are Speaker 2 consistent markers of antidepressant response and From next generation genomics to gene regulate MAPK/Wnt system genes therapy in psychiatry Gustavo Turecki, Canada Matthew State, USA

S12 SYMPOSIA Speaker 3 09.45 – 11.30 Hall F1 Closed loop DBS strategies for Topic: Depression neuropsychiatric applications: lessons from Translational research on etiopathogenesis movement disorders of late-life cognitive impairment and Hayriye Cagnan, UK depression: four different approaches toward the common goal. Chair: Gwenn Smith USA Co-Chair: Dietmar Winkler, Austria

25 Scientific Programme Monday 18th June 2018 CONTENTS

S13 SYMPOSIA S14-04 09.45 – 11.30 Room 0.96 & 0.97 Pharmacotherapy of Obsessive-Compulsive Topic: Addictive Disorders Disorder: A Translational Approach A translational approach to reducing drug- Naomi Fineberg, UK related memories and enhancing self-control in drug addiction S15 SYMPOSIA Chair: Rita Goldstein, USA 09.45-11.30 Hall M1 Co-Chair: Gabriella Gobbi, Canada Topic: Schizophrenia Schizophrenia: From genes to changed brain S13-01 function The prefrontal cortex in reducing drug memories Chair: Brian Dean, Australia and enhancing alternative behaviors in cocaine Co-Chair: Matthaeus Willeit, Austria addiction Rita Goldstein, USA S15-01 Towards understanding the genetics of S13-02 schizophrenia Habitual behaviours in cocaine addiction: possible Dan Rujescu, Germany mechanisms and predisposing factors Karen Ersche, UK S15-02 Understanding the impact of changes in cortical S13-03 gene expression in schizophrenia Modulation of goal-directed action by reward Brian Dean, Australia expectancy cues and hippocampal and ventral striatal synchronization S15-03 Carien Lansink, Netherlands The potential impact of changes in protein in the CNS from subjects with schizophrenia S13-04 Carol Tamminga, USA Neuronal ensembles in drug-related memories in drug addiction S15-04 Bruce Hope, USA Changes in cellular structure and function in schizophrenia: Possible contribution to S14 SYMPOSIA pathophysiology 09.45 – 11.30 Room 0.14 Peter Falkai, Germany Topic: Obsessive Compulsive Disorders Translational Neuroscience of Obsessive- WS03 WORKSHOP Compulsive Disorder 09.45 – 11.30 Hall M2 Chair: Dan Stein, South Africa Progress of the Neuroscience-based Co-Chair: Daniela Pollak, Austria Nomenclature (NbN) for Psychotropic Drugs Speakers: Pierre Blier, Canada S14-01 Joseph Zohar, Israel Nosology of obsessive-compulsive disorder: An Christoph Correll, USA international effort Hiroyuki Uchida, Japan Dan Stein, South Africa 11.30 – 13.00 S14-02 Poster Session and Lunch Genetic Architecture of Obsessive-Compulsive Disorder and Tourette's Disorder Lea Davis, USA

S14-03

Neuroimaging of obsessive-compulsive disorder:

Collaborative findings

Premika Boedhoe, Netherlands

26 Scientific Programme Monday 18th June 2018 CONTENTS

ASIAN SYMPOSIA S16-02 11.30 – 13.00 Room 0.14 Trajectories of response and relapse in TITLE: Addiction in Asia placebo-controlled major depression trials Chair: Toshikazu Saito, Japan John Krystal, USA Speakers: Anne Yee Hway Ann, Malaysia Chia Chun Hung, Taiwan S16-03 Tomohiro Shirasaka, Japan An update on the relative efficacy of different Masuo Tanaka, Japan antidepressant in children and adults Discussant: Ratta-apha Woraphat, Thailand Andrea Cipriani, UK

S16-04 Speaker 1 Influence of dose and baseline severity on the Randomized, Double-Blind, Parallel-Group, response to selective serotonin reuptake Placebo-Controlled Trial Of Bupropion inhibitors Hydrochloride Sustained Release In The Fredrik Heironymus, Sweden Treatment Of Sexual Dysfunction In Men On Methadone Maintenance Therapy S17 SYMPOSIA Anne Yee Hway Ann, Malaysia 14.45 – 16.30 Hall F1 Topic: Depression Speaker 2 It’s all in the wiring: Brain Circuits Involved in Neurocognitive and brain imaging studies on Depression and Antidepressant Actions chronic ketamine users in Taiwan Chair: Alan Frazer, USA Chia Chun Hung, Taiwan Co-Chair: Rupert Lanzenberger, Austria Speaker 3 Clinical and Pathological Characteristics of Social S17-01 isolation (Hikikomori) and Internet Gaming in Quetiapine as an antidepressant medication: Japan Activating effects on the mesolimbic Tomohiro Shirakasa, Japan dopamine system in a model of depression Anthony Grace, USA Speaker 4 S17-02 Many persons with alcohol dependence have The hippocampus as an initial target for novel hardships of their living antidepressants Masuo Tanaka, Japan Alan Frazer, USA

13.00-14.30 S17-03 SATELLITE SYMPOSIA Networks in the brain: using functional See page 78 for details connectivity to characterise psychiatric

disorders and guide treatment development S16 SYMPOSIA 14.45 – 16.30 Auditorium (Hall E) Christian Beckmann, Netherlands

Topic: Depression S17-04 The antidepressant controversy: what do re- The default mode network and antidepressant analyses of controlled trials reveal regarding treatment response the true efficacy of antidepressants? Prediction Chair: Elias Eriksson, Sweden Marie Spies, Austria Co-Chair: John Krystal, USA

S18 SYMPOSIA S16-01 14.45 – 16.30 Hall F2 Can the superiority of antidepressants over Topic: Addictive Disorders placebo in controlled trials be explained by Behavioural addiction: a research and clinical their side effects breaking the blind? update Elias Eriksson, Sweden Chair: Sam Chamberlain, UK Co-Chair: Christa Rados, Austria

27 Scientific Programme Monday 18th June 2018 CONTENTS

S18-01 S19 S20 SYMPOSIA Introduction to the concept of behavioural 14.45-16.30 Room 0.14 addiction: how did we get here? LATE BREAKING Naomi Fineberg, UK Topic: Depression D-lysergic acid diethylamide (LSD) and S18-02 classical hallucinogens: preclinical and clinical Neurobiology and treatment of gambling studies in psychiatric disorders disorder and compulsive sexual disorder Chair: Gabriella Gobbi, Canada Jon Grant, USA Co-Chair: S20-01 S18-03 D-lysergic acid diethylamide (LSD) and Hair-pulling and excoriation disorders: obsessive- classical hallucinogens: mechanism of action compulsive, impulsive, or addictive? and pharmacology Sam Chamberlain, UK Gabriella Gobbi, Canada

S18-04 S20-02 How to conceptualise and treat compulsive Low doses of d-lysergic acid diethylamide shopping, stealing, and Internet use (LSD) exerts antidepressant-like effect and Brian Odlaug, Denmark modulates serotonergic neurotransmission Danilo De Gregorio, Italy S19 S19 SYMPOSIA 14.45-16.30 Room 0.96 & 0.97 S20-03 Topic: Schizophrenia LSD-induced states: behavioral and Dopamine signal intensity in neuropsychiatric neuroimaging studies in humans disorders: etiology and therapy Katrin Preller, Switzerland Chair: Kazutaka Ikeda, Japan S20-04 Co-Chair: Gabriele Sachs, Austria The neurobiology of treatment resistant

schizophrenia in aspect of dopaminergic S19-01 systems in the brain Neuropsychiatric phenotypes in dopamine Junhee Lee, Republic of Korea deficient mice and dopamine-transporter knockout mice CP03 CLINICAL PERSPECTIVES Kazutaka Ikeda, Japan 14.45 – 16.30 Room M1 S19-02 Topic: Treatment Resistant Depression Multiple dopamine systems Chair Lakshmi Yatham, Canada Naoshige Uchida, USA Co-Chair Shih-Ku Lin, Taiwan Speaker: Siegfried Kasper, Austria S19-03 The pharmacological and clinical implications of SPECIAL LECTURE the dopamine D2 receptor partial agonists 14.45-15.45 Hall M2 aripiprazole and brexpiprazole From gene to behavior; analysis of the 22q11 Tetsuro Kikutchi, Japan microdeletion. Chair: Brian Dean, Australia S19-04 Speaker: Joshua Gordon, USA The neurobiology of treatment resistant schizophrenia in aspect of dopaminergic systems PL04 PLENARY LECTURE in the brain 16.45 –17.30 Auditorium (Hall E) Junhee Lee, Republic of Korea Modeling and Predicting Developmental Trajectories of Neuropsychiatric Dimensions Chair: Shigeto Yamawaki, Japan Speaker: Noboru Hiroi, USA

28 Scientific Programme Tuesday 19th June 2018 CONTENTS

PL05 PLENARY LECTURE S22-02 The Arvid Carlsson Lecture DBS of the nucleus accumbens for OCD: clinical 08.45 – 09.30 Auditorium (Hall E) experience A Circuits-First Approach to Mental Illness Damiaan Denys, Netherlands Chair: Pierre Blier, Canada Speaker: Amit Etkin, USA S22-03 The neurophysiology of the subthalamic nucleus S21 SYMPOSIA and nucelus accumbens. 09.45 – 11.30 Auditorium (Hall E) Hagai Bergman, Israel Topic: Depression Understanding the mechanism of action of S22-04 ketamine-like drugs in mood disorders and their DBS for OCD: Comparison of STN and nucleus implementation in the clinic accumbens targets Chair: Jennifer Phillips, Canada Eileen Joyce, UK Co-Chair: Richard Frey, Austria S23 SYMPOSIA S21-01 09.45 – 11.30 Hall F2 Molecular and cellular mechanisms for the rapid- Topic: Schizophrenia onset of antidepressant-like effects Recent updates on controversial issues in the Gerard Sanacora, USA management of schizophrenia Chair: Hiroyuki Uchida, Japan S21-02 Co-Chair: Carol Tamminga, USA Exploring the antidepressant effects of ketamine: Insights from multimodal neuroimaging S23-01 Milan Scheidegger, Switzerland Resistance to antipsychotic treatment, including clozapine S21-03 Takefumi Suzuki, Japan Behavioural, peripheral, and central nervous system biomarkers for treatment response of S23-02 ketamine-like drugs Do antipsychotics make the brain shrink?: Bashkim Kadriu, USA Neuroprotective vs. neurotoxic effects René Kahn, USA S21-04 Cumulative and sustained effects of ketamine on S23-03 depressive symptoms and suicidal ideation in Impact of dopamine supersensitivity on brain, treatment-resistant depression psychopathology, and treatment Jennifer Phillips, USA Jun Soo Kwon, Korea

S22 SYMPOSIA S23-04 09.45 – 11.30 Hall F1 Is antipsychotic necessary for maintenance Topic: Obsessive Compulsive Disorders treatment? Deep Brain Stimulation for Severe OCD: Effect and Wolfgang Fleischhacker, Austria Mechanisms of STN and Nucleus Accumbens Targets Chair: Eileen Joyce, UK S24 SYMPOSIA Co-Chair: Suzanne Haber, USA 09.45-11.30 Room 0.96 & 0.97 Topic: Depression S22-01 Neuroimaging in the treatment of depression The functional neuroanatomy of cortico-basal – acute neuronal response, treatment effects ganglia thalamic systems: relevance for OCD DBS and recurrence prediction Suzanne Haber, USA Chair: Andreas Hahn, Austria Co-Chair: Kamilla Miskowiak, Denmark

29 Scientific Programme Tuesday 19th June 2018 CONTENTS

S24-01 S25-04 Using real-time fMRI neurofeedback to enhance NMDAR - glycine modulatory site as treatment in mood and anxiety disorders pharmacological target in schizophrenia: Annette Brühl, Switzerland translational biomarkers and novel clinical findings S24-02 Daniel Javitt, USA Effects of acute ketamine and citalopram CP04 CLINICAL PERSPECTIVES challenge assessed with pharmacological fMRI The Paul Kielholtz Lecture Andreas Hahn, Austria 09.45 – 11.30 Hall M1

Topic: Rapid Acting Antidepressants S24-03 Chair Helena Calil, Brazil Neuronal correlates of electroconvulsive therapy Speaker: John Krystal, USA in depression

Kamilla Miskowiak, Denmark WS05 WORKSHOP S24-04 09.45 – 11.30 Hall M2 Brain connectivity markers in recurrence of Neuropsychopharmacology of the depression endocannabinoidome Henricus Ruhe, Netherlands Speakers: Alexandra Sulcova, Czech Republic Vincenzo Micale, Italy S25 SYMPOSIA Jana Rudá, Czech Republic

09.45-11.30 Room 0.14 11.30 – 13.00 Topic: Schizophrenia Poster Session and Lunch NMDAR dysfunction, neuromodulatory

dysfunction and glutathione deficit in BUSINESS MEETING schizophrenia pathogenesis 11.30-13.00 Room 0.14 Chair: Daniel Javitt, USA CINP Members only Co-Chair: Ulrich Sauerzopf, Austria

PL06 PLENARY LECTURE S25-01 13.00-13.45 Auditorium (Hall E) Roles of D-amino acid oxidase (DAO), DAOA Glutamatergic, GABAergic and dopaminergic (G72), and cystine/glutamate antiporter in abnormalities in antipsychotic-naive first-episode NMDAR hypofunction, glutathione deficit, and schizophrenia patients: Connected disturbances schizophrenia pathogenesis or independent biomarkers for outcome? Hsien-Yuan Lane, Taiwan Chair: Barbara Sahakian, UK

Speaker: Birte Glenthoj, Denmark S25-02

Interplay of glutathione and glutamate: S26 SYMPOSIA relationship of blood glutathione, MRS 13.45-15.30 Auditorium (Hall E) glutamate, and cognition Topic: Others Akira Sawa, USA Microbiome & Neuropsychiatry- Moving towards mechanisms S25-03 Chair: Caitlin Cowan, Ireland Linking early-life oxidative stress, inflammation Co-Chair: Hans-Jurgen Möller, Germany and NMDAR hypofunction in schizophrenia pathogenesis S26-01 Kim Do, Switzerland The Microbiota-gut-brain axis across the lifespan modulates stress and cognitive behaviours Caitlin Cowan, Ireland

30 Scientific Programme Tuesday 19th June 2018 CONTENTS

S26-02 S28 SYMPOSIA Gut microbiome pro-inflammatory and anti- 13.45-15.30 Hall F2 inflammatory mediators in brain functioning Topic: Schizophrenia and behaviour: identification of possible Developing new medications for the treatment pathways and treatment strategies of schizophrenia: Failures and hopes Anna Cattaneo, UK Chair: Wolfgang Fleischhacker, Austria Co-Chair: Istvan Bitter, Hungary S26-03 S28-01 Bacterial peptidoglycans as novel signalling Pharmacological treatment of schizophrenia: Still molecules from microbiota to brain barking up the wrong tree? Rochellys Diaz Heijtz, Sweden Wolfgang Fleischhacker, Austria

S26-04 S28-02 Microbiota as a key modulator of generalized Focusing on hippocampal (CA3/CA1) hyperactivity anxiety disorder- Towards mechanisms and/or dentate gyrus hypoactivity to modulate Premysl Bercik, Canada psychosis in schizophrenia Carol Tamminga, USA S27 SYMPOSIA 13.45-15.30 Hall F1 S28-03 Topic: Others Kv3 channel modulation with AUT00206, a novel Psychedelic medicine: The therapeutic potential rational approach for the treatment of of mind-altering substances schizophrenia Chair: Kim Kuypers, Netherlands Charles Large, USA Co-Chair: Georg Psota, Austria S28-04 S27-01 Inhibition of kynurenic acid synthesis in psychiatric Clinical, brain imaging, and personality data diseases from studies with psychedelics at Imperial Robert Schwarcz, USA College David Erritzoe, UK S29 SYMPOSIA 13.45-15.30 Room 0.96 & 0.97 S27-02 Topic: Depression The effects of psychedelics on empathy and Genes epigenome and environment in creative thinking- implications for its use in pathophysiology of brain illness therapy Chair: Maurizio Popoli, Italy Kim Kuypers, Netherlands Co-Chair: Johannes Berger, Austria

S27-03 S29-01 Acute effects, pharmacokinetics and Sex-specific Neuropigenomics: Implications for concentration-effect relations of Lysergic Acid Anxiety Disorders and Depression Diethylamide in healthy subjects and cancer Marija Kundakovic, USA patients S29-02 Matthias Liechti, Switzerland Genetic and epigenetic mechanisms targeting fear S27-04 extinction dysfunction in anxiety pathology Long-term use of psychedelic drugs- the effects Nicholas Singewald, Austria on brain structures and personality in humans Jordi Riba, Spain S29-03 Gene-environment interactions in anxiety-like behavior in mice Iiris Hovatta, Finland

31 Scientific Programme Tuesday 19th June 2018 CONTENTS

S29-04 S31-01 Modulation of epigenome and microRNAs in Deep TMS of the prefrontal and insula cortices animal models of acute and chronic stress reduces food craving and body weight in obese Laura Musazzi, Italy subjects Livio Luzi, Italy S30 SYMPOSIA 13.45-15.30 Room 0.14 S31-02 LATE BREAKING Transcranial Magnetic Stimulation of Medial Topic: Prefrontal and Cingulate Cortices and Cocaine Clinical, genetic, and molecular determinants of Self-Administration. mood fluctuations in bipolar disorder: focus on Diana Martinez, USA circadian rhythms. Chair: Stefano Comai, Italy S31-03 Co-Chair: Mirko Manchia, Canada Deep transcranial magnetic simulation of the prefrontal and insula cortices induces smoking S30-01 cessation in heavy smokers Circadian aspects of lithium response. Abraham Zangen, Israel Thomas G. Schulze, Germany S31-04 S30-02 dTMS in OCD -targeting the ACC– a new Cellular circadian rhythms in bipolar disorder therapeutic tool, a new concept of stimulation. patients: implications for pharmacotherapy. Joseph Zohar, Israel Michael J. McCarthy, USA PL07 PLENARY LECTURE S30-03 15.30-16.45 Auditorium (Hall E) Alterations of circadian rhythms in diverse stages Differential influence of pre- and early postnatal of bipolar disorder cannabis exposure on the developing brain Mirko Manchia, Canada Chair: Toshikazu Saito, Japan Speaker: Tibor Harkany, Austria S30-04

Melatonin MT1 receptors: neurobiological and psychopharmacological implications for drug discovery in bipolar disorders.

Stefano Comai, Italy

CP05 CLINICAL PERSPECTIVES 13.45-15.30 Hall M1 Topic: Anxiety Disorders and OCD Chair Michael Bach, Austria Co-Chair Alexandra Schosser, Austria Speaker: Naomi Fineberg, UK

S31 SYMPOSIA 13.45-15.30 Room 0.14 LATE BREAKING Topic: Advances in non-invasive brain stimulation approaches targeting prefrontal, cingulate and insular cortices for treatment of OCD and addictions Chair: Joseph Zohar, Israel Co-Chair: Diana Martinez, USA

32 Poster Abstracts

POSTER ABSTRACTS

RAF: Rafaelsen Award Winners posters displayed for the duration of the Congress PS: Displayed on Sunday 17th June 2018 PM: Displayed on Monday 18th June 2018 PT: Displayed on Tuesday 19th June 2018 LBT: Late Breaking Posters displayed on Tuesday 19th June 2018

RAF04 Higher interleukin 17 is associated with greater severity of anhedonia in male, but not female, Rafaelsen Award depressed outpatients: Findings from CO-MED trial Winner Posters: Manish Jha, Andrew Miller, Abu Minhajuddin, RAF01 – RAF10 Madhukar Trivedi

Displayed for the duration of the Congress RAF05 Altered fatty acid composition of phospholipids in the corpus callosum of patients with schizophrenia , Chie Shimamoto–Mitsuyama, Kayoko Esaki Tetsuo Ohnishi, Motoko Maekawa, Yoshimi Iwayama, Shabeesh Balan, Brian Dean, Takeo Yoshikawa

RAF06 RAF01 Targeting microRNAs to screen new compounds Value-Based Decision-Making of Cigarettes and to treat bipolar disorder.

Non-Drug Rewards in Dependent and Chiara Bortolasci, Srisaiyini Kidnapillai, Georgia Occasional smokers: An fMRI Study Caruana, Ben Wade, Bruna Panizzutti, Briana Spolding, Will Lawn, Tom Freeman, Abdelmalek Benattayallah, Timothy Connor, Andrew Sanigorski, Tamsyn Crowley, James Bisby, Ludivo Mitchener, Val Curran, Chris Dodds, Stéphane Jamain, Laura Gray, Marion Leboyer, Michael

Celia Morgan Berk, Ken Walder

RAF02 RAF07 The development of dissociable and common Elevation of p11 in Lateral Habenula Mediates aspects of psychopathology from childhood to Depression-Like Behavior adolescence and their brain structural correlates Ji-Seon Seo, Zhen Yan, Paul Greengard

Giovanni Abrahão Salum RAF08 RAF03 The impact of stress during adolescence or Therapeutic Drug Monitoring in quantifying in adulthood is dependent on the state of the vivo fetus/infant drug exposure to psychotropic critical period agents Felipe V. Gomes, Xiyu Zhu, Anthony A. Grace Georgios Schoretsanitis, Elmar Stickeler, Gerhard Gründer and Michael Paulzen

33 Poster Abstracts

RAF09 Peripheral methylome analysis in bipolar disorder patients suggests brain-relevant alterations in the glutathione system Gabriel R. Fries, Giovana Zunta-Soares, Consuelo Walss-Bass, Jair C. Soares

RAF10 Maternal prenatal psychological distress and the early infant gut microbiome in a South African birth cohort Petrus J.W. Naudé, Shantelle Claassen-Weitz, Sugnet Gardner-Lubbe, Heather J. Zar, Mark P. Nicol, Dan J. Stein

DOWNLOAD THE FREE CINP 2018 MOBILE APP!

Create your own personalised conference schedule, view speaker biographies and abstracts and network with other delegates!

Download the free CINP 2018 mobile app. Search 'CINP 2018' in your app store.

34 Poster Abstracts

Sunday 17th June 2018 PS003 Altered Corticostriatal Functional Connectivity

in Patients with Methamphetamine Psychosis Poster Level 1 Sub Topic By Number Topic Disorder Ming-Chyi Huang, Chia-Wei Li, Changwei Wu, Wing P.

PS001-PS012 Clinical Addictive Disorders Chan

PS013-PS015 Clinical Anxiety Disorders PS004 PS016 Translational Anxiety Disorders Morphological abnormalities in the globus PS017-PS018 Clinical Attention Deficit pallidum as a vulnerability marker for gambling Disorders PS019-PS027 Clinical Bipolar Disorders disorder Masanori Isobe, Sarah A. Redden, Samuel R. Chamberlain, PS028 Preclinical Anxiety Disorders Jon E. Grant PS029-PS041 Clinical Bipolar Disorders PS042-PS044 Clinical Childhood & PS005 Adolescent Disorders PS045-PS056 Clinical Dementia Cognitive and neuroanatomical alterations associated with chronic exposure to levamisole- PS057-PS080 Clinical Depression adulterated street cocaine PS081 Translational Depression Matthias Vonmoos, Sarah Hirsiger, Markus R. PS082 Clinical Bipolar Disorders Baumgartner, Boris B. Quednow PS083-PS097 Clinical Depression PS098 Preclinical Schizophrenia PS006 PS099-PS100 Clinical Depression Increased Serum Levels of PVRL4 in Ketamine- PS101 Clinical Attention Deficit Dependent Patients and the Correlation with Disorders Emotional Abuse PS102-PS110 Clinical Depression Hu-Ming Chang, Ming-Chyi Huang, Yu-Li Liu PS111 Clinical Epilepsy PS112-PS113 Clinical Obsessive- PS007 Compulsive Mesolimbic cue-reactivity predicts drinking Disorders outcome in OPRM1 A118G carriers: a functional PS114-PS128 Clinical Others imaging study in alcohol dependent subjects PS129 Translational Attention Deficit a ri Ba h, M , a ine olls -Klein, Ph.D., Anne Disorders Beck, Ph.D., Henrik Walter, M.D., Andreas Heinz, M.D., PS130-PS131 Clinical Panic Disorders Marcella Rietschel, M.D., Falk Kiefer, M.D. PS132-PS134 Clinical Post Traumatic Stress Disorders PS008 Sexual behaviour and satisfaction in ketamine PS001 abuser in Taiwan: a cross-sectional study Systematic evaluation of dose-escalation Kuan-Ying Hsieh, Ching‑Hong Tsai, Yu-San Chang, Chih- strategies after initial non-response to standard- Jen Wang dose antidepressant pharmacotherapy in unipolar depression PS009 Markus Dold, Lucie Bartova, Rainer Rupprecht, Siegfried Disulfiram-induced seizures with convulsions in

Kasper a young male patient: A case study Paramjeet Singh Khurana PS002 PS010 Deep Transcranial Magnetic Stimulation for Is the Glasgow Modified Alcohol Withdrawal Smoking Cessation study: Sampling Scale (GMAWS) a reliable tool for monitoring of characteristics. Bianca Bellini, Jaqueline Ribeiro Scholz, Debora Arnaut, alcohol withdrawal in an acute hospital setting? Rodrigo Lancelot Alberto, Tania Marie Ogawa, Manoel A Singapore-based study. Jacobsen Teixeira, Marco Antonio Marcolin Khai Ying Lau, Keng Chuan Soh, Thofique Adamjee

35 Poster Abstracts

PS011 PS018 A Decade Experience of Methadone Omega-3 Fatty Acids in Youth with Attention Maintenance Treatment In Taiwan From 2006 To Deficit Hyperactivity Disorder 2016 Jane Pei-Chen Chang, Kuan-Pin Su4, Valeria Mondelli,

Hung-Ming Tsai; Shin-Hsiung Lee; Min-Wei Huang; Shyh- Carmine M. Pariante Chyang Lee PS019 PS012 Efficacy and safety of treatments in bipolar APBB2 is associated with amphetamine use in a depression in randomized controlled trials: methadone maintenance treatment population Systematic review and meta-analysis Yu-Li Liu, Chia-Chen Liu, Chiu-Ping Fang, Tung-Hsia Liu, Katsuhiko Hagi, PhD, Tadashi Nosaka, Andrei Pikalov, MD, Hsiang-Wei Kuo, Shu-Chi Liu, Sheng-Chang Wang, PhD, Antony Loebel, MD, Christoph Correll, MD Andrew C.H. Chen PS020 PS013 Benefits and harms of atypical antipsychotics in Social Anxiety Disorder patients exhibits the treatment of bipolar depression: A reduced 5-HT1A receptor binding across the systematic review and meta-analysis cerebral cortex – Improved cortical quantitative Katsuhiko Hagi, PhD, Tadashi Nosaka, Andrei Pikalov, MD, analysis of positron emission tomography data PhD, Antony Loebel, MD, Christoph Correll, MD using Freesurfer James GM, Seiger R, Mitterhauser M, Wadsak W, Kasper S, PS021 Lanzenberger R. Safety/tolerability of atypical antipsychotics in the treatment of bipolar depression: A PS014 systematic review and meta-analysis “Anxious-Depressive Attack” among outpatients Katsuhiko Hagi, PhD, Tadashi Nosaka, Andrei Pikalov, MD, on first admission in an anxiety clinic PhD, Antony Loebel, MD, Christoph Correll, MD. Hisanobu Kaiya, Fusaka Minami, Haruna Suyama, Naoko Kawasaki, Yuri Kishino, Satomi Matumoto PS022 Efficacy of atypical antipsychotics in the PS015 treatment of bipolar depression: A systematic Mindfulness-based cognitive therapy for review and meta-analysis community-dwelling adults with anxiety Katsuhiko Hagi, PhD, Tadashi Nosaka, Andrei Pikalov, MD, symptoms: An exploration of efficacy and PhD, Antony Loebel, MD, Christoph Correll, MD cognitive mechanism Linda Lam, Arthur Mak PS023 Five year course of bipolar disorder following PS016 treatment of first manic episode (FEM) with Combinatorial Pharmacogenomic Testing risperidone versus olanzapine: a retrospective Decreases Benzodiazepine Use and Improves review. Antidepressant Response in Individuals with Karishma Kulkarni, MD; Gayatri Devasthali, MD; Abhishek Generalized Anxiety Disorder Purty, MD; Kesavan Muralidharan, MD; YC Janardhan Zai G., Tiwari, A.K., Zai C.C., Cheema S., Braganza N., Reddy, MD; Sanjeev Jain, MD Mueller D.J., Pessariello, C., Brown, L., Li, J., Dechairo, B., and Kennedy, J.L. PS024 The development of a “ Web-Mobile” integrated PS017 system to improve the medication adherence in Effects of methylation on the norepinephrine major mental illnesses transporter expression measured by PET in Chau-Shoun Lee, M.D., Ph.D.; Jung Chen Chang, Ph.D. ADHD. Sigurdardottir HL, Kranz GS, Vanicek T, James GM, Gregor Gryglewski, Spies M, Mitterhauser M, Wadsak W, Rujescu D, Kasper S, Lanzenberger R.

36 Poster Abstracts

PS025 PS032 Effectiveness and Safety of Long-term Prescription patterns in patients with bipolar Treatment with Lurasidone in Children and disorder at a tertiary care center in Japan Adolescents with Bipolar Depression: Interim Ryota Osada, Yoshihiko Harada, Haruka Tanabe, Yuka Analysis at 1-year of a 2-year Open-label Asai, Tomomi Ogihara, Daimei Sasayama, Shinsuke Extension Study Wasizuka Kiki Chang, MD; Robert Goldman, PhD; Michael Tocco, PhD; Andrei Pikalov, MD, PhD; Ling Deng, PhD; Antony PS033 Loebel, MD Demographic and therapeutic characteristics of Japanese outpatients with bipolar disorder: a PS026 nationwide survey. Efficacy and Safety of Lurasidone in Bipolar Koichiro Watanabe, Shun Igarashi, Yukihisa Kubota, Naoto Depression: Treatment Review Adachi, Eiichi Katsumoto, Yoichiro Watanabe, Masaki Kato, Andrei Pikalov, MD, PhD; Joyce Tsai, PhD; Yongcai Mao Norio Furukori, Atsuo Nakagawa, Reiji Yoshimura PhD; Michael Tocco, PhD; Antony Loebel, MD PS034 PS027 The Difference of Co-aggregation of major Use of Asenapine in the complex chronic psychiatric disorders in individuals with first- patient. degree relatives with Bipolar I or Bipolar II Laura Prats, María Cecilia Navarro, Carlos Alonso disorder: a nationwide population-based study Chih-Ming Cheng, M.D., Wen-Han Chang, M.S., Mu-Hong PS028 Chen, M.D., Tung-Ping Su M.D, Cheng-Ta Li, M.D., Ph.D., Overexpression of sigma-1 receptor rescues Ya-Mei Bai, M.D., Ph.D. (G4C2)RNA repeats-mediated defect in the nucleocytoplasmic transport of Ran GTPase: PS035 implication in ALS Lifetime psychiatric comorbidity moderates the Tsung-Ping Su and Pin-Tse Lee rate of accumulation of medical comorbidity associated with bipolar disorder PS029 P. Ferentinos, S. Pagonas, E. Porichi, K. Dafnas, I. Prediction of functional impairment in bipolar Michopoulos, A. Douzenis disorder with machine learning techniques Jairo Vinícius Pinto, MD; Diego Librenza-Garcia, MD; PS036 Daniel Prates Baldez, MD; Adriane Ribeiro Rosa, PhD; Prevalence and correlates of bipolar disorder Vicent Balanzá-Martinez, MD, PhD; Márcia Kauer- comorbid with substance use disorder. an ’Anna, M , h ; Ives Caval an e assos, M , h ; Authors: Jairo Vinícius Pinto, MD; Leonardo Simão Flavio Kapczinski, MD, PhD. Medeiros; Márcia Kauer- an ’Anna, M , h

PS030 PS037 Body Mass Index-related brain volume change Development and Preliminary Evaluation of in elder patients with bipolar disorder Manual-Based Group Intensive Outpatient Yu-Jui Huang M.D. ; Shang-Ying Tsai M.D. ; Kuo-Hsuan Program (M-IOP) for Patients with Bipolar Chung M.D. ; Pao-Huan Chen M.D.; Shou-Hung Huang Disorder in China

M.D. Sun Xia, Yuan Cheng-mei, Ye Chen-yu, Wang Yong, Wang Yu, Lu Wei-hong, Song Rui, Xue Li-li, Huang Jia, Wu Zhi- PS031 guo, Wu Dan-ping, Yi Ru-fang Effects of Lithium Monotherapy on Serotonin Transporter and Serotonin-1A Receptor Binding PS038 in Bipolar Depression Ginkgo Biloba Induced Mood Dysregulation: A Authors: Mala Ananth, Elizabeth Bartlett, Francesca Case Report Zanderigo, Chuan Huang, R. Todd Ogden, Christine Young Sup Woo, Kyung Joon Min, Bo-Hyun Yoon, Young DeLorenzo, Ramin V. Parsey Joon Kwon, Moon Doo Kim, Won-Myong Bahk

37 Poster Abstracts

PS039 PS048 Correlation of Pro-inflammatory Cytokine and Suvorexant decreases risk for nighttime falls in Reduced Gray Matter Volume between Bipolar the inpatient with dementia disorder and Unipolar depression Tomokazu Shimazu, Shingo Yako, Kazuki Fujita, Hakuei Ya-Mei Bai*, Mu-Hong Chen, Ju-Wei Hsu, Kei-Lin Huang, Yamashita, Tsutomu Maruki, Yuichi Maruki Pei-Chi Tu, Tung-Ping Su PS049 PS040 Role of genetics and functional imaging in the The relationship of N-methyl-D-aspartate differential diagnosis of pseudodementia: two receptor antibody and psychiatric disorders case reports Hiroki Kawai, Shinji Sakamoto, Makiko Kishimoto, Yuko Hugo Canas Simião; Nuno de Moura; Dóris Reis; Teresa Okahisa, Manabu Takaki and Norihito Yamada Trindade; Ricardo Caetano Silva; Bernardo Barahona- Corrêa PS041 Comparison of YKL-40 levels in manic- PS050 depressed-euthymic patients with bipolar Effect of education on Alzheimer’s disease- disorder and healty controls related neuroimaging biomarkers in healthy Şule özen, Refi Cihnioglu, Ozge Yu sel O suz, Tevfi controls, and participants with mild cognitive Kalelioglu, Ilnem Mehmet Cem, Nesrin Karamustafalioglu, impairment and Alzheimer’s disease - a cross- Pelin Unalan Ozpercin, Burcu Kok Kendirlioglu sectional study

Masataka Wada, Shinichiro Nakajima, Yoshihiro Noda, PS042 Shunichiro Shinagawa, Jun Ku-Chung, Kyosuke Sawada, Comparative Study on the Effect of Risperidone Sakiko Tsugawa, Takahiro Miyazaki, Bun Yamagata, Ariel and its Combination with Naltrexone in Graff-Guerrero, Masaru Mimura Pediatric Patients with Autistic Spectrum Disorders: A Clinical Trial Study PS051 Ebrahim Abdollahian, Fatemeh Mohareri, Azam Hosseini A Meta-Analysis of the Effect of Apolipoprotein E ɛ4 Carrier Status on the Cognitive Response to PS043 Acytelcholinestease Inhibitors in Patients with Alzheimer’s dementia Screening with the Korean version of the Mood Ying-Chih Cheng, MD, Yu-Chen Huang, MD ,Hsing-Cheng Disorder Questionnaire for Bipolar Disorders in Liu MD, PhD Adolescents: Korean validity and reliability study

Sehoon Shim, Soonchunhyang PS052 PS044 Expression of Intestinal endotoxemia (IETM) on Cortisol and cytokine/chemokine profiles APP, PS1 and BACE in Alzheimer’s disease associated with behavioral difficulties in Bai Han, Fan Wu, Jianying Li, Hejun Li, Kezhan Liu, Chen Li

children Daimei Sasayama, Masaki Yamaguchi, Shinsuke PS053 Washizuka, Hideo Honda Ritalin for Apathy in Dementia Prem Kumar Chandrasekaran, Stephen Thevanathan Jambunathan, PS046 Mortality risk associated with antipsychotics in PS054 Patients with Dementia in Hong Kong Tardive dyskinesia induced by donepezil; a Helen FK Chiu*, Estee Wong paradox

Ioannis Michopoulos, Marianna Papadopoulou,, Rossetos PS047 Gournellis, Sofia Tzortsou, Panos Ferentinos, Kalliopi Mortality risk in older adults with dementia Tournikioti, Athanasios Douzenis treated with atypical antipsychotics: a systematic review and network meta-analysis of PS055 randomized controlled trials Systemic Inflammation and long term outcome Ta-Chuan Yeh, MD; Haui-Te Hsieh, MD; Tien-Yu Chen, of Alzheimer disease MD; Ping-Tao Tseng, MD; Che-Sheng Chu, MD; San-Yuan Ying-Chih Cheng, MD,Hsing-Cheng Liu MD, PhD, Huang, MD, PhD; Chih-Sung Liang, MD

38 Poster Abstracts

PS056 PS064 Effects of Rivastigmine Transdermal Patch on Early effects on depressed mood, suicidality and Cognitive Function and Body Weight: An anxiety of duloxetine in depression Observational, Retrospective Study in Japanese Alexander Lisinski, Fredrik Hieronymus, Jakob Näslund,

Patients with Alzheimer Disease Staffan Nilsson, Elias Eriksson Yasuhiro Kaneda PS065 PS057 Discrepancies between nomenclature and An approach to clinical dose escalation in a indications of psychotropics Phase 1 study for TAK-653, a novel AMPA Fusaka Minami, Joseph Zohar, Takefumi Suzuki, Teruki Koizumi, Masaru Mimura, Gohei Yagi, Hiroyuki Uchida positive allosteric modulator Amir Inamdar Karen Asin, Lin Xu, Mahnaz Asgharnejad PS066 PS058 Efficacy and safety of intranasal esketamine plus The clinical impact of post-traumatic stress an oral antidepressant in elderly patients with disorder as comorbidity on patients with treatment-resistant depression unipolar depression as primary diagnosis – Rachel Ochs-Ross, Ella Daly, Yun Zhang, Rosanne Lane, results from a cross-sectional European Pilar Lim, Karen Foster, David Hough, Husseini Manji, Wayne Drevets, Gerard Sanacora, Caleb Adler, Rupert multicenter study McShane, Raphaël Gaillard, Jaskaran Singh Lucie Bartova, Markus Dold, Alexan er Kau z y, aniel

Souery, Julien Mendlewicz, Alessandro Serretti, Stefano Porcelli, Joseph Zohar, Stuart Montgomery, Siegfried PS067 Kasper Genes involved in neurodevelopment, neuroplasticity and Major Depression: No PS059 association for CACNA1C, CHRNA7 and MAPK1 Chiun Pae, Marco Calabrò, Laura Mandelli, Concetta Substance use disorders are risk factors for Crisafulli, Changsu Han, Alessandro Serretti treatment resistant depression Philip Brenner, Lena Brandt, David Hägg, Gang Li, Allitia PS068 DiBernardo, Robert Bodén, Johan Reutfors Randomized, Double-Blind Study of Flexibly- PS060 Dosed Intranasal Esketamine Plus Oral Drug for Depression vs. Active Control in Treatment- Enuresis induced by SSRI à case report Mohamedi Darghal Resistant Depression Vanina Popova, MD, Ella J. Daly, MD, Madhukar Trivedi, PS061 MD, Kimberly Cooper, MS, Rosanne Lane, MAS, Pilar Lim, PhD, Christine Mazzucco, MSc, David Hough, MD, Michael Drug-induced hyponatremia in the treatment of E. Thase, MD, Richard C. Shelton, MD, Patricio Molero, MD, depression PhD, Eduard Vieta, MD, PhD, Malek Bajbouj, MD, Husseini Daniel Esteves-Sousa; Margarida Albuquerque; Sérgio Manji, MD, Wayne C. Drevets, MD, Jaskaran B. Singh, MD Gomes-Pereira; João Facucho-Oliveira; Luis Mendonça; Joaquim Gago. PS069 PS062 Effects of gap in perception of subjective vs objective illness severity on subjective cognitive Efficacy of Fufangcongrongyizhi Capsule on impairments in depression? cognitive function of senile depression patients Kyosuke Sawada, Kazunari Yoshida, Chisa Ozawa, Bai Han, Jianying Li, Liqin Qi, Bo Zhang, Wenjing Li Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida

PS063

How did psychiatrists of the Karasuyama

Hospital prescribe antidepressants for psychiatric symptoms? Hideaki Kawai, Yosuke Sawanobori, Osamu Takashio, Hiroshi Tadama, Takashi Nishio, Fuminori Ishikawa, Mari Yamada, Hiromitsu Uno, Hiroki Yamada, Akira Iwanami

39 Poster Abstracts

PS070 PS076 Repeated two doses of ketamine followed by a Attitudes toward placebo-controlled clinical randomized double-blind placebo controlled trials of depressed patients in Japan add-on trial of D-Cycloserine in treatment Norio Yasui-Furukori, Masamichi Ishioka, Shoko resistant bipolar and major depression Tsuchimine, Koji Tsuruga, Yasushi Sato, Hanako Furukori, Tung-Ping Su, Mu-Hong Chen4, Hui-Ju Wu, Cheng-Ta Li, Shuhei Kudo, Tetsu Tomita, Taku Nakagami, Norio Wei-Chen Lin, Ya-Mei Bai, Pe-Chi Tu, Wen-Han Chang, Sugawara Chi-Ming Cheng PS077 PS071 Clinical characteristics associated with Down regulation of serotonin transporter therapeutic adherence of the patients with binding in raphe nuclei with long term major depressive disorder: a report from the pharmacological treatment for major depressive National Survey on Symptomatology of disorder Depression in China. Mikael Tiger, Lars Farde, Johan Lundberg, Qian Zhou, Wu Hong, Zhiguo Wu, Yun Wang, Xiaohua Liu, Jun Chen, Yong Wang, Yousong Su, Chen Zhang, Daihui PS072 Peng, Yiru Fang The effects of personality on the association between paroxetine plasma concentration and PS078 response Effect of aripiprazole augmentation on plasma Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, levels of homovanillic acid in major depressive Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, disorder Kazuhiko Nakamura Sho Hirikoshi, Itaru Miura, Mizue Ichinose, Shinnosuke Yamamoto, Masashi Ito, Keiko Nozaki, Kenya Watanabe, PS073 Haruka Kaneko, Hirooki Yabe Increased levels of CREB and pCREB in major depressive patients with antidepressant PS079 treatment Efficacy of Lurasidone in Major Depressive Shoko Tsuchimine, Norio Sugawara, Hiroshi Kunugi, Norio Disorder with Mixed Features: Treatment Yasui-Furukori Review Andrei Pikalov, MD, PhD; Joyce Tsai, PhD; Yongcai Mao, PS074 PhD; Michael Tocco, PhD; Antony Loebel, MD Long-Term Safety of Intranasal Esketamine plus Oral Antidepressant in Patients with Treatment- PS080 Resistant Depression: Phase 3, Open-label, The influence of benzodiazepine medication on Safety and Efficacy Study (SUSTAIN-2) the antidepressant effect of ketamine. Ewa Wajs, Leah Aluisio, Randall Morrison, Ella Daly, Veronika Andrashko, Tomas Novak, Jiri Horacek, Monika Rosanne Lane, Pilar Lim, Richard Holder, Gerard Sanacora, Klirova, Martin Brunovsky Allan H Young, Siegfried Kasper, Ahmad Hatim Sulaiman, Cheng-Ta Li, Jong Woo Paik, Husseini Manji, David Hough, PS081 Wayne Drevets, Jaskaran Singh Decreased brain pH in patients with depression

and in a social defeat mouse model PS075 Hideo Hagihara, Hirotaka Shoji, Hikari Otabi, Atsushi Obesity and Its Potential Effects on Toyoda, Tsuyoshi Miyakawa Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review. PS082 Young Sup Woo, Bo-Hyun Yoon, Young Joon Kwon, Moon Management of Treatment Resistant Bipolar Doo Kim, Won-Myong Bahk Depression with rTMS Angela L. Phillips, MSW, LICSW, Robert L. Burr, PhD, David L. Dunner, MD

40 Poster Abstracts

PS083 PS090 Repetitive Transcranial Magnetic Stimulation Neurofeedback-based treatment of major Effects in Patients with Co-Morbid Somatic Pain depression using functional magnetic resonance and Depressive Mood Disorders imaging Angela L. Phillips, MSW, LICSW, Robert Burr, PhD, David L. Manfred Klöbl, Andreas Hahn, Siegfried Kasper, Rupert Dunner, MD Lanzenberger

PS084 PS091 Plasma metabolites are potential biomarker of Behavioral activation for subthreshold antidepressant treatment response in patients depression changes neural activation during with major depression. intrinsic motivational task Chiyo Shibasaki, Takahiro A. Kato, Hisayuki Erabi, Daiki Asako Mori, Yasumasa Okamoto, Masahiro Takamura, Go Setoyama, Masahiro Takamura, Atsuo Yoshino, Go Okada, Okada, Koki Takagaki, Ran Jinnin, Satoshi Yokoyama, Yasumasa Okamoto, Shigeto Yamawaki Madoka Matsumoto, Kenji Matsumoto, Shigeto Yamawaki

PS085 PS092 The effect of Electroconvulsive therapy on Baseline functional connectivity between right Serum Brain-Derived Neurotrophic Factor amygdala and cingulate gyrus predict ketamine Thomas Vanicek, Georg S. Kranz, Benjamin Vyssoki, Gernot mood response in patients with treatment- Fugger, Arkadiusz Komorowski, Anna Höflich, Rupert resistant depression. Lanzenberger, Anne Eckert, Siegfried Kasper, Richard Frey. Tomoyuki Nakamura, Takamasa Matsunaga, Naoki

Horikawa, Ken Uematsu, Masaru Tomita, Naohisa PS086 Uchimura Meta-analysis of hippocampal volume change following electroconvulsive therapy in major PS093 depression The Normalization of Brain 18F-fluorodeoxy-D- Pia Baldinger-Melich, Gregor Gryglewski, Karolin E. glucose Positron Emission Tomography Einenkel, Richard Frey, Siegfried Kasper, Rupert Hypometabolism following Electroconvulsive Lanzenberger Therapy in a 55-year-old

Sehoon Shim PS087 The why and how of cross-validation in clinical, PS094 predictive fMRI studies: The case of major Comparison of serotonin transporter occupancy depressive disorder obtained at PET and PET/MR imaging systems Thomas Blank, Bernhard Meyer, Ulrich Rabl, Lucie Bartova, Silberbauer L, Gryglewski G, Berroterán-Infante N, Rischka Julian Provenzano, Siegfried Kasper, Alan Schatzberger, L, Pichler V, James GM, Wadsak W, Mitterhauser M, Kasper Ewald Moser, Gang Chen, Lukas Pezawas S, Hahn A, Lanzenberger R

PS088 PS095 Elevated tumor necrosis factor-alpha receptor Rapid inflammation modulation and subtype 1 and the association with abnormal antidepressant efficacy of a low-dose ketamine brain function in treatment-resistant depression infusion in treatment-resistant depression: a Mao-Hsuan Huang, MD, Mu-Hong Chen, MD, Pei-Chi Tu, randomized, double-blind control study MD, Ya Mei Bai, PhD, Tung-Ping Su, MD, Bang-Hung Mao-Hsuan Huang, M.D., Mu-Hong Chen, M.D., Cheng-Ta Yang, MSc, Ren-Shyan Liu, MD, Cheng-Ta Li, PhD Li, M.D., Ph.D., Wei-Chen Lin, M.D, Chen-Jee Hong, M.D.,

Pei-Chi Tu, M.D. Ph. D., Ya-Mei Bai, M.D. Ph. D., Chih-Ming PS089 Cheng, M.D, Tung-Ping Su, M.D. PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naïve, first- PS096 episode major depressive disorder Catecholaminergic Activity and Brain-Derived Ryohei Igata, Asuka Katsuki, Shingo Kakeda, Keita Neurotrophic Factor in Patients with Drug-Naïve Watanabe, Natsuki Igata, Hikaru Hori, Kiyokazu Atake, Major Depressive Disorder Yukunori Korogi, and Reiji Yoshimura Reiji Yoshimura, Ryohei Igata, Taro Kishi, Nakao Iwata

41 Poster Abstracts

PS097 PS105 Factors of associated with delirium following Psilocybin impairs fear recognition in emotional electroconvulsive therapy: a systematic review morphing paradigm Takashi Tsujii, Takahito Uchida, Jinichi Hirano, Masaru Peter Zach, Ezequiel Mikulan, Michaela Viktorinová, Mimura, Hiroyuki Uchida Filip Tylš, Rená a An rovičová, Ja u Korčá , Jiří Horáče , Martin Brunovský & Tomáš áleníče PS098 Isolation rearing produced DNA methylation PS106 changes in GABAergic and glutamergic systems Associations of polymorphic variants of protein in rat brain kinases genes with depression and response to Fachim HA, Loureiro CM, Zuelli FC, Joca SR, Louzada- antidepressant therapy Júnior P, Menezes PR, Del-Ben CM, Dalton CF and Svetlana Ivanova, Natalya Vyalova, Innokentiy Losenkov, Reynolds GP. Ivan Pozhidaev, Diana Osmanova, German Simutkin, Nikolay Bokhan PS099 The effect of DLPFC regulation training using PS107 fMRI neurofeedback in healthy individuals CYP2D6 and CYP2C19 genotyping in routine Masahiro Takamura, Yasumasa Okamoto, Naho Ichikawa, psychiatric care Go Okada, Atsuo Yoshino, Chiyo Shibasaki, Yoshikazu Rabl U, Dorninger L, Klostermann M, Papageorgiou K,

Masuda, Satoshi Yokoyama, Shigeto Yamawaki Sunder-Plassmann R, Hoermann G, Kasper S

PS100 PS108 Sensing Depression: Using Smartphone Sensors Impact of comorbid thyroid disease in patients to Predict Changes in Depression Severity with major depressive disorder Ellen Frank, Hane Aung, Claudio Soares, Sidney Kennedy, Gernot Fugger, Markus Dold, Lucie Bartova, Alexander Mark Matthews, David Kupfer, Aleksandra Lalovic, Kautzky, Daniel Souery, Julien Mendlewicz, Alessandro Tanzeem Choudhury Serretti, Joseph Zohar, Stuart Montgomery, Richard Frey, Siegfried Kasper PS101 Methylphenidate-induced Raynaud’s PS109 phenomenon developed after increasing Kynurenine pathway in Major Depressive methylphenidate in an adult with attention Disorder: A Systematic Review and Meta- deficit hyperactivity disorder analysis Pornjira Pariwatcharakul, Yuwarat Montreerarat Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, Sakiko Tsugawa, Ryosuke Tarumi, Ryosuke Kitahata, Eric Plitman, PS102 Hiroyuki Uchida, Ariel Graff-Guerrero, Masaru Mimura, Longitudinal associations between Shinichiro Nakajima glucocorticoid receptor methylation and late- life depression PS110 Hee-Ju Kang, Ji-Yeon Kim, Ja-Youn Hur, Ju-Yeon Ahn, Phospholipase A2 gene expressions related to Kyung-Yeol Bae, Sung-Wan Kim, Il-Seon Shin, Jin-Sang omega-3 fatty acids treatment in acute Yoon, Jae-Min Kim depressed patients Kuan-Pin Su, MD, PhD PS103 Geriatric Depression Scale (GDS) for classifying PS111 late-life depression as normal, minor depressive Improvement of hyponatremia in patients with disorder and major depressive disorder epilepsy after switching from carbamazepine to Cheolmin Shin, Changsu Han, Kyu-Man Han lacosamide; a retrospective cases report Hakuei Yamashita, Tomokazu Shimazu, Tsutomu Maruki, PS104 Yuichi Maruki Association between depressive symptoms and metabolic syndrome in Korean Employees Young-Chul Shin, Se-Won Lim, Eun-Jin Kim, Sang Won Jeon

42 Poster Abstracts

PS112 PS119 Relationship Between Obsessive Compulsive Dopamine release is enhanced in healthy Disorder and Retinal Nerve Fiber Layer subjects after repeated amphetamine exposure: Nesrin Karamustafalioglu, Veysel Akansel, Abdullah Genç, A [11C]-(+)-PHNO PET study Saniye Üke Uzun, Zeliha Cengiz, Dilek Güven, Ömer Akil Weidenauer Ana,, Sauerzopf Ulrich, Bauer Martin, Bartova Özer, Oguz Karamustafalioglu Lucie, Nics Lukas Wadsak Wolfgang, Kasper Siegfried, Lanzenberger Rupert, Praschak- Rieder Nicole, Willeit PS113 Matthäus N-acetylcysteine therapy for the treatment of obsessive-compulsive disorder: a systematic PS120 review & meta-analysis ALKS-7119, a novel 5-HT transporter antagonist Dr Christopher W.P. Hopkins, Dr Calum D. Moulton and NMDA receptor antagonist caused dose- dependent increases of cortisol and prolactin in PS114 a first-in-human, randomized, controlled trial An open trial of aripiprazole for the treatment with healthy volunteers of delirium F.M. Dijkstra, R.G.J.A. Zuiker, P.S. Siebenga, R.A. Leigh- Takahiro Tsutsumi, Hiroko Sugawara, Hidehiro Oshibuchi, Pemberton, L. Sun, J.D. Manthis, H. Lin, L.L. von Moltke, D.

Takaaki Kawano, Tatsunori Nakano, Choryo Hokama, Rezendes and J.M.A. van Gerven Masahiko Kawano, Miho Kawano, Ken Inada, Jun Ishigooka, Katsuji Nishimura PS121 No acute tolerance to the effects of LSD in PS115 healthy subjects The role of melatonin and melatonin agonists in Patrick C Dolder, Edna Grünblatt, Felix Müller, Stefan J counteracting antipsychotic-induced metabolic Borgwardt, Matthias E Liechti side effects: a systematic review Kyung Joon Min, Young Sup Woo, Bo-Hyun Yoon, Young PS121B Joon Kwon, Moon Doo Kim, Won-Myong Bahk Effect of physical exercise intervention on mood and frontal alpha asymmetry in Internet gaming PS116 disorder Prevalence of Insomnia and Its Related Ji Sun Hong MD, MA, Sun Mi Kim MD, PhD, Doug Hyun Problems in Clinical Practice According To Han MD, PhD, Jeong Ha Park MD, PhD, Young Sik Lee MD, Primary Physician PhD, Hee Jin Kim, MD Andri Andri PS122 PS117 Anxiety, depressed mood, and insomnia Transcranial direct-current stimulation may experienced by newly diagnosed patients with reduce the expired carbon monoxide levels breast cancer and thyroid cancer in initial stage among cigarette smokers with heroin of cancer treatment in Korea dependence Weon-Jeong Lim, So-Hyun Park, Hee-Yeon Choi, Wonshin Yen Kuang Yang Lim, Young Chul Shin

S118 PS123 Comparing spray vs nebulized oxytocin A Study on the Initial Distress Assessment of the modulation of brainwide resting-state First Diagnosed Gynecologic Cancer Patients in functional connectivity: a peripherally controlled Korea pharmaco-MRI study Weon-Jeong Lim, Seong-Youn Kim, Hee-Yeon Choi, D. Martins, O. Dipasquale, F. Zelaya, N. Mazibuko, O. Wonshin Lim, Young Chul Shin

O’ aly, J O'Muir hear aigh, Mal ezos, U hus hnig, PS124 Williams, Y. Paloyelis Comparison of electroencephalographic parameters during electroconvulsive therapy under thiopental and propofol

Tomomi Ogihara, Kazuhito Takahashi, Mifumi Iizawa, Dai Oya, Masahiro Uzawa, Daimei Sasayama, Tokiji Hanihara, Shinsuke Washizuka

43 Poster Abstracts

PS125 PS133/4 Psychotic features of DiGeorge Syndrome New drug treatment and mechanism of the Sérgio Pereira, Daniel Sousa, Ricardo Duque, Hugo Silva, central anticholinergic drug trihexylphenidyl in Margarida Albuquerque, Miguel Costa, António Neves reducing posttraumatic nightmares in patients with PTSD PS126 Katsumasa Sogo, Japan Lasting subjective effects of Lysergic acid diethylamide (LSD) in healthy subjects Y. Schmid, M.E. Liechti

PS127 The prediction of the occurrence of postoperative nausea and vomiting using pharmacokinetic/pharmacodynamic factors in Japanese patients administered fentanyl Midori Soda, Yoko Sugiyama, Saeri Goto, Yuki Imamura, Maika Nishina, Rina Bito, Maki Fukumoto, Hajime Kosemoto, Katsura Tsukamoto, Hiroki Iida, Kiyoyuki Kitaichi

PS128 Effects of oxytocin receptor gene variations on socio-emotional effects of 3,4- methylenedioxymethamphetamine in humans Patrick Vizeli, Matthias E. Liechti

PS129 The certain role of SOD/CAT imbalance and mytochondrial dysfunction in development of autism spectrum disorders Konstantin Yenkoyan, Hayk Harutyunyan, Katarine Fereshetyan, Aida Harutyunayn

PS130 Seed-based resting-state functional connectivity in patients with Persistent Somatoform Pain Disorder(PSPD) Yanli Luo, Xiandi Pan, Chao Yan, Tianming Huang

PS131 Panic disorder with or without agoraphobia: changes in symptoms of 500 patients over 20 years in Japan Hisanobu Kaiya, Fusaka Minami, Mina Masaki, Chika Komatsu, Kyouko Noguchi

PS132 Prevalence and Clinical Correlates of Dissociative Subtype of Posttraumatic Stress Disorder at an Outpatient Trauma Clinic in South Korea Seok Hyeon Kim MD, PhD, Dongju Kim MD, Hyunji Lee MA, Ji Young Min MA, Daeho Kim MD, PhD

44 Poster Abstracts

Monday 18th June 2018 PM136 Patterns of antipsychotic prescription in patients Poster Level 1 Sub Topic By Disorder with schizophrenia at a tertiary care center in Number Topic Japan PM135- Clinical Schizophrenia Yuka Asai, Ryota Osada, Yoshihiko Harada, Haruka PM190 Tanabe, Tomomi Ogihara, Daimei Sasayama, Shinsuke PM191 Preclinical Others Washizuka PM192- Clinical Sleep Disorders PM194 PM195- PM137 Clinical Suicide PM199 Prescription patterns in patients with PM200 Others Anxiety Disorders schizophrenia who discontinued long-acting PM201 Others Bipolar Disorders injectable antipsychotics: a chart-review Childhood & Adolescent Keisuke Asano, Hiroyuki Uchida, Masaru Mimura, PM203 Others Disorders Takefumi Suzuki PM204 Others Dementia PM205- PM138 Others Depression PM206 Idiopathic or Antipsychotic induced PM207 Others Epilepsy Thrombocytopenia? A treatment Dilemma PM208- Others Others Sanjay S Chandragiri MD, DFAPA Antonio Adiletta BS , PM211 Zara Chaudhry BS, Rooshi Patel MD, Alex Slaby MD, Qais PM212 Others Personality Disorders Zalim MD, Hema Venigalla MD PM213- Others Schizophrenia PM218 PM139 PM219 Others Suicide Association between thioridazine use and cancer PM220- Preclinical Addictive Disorders risk among patients with schizophrenia- a PM228 PM229- population-based study Preclinical Anxiety Disorders * PM232 Cheng-Chen Chang , Ming-Hong Hsieh, Nan-Ying Chiu, PM233 Preclinical Schizophrenia Yu-Hsun Wang, Jong-Yi Wang, Hsiang-Hsiung Huang, Po- Chung Ju, Jeng-Yuan Chiou PM234 Preclinical Anxiety Disorders

PM235 Preclinical Attention Deficit Disorders PM140 PM236- Preclinical Bipolar Disorders PM238 Clozapine-induced procalcitonin elevation , Childhood & Adolescent Tiago A Duarte, Filipe Godinho, André Ferreira Frederico PM239 Preclinical Disorders Simões do Couto, Paulo T Martins PM240 Preclinical Others PM241- Childhood & Adolescent PM141 Preclinical PM243 Disorders Antipsychotic treatment in patients with PM244- Preclinical Dementia catatonic schizophrenia PM248 PM249- Yoshihiko Harada, Tetsuya Hagiwara, Shin Inuzuka, Ryota Preclinical Depression PM272 Osada, Haruka Tanabe, Yuka Asai, Tomomi Ogihara, Daimei Sasayama, Shinsuke Washizuka

PM135 PM142 Addition of Evenamide (NW-3509), a Selective Early response to aripiprazole and plasma levels Voltage Gated Sodium Channel (VGSC) of monoamine metabolites in patients with Antagonist, to Atypical Antipsychotics is acute schizophrenia Efficacious in Patients Worsening on their Mizue Ichinose; Itaru Miura; Masashi Ito; Shinnosuke Current Medication. Yamamoto; Keiko Kanno-Nozaki; Kenya Watanabe; Sho R. Anand, R. Hartman, E. Forrest, and S. M Graham Horikoshi; Haruka Kaneko; Hirooki Yabe

45 Poster Abstracts

PM143 PM150 Risk factors for low bone mineral density in Sodium Benzoate, a D-amino Acid Oxidase patients taking antipsychotics for psychosis Inhibitor, Added to Clozapine for the Treatment Sung-Wan Kim, Min Jhon, Ju-Wan Kim, Seon-Young Kim, of Schizophrenia: A Randomized, Double-Blind, Jae-Min Kim, Il-Seon Shin, Lana Williams, Michael Berk, Placebo-Controlled Trial Jin-Sang Yoon Chieh-Hsin Lin, M.D., Ph.D., Ching-Hua Lin, MD, PhD, Yue- Cune Chang, PhD, Yu-Jhen Huang, MD, Po-Wei Chen, MD, PM144 Hsien-Yuan Lane, M.D., Ph.D. Relationship between Polydipsia and Antipsychotics: A Systematic Review of Clinical PM151 Studies and Case Reports Variation in response to clozapine vs. all other So Kirino, Mutsuki Sakuma, Fuminari Misawa, Yasuo Fuji, antipsychotics in patients with schizophrenia: A Masaru Mimura, Hiroyoshi Takeuchi systematic review and meta-analysis Yuya Mizuno, Robert McCutcheon, Stefan Brugger, PM145 Oliver Howes

Placebo Effects in Trials for Schizophrenia: PM152 Combined Analysis of Nine RCTs Kaoruhiko Kubo, Wolfgang Fleischhacker, Takefumi Clinical characteristics of patients with Suzuki, Norio Yasui-Furukori, Aki Endo, Ai Gounaridis, schizophrenia who were maintained without Masaru Mimura, Hiroyuki Uchida antipsychotics: A cross-sectional survey and a literature review PM146 Nobuhiro Nagai, Hideaki Tani, Takefumi Suzuki, Wolfgang Fleischhacker, Chisa Ozawa Placebo Effects in Long-Acting Injection Trials

for Schizophrenia: Combined Analysis of Four RCTs PM153 Fumiaki Kumagai, Wolfgang Fleischhacker, Takefumi Safety switching from daily to once-monthly Suzuki, Aki Endo, Ai Gounaridis, Masaru Mimura, Hiroyuki long-acting injectable antipsychotics associated Uchida with prolactin levels in schizophrenia patients Masaru Nakamura, Takahiko Nagamine, Yasutaka Fujita, PM147 Goro Sato Time Courses of Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentrations PM154 of Antipsychotics: A Systematic Review Lurasidone and Risk for Metabolic Syndrome in Shin Kurose, Hiroyuki Uchida, Keisuke Takahata, Takefumi Patients with Schizophrenia: A Comprehensive Suzuki, Masaru Mimura, Hiroyoshi Takeuchi Database Analysis John W. Newcomer, MD; Michael Tocco, PhD; Andrei PM148 Pikalov, MD, PhD; Jay Hsu, PhD; Josephine Cucchiaro, PhD; Antony Loebel, MD Serum IL-1ra, a novel biomarker predicting

olanzapine-induced dyslipidemia and hyperleptinemia in Schizophrenia PM155 Yezhe Lin, Yanmin Peng, Shen He, Jingjie Xu, Yuan Shi, Prediction of Relapse with Residual Symptoms Yousong Su, Cuizhen Zhu, Jinrui Rao, Xinyi Zhang, Rubai in Schizophrenia: A Reanalysis of the Zhou, Donghong Cui PROACTIVE trial data Yuta Saito, Hitoshi Sakurai, John Kane, Nina Schooler, PM149 Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida Frequency of Tardive Dyskinesia in Research on Asian Psychotropic Prescription Pattern (REAP) PM156 survey (2001-2016) Typical and Atypical Long acting injectable Shih-Ku Lin, Shu-Yu Yang antipsychotics in schizophrenia: a 2-year prospective cohort study Carla Spínola, Daniel Neto, Margarida Albuquerque, Joaquim Gago

46 Poster Abstracts

PM157 PM164 Needs to psychopharmacological treatment in Relation between psychotropic drugs and patients with schizophrenia and their seizure threshold in electroconvulsive therapy psychiatrists’ oversight: a cross-sectional study Seung Hyun Kim, Hyun Ghang Jeong, Jung Seo Yi, Jung Jin Kie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, Kim Masaru Mimura, Hiroyuki Uchida PM165 PM158 Lower glutamate level in temporo-parietal area Changes of Body Weight, LDL and HDL may predict a better response to tDCS in Cholesterol Level in Schizophrenia Patients schizophrenia: A pilot study Treated with Atypical Antipsychotics Junhee Lee, Youngwoo B. Yoon, Andrea S. Wijtenburg, Andi Jayalangkara Tanra, Agustine Mahardika, Saidah Laura M. Rowland, In Chan Song, Kang Ik K. Cho, Minah Syamsuddin, Hawaidah, Sonny T. Lisal Kim, Tae Young Lee, Jun Soo Kwon

PM159 PM166 Effect of Lurasidone on Cognition in Adolescents Prediction of response to transcranial direct with Schizophrenia: Interim Analysis of a 2-year current stimulation by near-infrared Open-label Extension Study spectroscopy in schizophrenia Philip D. Harvey, PhD Robert Goldman, PhD; Michael Tomiki Sumiyoshi, Takamasa Noda, Shiori Setoyama, Tocco, PhD; Ling Deng, PhD; Josephine Cucchiaro, PhD; Kazuki Sueyoshi, Takuma Inagawa, Zui Narita Antony Loebel, MD PM167 PM160 Genome-wide association analysis of Efficacy and Safety of Lurasidone in Adolescents psychopathological dimensions in bipolar with Schizophrenia: Interim Analysis of a 2-year, disorder and schizophrenia Open-label Extension Study Filippo Corponi, Chiara Fabbri, Stefano Bonassi, Alessandra Robert Goldman, PhD; Michael Tocco, PhD; Andrei Pikalov, Frustaci, Stefano Landi, Diego Albani, Giuseppe Ducci, MD, PhD; Ling Deng, PhD; Antony Loebel, MD Eduard Vieta, Alessandro Serretti

PM161 PM168 Favorable Clinical Safety Profile for Association of RUNX2 gene polymorphisms with Lumateperone (ITI-007) - Switching from schizophrenia in Korean population a Standard-of-Care (SOC) Antipsychotic Therapy Won Sub Kang, Jong Woo Paik , Jong Woo Kim in Patients with Schizophrenia Kimberly Vanover, Christoph U. Correll, Robert E. Davis, PM169 Alex Dmitrienko, Steven Glass, Jelena Saillard, Michal Association between CCND2 gene Weingart, Sharon Mates, Andrew Satlin polymorphisms and the risk of schizophrenia in Korean population PM162 Won Sub Kang, Jong Woo Paik, Jong Woo Kim A preliminary multi-genic prediction model for antipsychotic-induced weight gain PM170 Kazunari Yoshida, Arun Tiwari, Malgorzata Maciukiewicz, Concomitant Use of Alcohol and Benzodiazepine Ilona Gorbovskaya, Vanessa Goncalves, Clement Zai, Eva Hypnotics in Psychiatric Outpatients: A Brandl, Jeffrey Liebermann, Herbert Meltzer, James Questionnaire Survey Kennedy, Daniel Müller Takahito Uchida, Takefumi Suzuki, Jinichi Hirano, Hitoshi Sakurai, Naohiro Arai, Masaru Mimura, Hiroyuki Uchida PM163 Effectiveness of continuation and maintenance PM171 ECT and combination of ECT and clozapine for The effect of Suvorexant introduction on treatment resistance schizophrenia ; A hypnotic prescription of schizophrenic patients retrospective study for 1-year relapse rate after Junji Uno initial ECT Yasutaka Fujita, Keigo Nakatsu, Yukiteru Takahashi, Yoko Iwasaki, Hiroki Yada, Goro Sato

47 Poster Abstracts

PM172 PM179 Fronto-Striatal Functional Connectivity and Comparison of emotional cognition assessed Striatal Dopamine Capacity in Treatment- with fear conditioning by interpersonal conflicts Responsive and -Resistant Schizophrenia in patients with depression and schizophrenia Seoyoung Kim, M.D., Euitae Kim, M.D., Ph.D., Wi Hoon and healthy subjects Jung Ph.D., Jun Soo Kwon, M.D., Ph.D. Hideaki Tani, Mitsuhiro Tada, Takefumi Suzuki, Kenichi Tsunoda, Saeko Ikai, Maki Nagaoka, Masaru Mimura, PM173 Hiroyuki Uchida Functional neuroanatomy of negative schema: comparison between patients with PM180 schizophrenia and healthy controls using fMRI Usefulness of pharmacists to accompany visit

Woo-Sung Kim, Guang Fan Shen, Young-Chul Chung nursing on prevention of re-hospitalization in patients with schizophrenia: an interventional PM174 pre / post study Effect of oxytocin on trust behaviour and neural Yasuhiko Hashimoto, Hidenori Kuwabara, Kazue Bessho, circuitry of trust in Schizophrenia Hiroko Kitoh, Hiroko Baba, Tomohisa Nakamura, Arpitha Jacob, Dona Maria Chako, Bhargavi Nagendra, Tomoyuki Yanagi, Takashi Yoshio, Masami Tensho Mugdha Kunte, Avyarthana Dey, Chaitra Hiremath, Rose Dawn Bharath, Shivarama Varambally, Ganesan PM181 Venkatasubramanian, Frank Krueger, Naren Rao Difference in executive function among with

patients with schizophrenia, their first-degree PM175 relatives and healthy subjects Increased D2/3 receptor availability in the retina Yuzuru Kataoka, Kazutaka Ohi, Takamitsu Shimada, Aki of medication-naive patients with schizophrenia. Kuwata, Hiroaki Okubo, Kohei Kimura, Toshiki Yasuyama, 11 A [ C]-(+)-PHNO PET study. Takashi Uehara and Yasuhiro Kawasaki Sauerzopf Ulrich, Weidenauer Ana, Bauer Martin, Bartova Lucie, Philippe Cecile, Sarah Pfaff, Nics Lukas, Wadsak PM182 Wolfgang, Kasper Siegfried, Lanzenberger Rupert, Pezawas Association between clinician’s attitude to Lukas, Praschak- Rieder Nicole, Willeit Matthäus patient and medication adherence in

schizophrenia PM176 Jhin Goo Chang, Daeyoung Roh, Chan-Hyung Kim Hallucinations in Schizophrenia and Parkinson’s disease: illustration of common pathway PM183 I de Chazeron, PM Llorca Differences in Quality of Life among patients with schizophrenia, their first-degree relatives PM177 and healthy subjects MEG study of cross-frequency coupling in Aki Kuwata, Kazutaka Ohi, Takamitsu Shimada, Yuzuru auditory cortex in early vs. chronic phase Kataoka, Hiroaki Okubo, Kohei Kimura, Toshiki Yasuyama, schizophrenia. Takashi Uehara, Yasuhiro Kawasaki Murphy,N., Ramakrishnan, N., Walker, C., Polizzotto, N.R., Womack, D., Rafferty, M., Rodriguez, C., Cho, R. Y. PM184 A 1.5-year longitudinal study on social activity PM178 in schizophrenia Psychopharmacological treatment and length of Kazutaka Ohi, Chika Sumiyoshi, Haruo Fujino, Yuka stay in psychiatric hospitals among patients with Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Tomiki schizophrenia: a systematic review Sumiyoshi and Ryota Hashimoto Takamasa Miura, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida PM185 Differences in social functioning among schizophrenia patients, their first-degree relatives and healthy subjects Takamitsu Shimada

48 Poster Abstracts

PM186 PM193 Pharmacogenetics of tardive dyskinesia in Relationship between withdrawal symptoms of schizophrenia: the role of muscarinic receptors benzodiazepine sleeping pills and background Anastasiia Boiko, Ivan Pozhidaev, Diana Osmanova, Olga factors Fedorenko, Arkady Semke, Nikolay Bokhan, Bob Wilffert, Choryo Hokama, Takahiro Tsutumi, Takaaki Kawano, Svetlana Ivanova, Anton J.M. Loonen Masahiko Kawano, Hidehiro Oshibuchi, Ken Inada, Kazuo Mishima, Yuichi Inoue, Katsuji Nishimura PM187 Childhood maltreatment and inflammation in PM194 First-Episode Psychosis and unaffected siblings: Sleep disorders in older adults and elderly Results from the STREAM study in Brazil following the catastrophic stressful life events Corsi-Zuelli, F., Loureiro, C. M., Fachim, H. A., Shuhama, R., Habib A. Rabbani (Ph. D.) Menezes, P. R., Louzada-Junior, P., Mondelli, V., Del-Ben, C. M. PM195 Psychotropic medication and long-term suicide PM188 risk in a nationwide population-based cohort Signs of impaired blood-brain barrier function study in South Korea and lower IgG synthesis within the central Woojae Myung MD, PhD, Hyewon Lee MPH*and Doh Kwan

nervous system in patients with schizophrenia or Kim MD, PhD related psychosis, compared to in controls K. Melkersson, S. Bensing PM196 Prison Adolescent Suicide Risk factors. PM189 Nigar Allahverdiyeva Clinical and functional correlates of Vitamin D deficiency in patients with schizophrenia PM197 Pelayo-Terán, José María; Zapico-Merayo, Yolanda The association between suicide attempts and Toxoplasma gondii infection PM190 Se-Hoon Shim MD, PhD, Woong Hahm MD, PhD, Han- Neuronal cell-surface autoantibodies in first yong Jung MD, PhD episode patients with schizophrenia Gabriele Sachs, Julia Lang, Marzena Lenczowski, Andreas PM198 Erfurth, Romana Höftberger Naturally absorbed omega fatty acids, lithium, and suicide-related PM191 Takeshi Terao, Keiko Kurosawa, Masayuki Kanehisa, Ippei Shiotsuki, Nobuyoshi Ishii, Yutaka Matsuoka, Teruo Influence of benzodiazepine medications and Sakamoto, Takehisa Matsukawa, Kazuhito Yokoyama, GABAA receptor function on the pentobarbital- Shuntaro Ando, Atsushi Nishida induced sleep behaviour of lipopolysaccharide- treated mice PM199 Yoshihisa Kitamura, Ayumi Okada, Shiho Hongo, Kanami Otsuki, Akihisa Miki, Ikuko Miyazaki, Masato Asanuma, Suicidal Behavior and Thyroid Pathology,Lima- Toshiaki Sendo Peru Freddy Vasquez1, Ysela Nicolas, Sylvia Falconi PM192 Add-on therapy with tandospirone, a serotonin PM200 1A receptor partial agonistic anxiolytic, is useful Escitalopram Attenuates Fear Stress-Induced for dose-tapering of concomitant Increase in Amygdala Dopamine According to benzodiazepines in psychiatric patients using Dopaminergic Sensitisation: Implications of long-term benzodiazepines. Fine-Tuning Action of Selective Serotonin Taisuke Fukushima, Shingo Tatsumi, Masako Azeura, Reuptake Inhibitors on Emotional Processing Hiroaki Hayashi, Yuki Ohira, Koichi Watanabe, Yasufumi Hidehiro Oshibuchi, Hiroyuki Muraoka, Masahiko Kawano, Nagahama, Chiemi Takazawa Takaaki Kawano, Takahiro Tsutsumi, Ken Inada, Jun Ishigooka, Katsuji Nishimura

49 Poster Abstracts

PM201 PM208 An atlas-based whole brain tractography study rs6738544 SNP of STAT4 and rs2298170 SNP of in major depressive disorder and bipolar STAT6 associate with nicotine dependence disorder. Seii Ohka, Daisuke Nishizawa, Junko Hasegawa, Naomi Yoshikazu Masuda , Go Okada, Masahiro Takamura, Chiyo Sato, Hidetaka Yamada, Fumihiko Tanioka, Haruhiko Shibasaki, Atsuo Yoshino, Satoshi Yokoyama, Naho Sugimura and Kazutaka Ikeda Ichikawa, Shiho Okuhata, Tetsuo Kobayashi, Shigeto Yamawaki, Yasumasa Okamoto PM209 Comparison of glucose metabolism and blood PM202 oxygenation during neuronal activation Neuroprotective effect of lithium at Andreas Hahn, Lucas Rischka, Gregor Gryglewski, Sarah therapeutic and subtherapeutic doses in Pfaff, Thomas Vanicek, Manfred Klöbl, Markus Hartenbach, GSK3beta autonomous pathways at primary Wolfgang Wadsak, Markus Mitterhauser, Siegfried Kasper, hippocampal neurons cell culture Rupert Lanzenberger

De-Paula V.J, Barbosa A.R, Kerr D.S., Forlenza O.V., Brentani H.P. PM210 Oxytocin modulation of resting state regional PM203 cerebral blood flow (rCBF): comparing the Paternal Pax6 haploinsufficiency precociously effects of intranasal and intravenous methods of accelerated vocal communication deficits by administration advanced paternal aging Y. Paloyelis, F. Zelaya, N. Mazibuko, S. Maltezos, U. Schuschnig, S. Williams Kaichi Yoshizaki, Ryuichi Kimura, Hitoshi Inada and Noriko

Osumi PM211 PM204 Hyaluronan Binding Protein Involved in Protective effects of Huperzia Serrata against Hyaluronan Depolymerization (HYBID, oxidative damage and cognitive dysfunction KIAA1199) is responsible for hyaluronan turn ○Ta uya Oh a, hini hi omo o, hinsu e Na amura, over in mouse central nerve system. Masamitsu Shimazawa, Hiroyuki Kono, Takeshi Tabira, Yuta Yoshino, Masamitsu Shimazawa, Hiroyuki Yoshida, Hideaki Hara Shintaro Inoue, Masayuki Shimoda, Yasunori Okada, Hideaki Hara PM205 Data driven assessment of pharmacological MRI PM212 data investigating an acute selective serotonin Periaqueductal gray glutamatergic transmission reuptake inhibitor challenge mediates depressive-like behaviors in the Murray Reed, Gregor Gryglewski, Manfred Klöbl, Godber remission of visceral pain Mathis Godbersen, Markus Hartenbach, Wolfgang Wadsak, Dylan Chou, Hsien-Yu Peng, Cheng-Yuan Lai, Ming-Chun Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Hsieh, Yang-Cheng Wen, Tzer-Bin Lin, Yu-Cheng Ho Andreas Hahn, Rupert Lanzenberger PM213 Involvement of miR-132 in PACAP-dependent PM206 morphological changes of dendritic spines The Pharmacolical treatment of major Atsuko Hayata-Takano, Harui Kijima, Toshihiko Kamo, depressive episodes with mixed features Yusuke Shintani, Yukio Ago, Kaoru Seiriki, Takanobu In Hee Shim, Dong Sik Bae Nakazawa, Norihito Shintani, Hitoshi Hashimoto

PM207 PM214 Role of SCN1A and SCN2A gene polymorphisms Cobalt chloride exposure in neonatal rats induce in epilepsy syndromes-a study from India behavioral alterations: an new animal model of Musadiq Ahmad Bhat, Sameer Ahmad Guru, Rashid Mir, schizophrenia? Mariyam Zuberi, Mamta Sumi, Vinod Puri and Alpana Aline Ramos, Mayra Suiama, Neide Derci, Bianca Muniz, Saxena Tatiana Rosenstock, Mariana Calzavara

50 Poster Abstracts

PM215 PM222 Examination of the effects of carbonyl stress Enhancing adult hippocampal neurogenesis with elicited by GLO1 gene knockout in human iPS lysophosphatidic acid: A proposal for erasing cells cocaine contextual memory Manabu Toyoshima, Wado Akamatsu, Tetsuo Ohnishi, David Ladrón de Guevara-Miranda, Román Darío Moreno- Makoto Arai, Masanari Itokawa, Hideyuki Okano, Takeo Fernández, Sara Gil-Rodríguez, Cristina Rosell-Valle, Yoshikawa Guillermo Estivill-Torrús, Antonia Serrano, Francisco J. Pavón, Fernando Rodríguez de Fonseca, Luis J. Santín, PM216 Estela Castilla-Ortega

Analysis of sphingolipids in schizophrenia: PM223 postmortem brain study Kayoko Esaki, Chie Shimamoto, Yoshimi Iwayama, Galanin N-terminal fragment (1-15) decreases Shabeesh Balan, Yoshio Hirabayashi, Brian Dean, Takeo the voluntary alcohol intake in rats. Yoshikawa C. Millón, A. Flores-Burgess, E. Castilla-Ortega, B. Gago, A. Serrano, A. Sturla, L. García-Durán, JA. Narváez, K. Fuxe, L. PM217 Santín, Z. Díaz-Cabiale

Paranoid Schizophrenia versus Residual PM224 Schizophrenia: Neuropsychological Aspects Alexandr Kim, Egor Cherapkin The acute effects of Deschlorketamine in animal model PM218 Kristýna Š ef ová, Ni ola in erová, Klára Ší hová, Eva Lho ová, Hyne an a, Tomáš áleníče Impaired cerebellar development in mice overexpressing VGF nerve growth factor PM225 inducible (VGF) via promoting MAPK signaling Attenuation of the formation of CPP by Takahiro Mizoguchi, Masamitsu Shimazawa, Kazuki Ohuchi, Shinsuke Nakamura, Hideaki Hara methamphetamine in Shati/Nat8l overexpressed mice in the prefrontal cortex. PM219 Meriem Haddar, Kyosuke Uno, Shin-ichi Muramatsu, Atsumi Nitta Genetic Associations with Suicide Attempt

Severity Daniel F Levey, Renato Polimanti, Zhongshan Cheng, Hang PM226 Zhou, Yaira Z Nuñez, Sonia Jain, Feng He, Xiaoying Sun, Gene expression profile of dopamine-deficient Robert J. Ursano, Ronald C. Kessler, Jordan W. Smoller, mouse brain for underlying molecular pathology Murray Stein, Henry Kranzler, Joel Gelernter in psychiatric disorders Shinya Kasai, Yoko Hagino, Masayo Fujita, Kazuto PM220 Kobayashi, Kazutaka Ikeda The Effect of Primary Cannabinoid Pre-Exposure on the Addictive Potential of Psychostimulant PM227 Drugs Attenuation pharmacological effects of Pinterova N., Danda H., Sichova K., Stefkova K., Lhotkova methamphetamine by Piccolo knockdown in the

E., Palenicek T. nucleus accombens in mice Yuka Kusui, Kyosuke Uno, Bin Ge, Seiya Morishita, Yoshiaki PM221 Miyamoto, Shin-ichi Muramatsu, Atsumi Nitta Spine density in the nucleus accumbens is differentially changed after rat gambling task PM228 with different housing condition Alpha-amino-3-hydroxy-5-methyl-4- Myung Ji Kwak, Wha Young Kim, Bo Ram Cho, Wen Ting isoxazolepropionic acid (AMPA) receptor Cai, Jeong-Hoon Kim subunit expression and receptor binding in patients with addictive disorders: A systematic review of human postmortem studies Fumihiko Ueno, Shinichiro Nakajima, Takefumi Suzuki, Sachio Matsushita, Masaru Mimura, Hiroyuki Uchida

51 Poster Abstracts

PM229 PM238 Involvement of enhanced 5-HT2A receptor Sustained administration of cariprazine function on doxorubicin and cyclophosphamide- increases norepinephrine but not serotonin and induced anxiety-like behavior in rats dopamine neuronal activity in rats Nanami Naito, Yoshihisa Kitamura, Yuka Nakamura, M. El Mansari, M. Ebrahimzadeh, N. Adham, B. Kiss, B. Yusuke Sumiyoshi, Shihi Kan, Ikuko Miyazaki, Masato Farkas, P. Blier Asanuma, Toshiaki Sendo PM239 PM230 Rapamycin ameliorates impairment of social Orexin A antagonist SB-408124 reduces anxiety interaction in the mice exposed in utero to signs via extrahypothalamic CRF in a rat PTSD valproic acid model Hiroko Murakami, Toshiyuki Kobayashi, Hirofumi Kashii, Ilia Tissen, A.A. Lebedev, E.R. Bychkov, P.P. Khokhlov, P.D. Atsushi Sato, Yoko Hagino, Miho Tanaka, Yasumasa Shabanov Nishito, Yukio Takamatsu, Shigeo Uchino, Kazutaka Ikeda

PM231 PM240 5-HT2A receptor antagonism unmasks a marked Effects of modafinil on feedback-dependent immobility-reducing effect of acute SSRI reinforcement learning administration in a contextual fear paradigm Zhenyu Wei, Jialin Li, Xi Yang, Keith M. Kendrick, Benjamin Robert Pettersson, Sven Melker Hagsäter, Jakob Näslund, Becker Elias Eriksson PM241 PM232 Oxidative damage and mitochondrial An anxiogenic-like response to predator odour dysfunction in autism model rats in rats depend on baseline temperament and Kohji Fukunaga, Kazuya Matsuo, Yasushi Yabuki can be prevented by SSRI treatment Jakob Näslund, Fredrik Hieronymus, Elias Eriksson PM242 Evaluation of Naringenin & its Surface Modified PM233 Nanocarriers as Neurotherapeutic for Autism Overexpression of sigma-1 receptor rescues Spectrum Disorders (ASD) (G4C2)RNA repeats-mediated defect in the Ranjana Bhandari, Anurag Kuhad, Jyoti Paliwal nucleocytoplasmic transport of Ran GTPase: implication in ALS PM243 Tsung-Ping Su and Pin-Tse Lee Behavioral impairment via delay myelination development in the prefrontal cortex of PM234 SHATI/NAT8L knockout mice Distinguishing Quantitative Atsumi Nitta, Kazuyuki Sumi, Hiroshi Noike, Yoshiaki Electroencephalogram Findings between Panic Miyamoto, Kyosuke Uno Disorder and Generalized Anxiety Disorder Ho-Suk Suh, Kang-Uk Lee, Kang-Soo Lee PM244 A study of the Mixture of Rhubarb and Salvia PM235 Miltiorrhiza,Tanshinone II A on the prevention Amelioration of Scopolamine-induced Attention and treatment of AD Deficit by the Extracts from the Brown Alga Bai Han, Fan Wu, Jianying Li, Kezhan Liu, Chen Li, Hejun Li, Shuyue Zhao, Feng Wang Ecklonia Stolonifera Okamura So-Yeon Jeon, Na-Hyun Kim, Yukiori Goto, Jae-Sue Choi, and Young-A Lee PM245 Effects of Tanshinone II A on a rat model of PM236 Alzheimer's disease with intestinal endotoxemia Effects of lithium on immune activation in an (IETM) animal model of mania Bai Han, Fan Wu, Jianying Li, Chen Li, Hejun Li, Kezhan Liu Jairo Vinícius Pinto, MD; Giovana Bristot; Bruna Maria Ascoli; Ellen Scotton; Luiza Paul Géa; Bianca Pfaffenseller; Márcia Kauer- an ’Anna

52 Poster Abstracts

PM246 PM253 Study on Donepezil on Alzheimer's disease Flotillin-1 interacts with the serotonin rats’model with intestinal endotoxemia (IETM) transporter and modulates susceptibility to Bai Han, Fan Wu, Chen Li, Kezhan Liu, Jianying Li, Hejun Li depression-like behavior Sonali N. Reisinger, Eryan Kong, Barbara Molz, Ana PM247 Cicvaric, Thomas Steinkellner, Jae-Won Yang, Thomas Functional expression of choline transporter-like Humberg, Francisco J. Monje, Harald H. Sitte, Benjamin J. Nichols and Daniela D. Pollak proteins in human neural stem cells and its link

to self-renewal system and neural PM254 differentiation Strain dependent effects of chronic stress on Masato Inazu, Yousuke Fujita, Tomoki Nagakura, Tusuyoshi Yamanaka, Hiroyuki Uchino microRNAs expression in mice Shusaku Uchida, Hirotaka Yamagata, Tomoe Seki, Kumiko PM248 Hara, Ayumi Kobayashi, Shin Nakagawa, and Yoshifumi Watanabe Sexual differences of cognitive impairment induced by deletion of Shati/Nat8l PM255 Kyosuke Uno, Kousuke Endo, Kazuyuki Sumi, Meriem Extracellular glutamate levels in the rat Haddar, Shin-ichi Muramatsu, Yoshiaki Miyamoto, Atsumi Nitta prefrontal cortex after treatment with different N-methyl-D-aspartate receptor antagonists PM249 Ionescu, K. Allers, R. Arban, C. Dorner-Ciossek, L. Kussmaul

Multiple modality monitoring of animals in PM256 toxicology studies allows more precise D-lysergic acid diethylamide (LSD) reverses preclinical assessment of PD/PK/toxicity for depressive-like behavior and serotonergic (5- early clinical dose selection. Karen E. Asin, Heather Barsalou, and Mary Carsillo HT) neurotransmission impairments in a murine model of chronic stress. PM250 De Gregorio D., Enns J., El Rahimy Y., Posa L., Aguilar- Valles A., Lopez-Canul M., Comai S., Sonenberg N., Gobbi Acute intermittent porphyria – pathogenic G. principles and neurobiological mechanisms Stefanie Berger, Miranda Stattmann, Ana Cicvaric, PM257 Francisco Monje, Gerda Ricken, Johannes Hainfellner, Margot Ernst, Petra Scholze, Susanne Greber-Platzer, Comparing all-cause mortality and external Makiko Yasuda, Robert Desnick, Daniela Pollak causes of deaths in different definitions of treatment resistant depression David Hägg, Johan Reutfors, Philip Brenner, Gang Li, Allitia PM251 Role of 5-HT1A receptors in the effect of DiBernardo, Robert Bodén, Lena Brandt

galanin(1-15) on fluoxetine-mediated action in PM258 the forced swimming test Zaida Diaz-Cabiale, Antonio Flores-Burgess, Carmelo Definitions of treatment resistant depression: A Millón, Belen Gago, Manuel Narváez, Dasiel Borroto- comparison between different methods in a Escuela, Jose Angel Narváez, Kjell Fuxe, Luis Santín register based environment David Hägg, Johan Reutfors, Philip Brenner, Gang Li, Allitia

PM252 DiBernardo, Robert Bodén, Lena Brandt

Maternal fluoxetine treatment causes glutamatergic and GABAergic dysregulation in PM259 the cortex of adolescent offspring The long-lasting antidepressant effects and the Samuel J. Millard, Jeremy S. Lum, Katrina Weston-Green, cognitive impairment effects of (R)-ketamine Kelly A. Newell are abolished in NMDA receptor GluN2D subunit knockout mice Soichiro Ide, Yuiko Ikekubo, Masayoshi Mishina, Kenji Hashimoto, Kazutaka Ikeda

53 Poster Abstracts

PM260 PM267 Structural interference at Ser743 in AMPA-R is a Quinolinic acid as pro-oxidant in depression: key to lower the agonistic effect of AMPA-R Implications through Nrf2 activity in potentiators hippocampus of restrain-stressed rats Akiyoshi Kunugi, Maiko Tanaka, Atsushi Suzuki, Yasukazu Yashika Bansal, Raghunath Singh, Tomoko Soga, Anurag Tajima, Noriko Suzuki, Motohisa Suzuki, Shinji Nakamura, Kuhad and Ishwar Prahar Haruhiko Kuno, Akihiro Yokota, Satoshi Sogabe, Yohei Kosugi, Yasuyuki Awasaki, Tomohiro Kaku, and Haruhide PM268 Kimura Effect of chronic treatment with desipramine or

milnacipran on the glycogen synthase kinase-3 PM261 phosphorylation in cerebral prefrontal cortex: TAK-653, an AMPA receptor potentiator, study in alpha1B-adrenergic receptor knockout produces an antidepressant-like effect with mice potential fast onset of action like ketamine Irena Nalepa, Katarzyna Chorazka, Agnieszka Zelek-Molik, Atsushi Suzuki, Akiyoshi Kunugi, Yasukazu Tajima, Hiroe Justyna Kusmierczyk, Grzegorz Kreiner, Monika Baginska,

Hara, Ryuji Yamada and Haruhide Kimura Marta Kowalska

PM262 PM269 TAK-137 is an AMPA-R potentiator with lower Role of Kir4.1 channels in modulating BDNF risks of bell-shaped response and seizure expression in astrocytes Akiyoshi Kunugi, Maiko Tanaka, Atsushi Suzuki, Yasukazu Yukihiro Ohno, Masato Kinboshi, Takahiro Mukai, Yuki

Tajima, Noriko Suzuki, Motohisa Suzuki, Shinji Nakamura, Nagao, Hidefumi Ito, Akio Ikeda, Saki Shimizu Haruhiko Kuno, Akihiro Yokota, Satoshi Sogabe, Yohei Kosugi, Yasuyuki Awasaki, Tomohiro Kaku, and Haruhide PM270 Kimura Association of serum levels of endogenous

estrogen receptor β with depression and body PM263 weight Identification of BDNF-enhancing targets by Haruka Tada, Daimei Sasayama, Nobuhiro Sugiyama, phenotypic screening modalities Miyuki Kobayashi, Shinsuke Washizua Michael Schuler, Bastian Hengerer, Ralf Heilker, Cornelia Dorner-Ciossek and L. Kussmaul PM271

Protective Effect of Formononetin and PM264 Biochanin A against Fluoxetine induced hepatic Ketamine and Ro 25-6981 reverse behavioral damage via curtailment of apoptosis and disturbances induced by zinc deficiency oxidative stress Bar łomiej o hwa , Berna e a zew zy , Ga riel Nowa M Wahajuddin, Swati Chaturvedi, Yaseen Malik, Mamunur

Rashid, Sandeep Singh PM265 Ketamine promotes early changes in dendritic PM272 morphology in the hippocampus of a genetic rat Increased cyclophilin A expression in the model displaying depressive-like behavior. anterior cingulate cortex of subjects with major G. Treccani, M. Ardalan, F. Chen, S. Tillmann, N. depressive disorder Liebenberg, L. Musazzi, M Popoli, Greger Wegener, Jens Kate McPherson, Andrew Gibbons, Andrea Gogos, Brian Nyengaard, Heidi K. Müller Dean

PM266 Functional connectivity of the subgenual cingulate cortex - Impact of genotypic variation Benjamin Vyssoki, Keith Sudheimer, Alan F. Schatzberg

54 Poster Abstracts

th PTL389- Clinical Suicide Tuesday 19 June 2018 PTL391 PTL392- Others Addictive Disorders Poster PTL393 Level 1 Topic Sub Topic By Disorder Number Childhood & Adolescent PTL394 Others PT273 Preclinical Depression Disorders PTL395 Others Others PT274 Preclinical Epilepsy PT275- PTL396 Preclinical Anxiety Disorders Preclinical Others PT283 Childhood & Adolescent PTL397 Preclinical PT284- Disorders Preclinical Pain PT287 PTL398 Preclinical Others PT288 Preclinical Personality Disorders PTL400- Preclinical Schizophrenia Post Traumatic Stress PTL401 PT289 Preclinical Disorders PTL402 Translational Addictive Disorders PT290- PTL403- Preclinical Schizophrenia Translational Depression PT308 PTL404 PT309 Preclinical Sleep Disorders PTL404 Translational Depression PT310 Preclinical Suicide Post Traumatic Stress PTL405 Translational PT311 Translational Anxiety Disorders Disorders PTL406 Translational Schizophrenia PT312 Translational Attention Deficit Disorders PT313- PTL407 Translational Sleep Disorders Translational Bipolar Disorders PT318 PT319 Translational Dementia PT273 PT320- Translational Depression The Impact of Economic Problems on PT328 Depression of Single Mothers in Korea: A PT329 Others Depression Comparative Study with Married Women PT330- Translational Depression PT331 Weon-Jeong Lim, Hee-Yeon Choi, Wonshin Lim, Eui-Jung Kim PT332 Translational Epilepsy

PT333- Translational Others PT338 PT274 PT340- Translational Pain Prenatal exposure to valproic acid (VPA) is PT341 associated with altered neurocognitive functions Post Traumatic Stress PT342 Translational and neurogenesis in dentate gyrus of offspring Disorders PT343- rats. Translational Schizophrenia PT356 Tomoya Kinjo, PhD, Masanobu Ito, MD, PhD, Toshihito PT357- Suzuki, MD, PhD, Heii Arai, MD, PhD Translational Suicide PT359 PTL360 Clinical Addictive Disorders PT275 PTL361- Clinical Anxiety Disorders The Roles of Serotonin on Conflicting Decision PTL362 Making under Social Groups in Rodents PTL363- Clinical Attention Deficit Disorders PTL364 Young-A Lee and Yukiori Goto PTL365- Clinical Bipolar Disorders PTL367 PT276 Childhood & Adolescent PTL368 Clinical Protective role of Hemin against experimental Disorders role of Chronic Fatigue Syndrome in mice PTL369- Clinical Depression PTL370 Puneet Kumar, Vandana Thakur

PTL371 Translational Suicide PTL372- PT277 Clinical Depression PTL375 Venlafaxine, but not fluoxetine reduces PTL376- Clinical Others cuprizone-induced demyelination and PTL380 neuroinflammation PTL381 Clinical Personality Disorders Yanbo Zhang, Xin-Min Li, Olubunmi Adebiyi, Xiaoying Bi, PTL382- Post Traumatic Stress Clinical Juihui Wang PTL384 Disorders PTL385- Clinical Schizophrenia PTL388

55 Poster Abstracts

PT278 PT285 S100B Polymorphisms are Associated with Age The involvement of free fatty acid- of Onset of Parkinson’s Disease GPR40/FFAR1 signaling in chronic social defeat Camilla Fardell Sandberg, Anna Zettergren, Caroline Ran, stress-induced pain prolongation in C57BL/6J Andrea Carmine Belin, Agneta Ekman, Olof Sydow, Lars male mice Bäckman, Björn Holmberg, Nil Dizdar, Peter Söderkvist, Shogo Tokuyama, Fuka Aizawa, Kazuo Nakamoto Hans Nissbrandt PT286 PT279 Low-doses of cannabidiol reduce neuropathic LSD increases social adaptation to opinions pain and associated anxious behavior by similar to one’s own normalizing serotonergic activity Katrin H. Preller, PhD; Leonhard Schilbach, MD; Patricia Danilo De Gregorio, Ryan McLaughlyn, Luca Posa, Justine Dürler, Msc; Thomas Pokorny, Msc; Franz X. Vollenweider, Enns, Rafael Ochoa-Sanchez, Martha Lopez-Canul and MD Gabriella Gobbi

PT280 PT287 Deschloroketamine – a new ketamine analogue Inhibition of peripheral macrophages by K. Hajkova, B. Jurasek, A. Nemeskalova, D. Sykora, T. perineural administration of nicotinic Palenicek, M. Kuchar acetylcholine receptor agonists suppresses

spinal microglial activation, resulting in the PT281 improvement of neuropathic pain in mice The pharmacological properties of the new Shiroh Kishioka, Norikazu Kiguchi, Daichi Kobayashi, psychoactive substance Fumihiro Saika, Shinsuke Matsuzaki (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) Julian Maier, Felix P Mayer, Dino Luethi, Marion Holy, Kathrin Jäntsch, Harald Reither, Lena Hirtler, Marius C PT288 Hoener, Matthias E Liechti, Christian Pifl, Simon D Brandt, Modulation of impulsive aggression through Harald H Sitte ventral hippocampus to ventromedial hypothalamus projection PT282 Chih-Hua Chang and Po-Wu Gean

Prenatal disruption of D1R-SynGAP complex PT289 impairs GABAergic interneuron migration and A role for miR-132 in learned safety causes behavioural deficits in adulthood Marianne Ronovsky, Alice Zambon, Vincent Boehm, Ping Su, Terence K.Y. Lai, Frankie H. F. Lee, Andrew R. Bastian Hoesel, Bernhard Moser, Jiaye Yang, Ana Cicvaric, Abela, Paul J. Fletcher and Fang Liu Franisco J. Monje, Johannes A. Schmid, Wulf E. Haubensak

and Daniela D. Pollak PT283 The role of the OX1R orexin antagonist SB- PT290 408124 on the lienocytogram of the spleen of The impact of fatty-acid amide hydrolase animals inhibitors in an animal model of schizophrenia Blazhenko A.A, Shalyapin P.V., Kosyakova G.P., Lebedev Biala G., Banaszkiewicz I., Kruk-Slomka M. A.A. Shabanov P.D.

PT291 PT284 Exploring participant-level trajectories of Astrocyte Activation in Locus Coeruleus Is cognitive performance among patients with Involved in Neuropathic Pain Exacerbation schizophrenia in a multi-national trial Mediated by Maternal Separation and Social Kiri Granger, Jack Cotter, Elizabeth Baker, John Evenden, Isolation Stress Jennifer H Barnett, Michael Sand Kazuo Nakamoto, Fuka Aizawa, Yutaka Koyama, Shogo Tokuyama

56 Poster Abstracts

PT292 PT299 Elucidating the interaction between brain- Muscarinic M1/M4 receptor density alterations derived neurotrophic factor (BDNF) and the in the brain following cannabidiol treatment in a dopamine D3 receptor in methamphetamine prenatal infection model of schizophrenia. psychosis Carlos Jimenez Naranjo, Ashleigh L. Osborne, Katrina Hogarth SJ, Jaehne E, van den Buuse M Weston-Green

PT293 PT300 The protective effect of hemin against Towards molecular insights into psychiatric experiemental chronica fatigue syndrome in disorders using affinity proteomics mice: possible role of neurotransmitters David Just, Anna Månberg, Eva Lindholm-Carlström, Janet

Puneet Kumar, Vandana Thakur Cunningham,Peter Nilsson

PT294 PT301 Understanding the developmental profile of In vitro screening of antipsychotics using a excitatory and inhibitory neurotransmission in a neuronal network dysregulation model of maternal immune activation model: Impact of psychosis cannabidiol treatment and therapeutic Uwe Henning, Philipp Görtz, and Christian Lange- implications for schizophrenia Asschenfeldt

Ashleigh L. Osborne, Danielle Bradd, Nadia Solowij, Jeremy Lum, Ilijana Babic, Xu-Feng Huang, Katrina Weston-Green PT302 Rapid augmentation of antipsychotic drugs by PT295 sodium nitroprusside (SNP). Behavioral Synaptic vesicle protein 2A regulates the assessment and effect on brain dopaminergic susceptibility to methamphetamine-induced transmission in rats. hyperactivity in rats. Torgny H. Svensson, Joep Titulaer, Anna Malmerfelt, Saki Shimizu, Kentaro Tokudome, Ayako Ikari, Yumiko Monica M. Marcus, Alessia Perrone, Giesbert Alken, John Iguchi, Takafumi Sugahara, Tadao Serikawa, Yukihiro Lowry Ohno PT303 PT296 Polygenic risk for schizophrenia does not Development and validation of animal model predict subclinical psychosis in adolescents for antipsychotics-induced metabolic alterations Kirs ie O’Hare, rof Tony Merriman, an r Ri har J Raghunath Singh, Yashika Bansal, Priyanka Saroj, Bikash Linscott Medhi, Anurag Kuhad PT304 PT297 A novel therapeutic target for neuropsychiatric Sex-dependent disruption of myelination in the disorders: The cerebellar alpha6-GABA-A neurodevelopmental model of schizophrenia receptor Tibor Stark, Eva Drazanova, Nadezda Vaskovicova, Lih-Chu Chiou, Hsin-Jung Lee, Margot Ernst, Wei-Jan Vladimir Pekarik, Radim Skoupy, Pavel Kulich, Marcela Huang, Akihiro Mouri, Marco Treven, James Cook, Werner Buchtova, Jana Ruda-Kucerova, Zenon Starcuk Jr, Filippo Sieghart and Toshitaka Nabeshima Drago, Alexandra Sulcova, Vincenzo Micale PT305

PT298 Allosteric modulation of muscarinic M1 A systematic review of the consequences of receptors is reduced in the hippocampus, maternal immune activation with poly I:C on striatum, and cortex of a sub-group of subjects neurotransmission in offspring: the need for a with schizophrenia methodological consensus? Shaun Hopper, Geoffrey Mark Pavey, Madhara Udawela, Danielle Bradd, Ashleigh Osborne, Katrina Weston-Green Andrea Gogos, Brian Dean

57 Poster Abstracts

PT306 PT314 Increased Excitatory Amino Acid Transporter 1, The effects of valproic acid on dopamine isoform 1 (EAAT1) mRNA in subjects with transporter availability in euthymic bipolar II schizophrenia disorder Georgia Parkin, Madhara Udawela, Andrew Gibbons, Brian Yu Chia Liu, Huai-Hsuan Tseng, Hui Hua Chang, Wei Dean Hung Chang, Yen Kuang Yang, Po See Chen

PT307 PT315 Diazepam suppresses the stress-induced DNA methylation analyses of the candidate dopaminergic release in the amygdala of genes identified by a methylome-wide methamphetamine-sensitized rat association study revealed common epigenetic Takaaki Kawano, Ken Inada, Hidehiro Oshibuchi, alterations in schizophrenia and bipolar disorder Masahiko Kawano, Hiroyuki Muraoka, Takahiro Tsutsumi, Hiroko Sugawara, Yui Murata, Tempei Ikegame, Rie Makiko Yamada, Jun Ishigooka, Katsuji Nishimura Sawamura, Tsukasa Sasaki, Nakao Iwata, Mamoru Hashimoto, Kiyoto Kasai, Tadafumi Kato, Miki Bundo, PT308 Kazuya Iwamoto Prolonged periods of social isolation from weaning is marked by an impaired blood-brain PT316 anti-inflammatory response Eye movements at the crossroads of attention Corsi-Zuelli, F., Fachim, H. A., Loureiro, C. M., Shuhama, R., and emotion processing in adults with Bipolar Bertozzi, G.; Joca, S.R.L., Menezes, P. R., Louzada-Junior, P., Disorder or ADHD. Del-Ben, C. M. Alina Marin, Douglas Munoz, Rachel Yep

PT309 PT317 Receptor gene npas2 rs4851377 polymorphism Clozapine metabolism and plasma levels in and its association with circadian rhythm in bipolar psychotic mood disorders: the effect of male population in Russia/Siberia: MONICA- valproic acid and antidepressants psychosocial Study Donatella Marazziti, Federico Mucci, Stefano Baroni, I. Gagulin, E. Gromova, D. Panov, A. Gafarova, E.Krymov, M. Voevoda, V. Maximov, V. Gafarov PT318 The Kynurenine Pathway and Mood Disorders: PT310 An Intersection of Monoaminergic, The influence of the Serotonin Transporter 5- Glutamatergic and Immune Response HTTLPR polymorphism on Suicidal Behavior: a Bashkim Kadriu, Ruin Moaddel, Peixiong Yuan, Carlos meta-analysis Zarate, Jr Giuseppe Fanelli, Alessandro Serretti PT319 PT311 Genetic dissection of severity and onset Unilateral Endothelin-1 injections into the modulators for Alzheimer’s pathology in Down medial prefrontal cortex and nucleus accumbens syndrome using cellular systems – a possible model for post-stroke depression Aoife Murray, Pollyanna Goh, Ivan Alic, Gillian Gough, and anxiety? Anne Rovelet-Lecrux, David Wallon, Marie-Claude Potier,

Happ DF, Tasker RA, Wegener G Andre Strydom, John Hardy, & Dean Nizetic

PT313 PT320 The effect of prebiotics on mania-like behavior: Development of touchscreen-based objective a behavioral study in CLOCK transgenic mice evaluation methods for motivation using NB Sommerdahl, I Hageman, SD Østergaard, G Wegener, common marmoset C Bay-Richter Tomokazu Nakako, Atsushi Takemoto, Takeshi Enomoto1, Manato Kotani, Naho Konoike, Katsuki Nakamura, Kazuhito Ikeda

58 Poster Abstracts

PT322 PT329 Epistasis in HTR1A and BDNF influences cortical Management of antidepressants in pregnancy

5-HT1A receptor binding: a PET study in 46 and lactation healthy subjects Cristina Emeterio, Lara García, Maria Marta Jalón, A Kautzky, GM James, C Philippe, P Baldinger-Melich, C Covadonga Huergo Kraus, G Gryglewski, W Wadsak, M Mitterhauser, D

Rujescu, S Kasper, R Lanzenberger PT330 Brain Glucose Uptake during Transcranial Direct PT323 Current Stimulation A genome-wide association study identifies a Kraus C, Hahn A, Sigurdardottir H, Spurny B, Döckinger E, novel locus associated with depressive state in Wadsak W, Mitterhauser M, Hacker M, Kasper S, the Japanese population Lanzenberger R Hisatsugu Koshimizu, Shun Nogawa, Shinya Asano, Shoko Takahashi, Kenji Saito, and Tsuyoshi Miyakawa PT331 The portuguese alimentary pattern, depression PT324 and the link Brain connectivity changes by associative Margarida Albuquerque, Daniel E. Sousa, Carla Spínola, learning measured with resting-state fMRI as an Miguel Costa, Pedro Cintra approach to investigate treatment-induced neuroplastic changes PT332 Patricia Anna Handschuh, Manfred Klöbl, Rene Seiger, Relationship between ciliary neurotrophic factor Benjamin Spurny, Mathis Godbersen, Gregor Gryglewski, concentration and severity of temporal-lobe Georg S. Kranz, Andreas Hahn, Rupert Lanzenberger, epilepsy in women under the tereament with Siegfried Kasper, Thomas Vanicek citicoline.

Marat Uzbekov and Ludmila Musina PT325 Prefrontal Neural Markers to Predict PT333 Antidepressant Treatment Outcome Striatal brain activity alterations in Tourette´s Bernhard Meyer, Ulrich Rabl, Lucie Bartova, Klaudius Kalcher, Thomas Blank, Julian Provenzano, Alan Syndrome 11 Schatzberg, Siegfried Kasper, Ewald Moser, Gang Chen, A meta-analysis of [ F] Fluorodeoxyglucose Lukas Pezawas (FDG) PET studies Marius Hienert, Gregor Gryglewski, Mara Stamenkovic, PT326 Siegfried Kasper, Rupert Lanzenberger Increased cerebrospinal fluid fibrinogen and brain-blood barrier disruption in a PT334 subpopulation of psychiatric disorders In vivo dopamine D2 and D3 receptor binding Kotaro Hattori, Daimei Sasayama, Shinsuke Hidese, measured with [¹¹C]-(+)-PHNO and PET Hiroaki Hori, Christoph W. Turck, Hiroshi Kunugi correlates with post-mortem mRNA expression Komorowski A, Weidenauer A, James GM, Sauerzopf U, PT327 Wadsak W, Mitterhauser M, Praschak-Rieder N, Kasper S, In vitro human lymphocyte activation fails to Lanzenberger R, Willeit M elucidate 5-HT2C receptor functioning Anton Loonen, Svetlana A. Ivanova, Melloney J. Dröge, PT335 Haukeline H. Volders, Bernard J. van Vliet, Nicolay A. Alterations of central metabotropic glutamate Bokhan, Fokko J. Bosker, Bob Wilffert receptor 5 binding and glutamate concentrations by food intake PT328 Manabu Kubota, Yasuyuki Kimura, Masanori Ichise, Chie Apathetic and agitated aspects of depression are Seki, Hitoshi Shimada, Hitoshi Shinotoh, Keisuke Takahata, differently associated with responses of Soichiro Kitamura, Sho Moriguchi, Tatsuya Ishii, Kenji hormones and nicotine craving to Tagai, Yuhei Takado, Hiromi Sano, Takayuki Obata, neurotransmitter challenge tests Masaki Tokunaga, Jun Maeda, Ming-Rong Zhang, Tetsuya Suhara, Makoto Higuchi Petra Netter, Martin Reuter, Juergen Hennig

59 Poster Abstracts

PT336 PT343 D-Amphetamine response in female subjects is MiRNA-19 and the enhanced vulnerability of mediated by sex hormones developing stress-related disorders: focus on the Praschak-Rieder Nicole, Weidenauer Ana, Sauerzopf crucial role of this miRNA during Ulrich, Bauer Martin, Bartova Lucie, Pichler Verena, neurodevelopment Philippe Cecile, Kasper Siegfried, Wadsak Wolfgang, Cattane N, Mora C, Mariani N, Riva MA, Pariante CM, Lanzenberger Rupert, Willeit Matthäus Cattaneo A PT337 Neuroprotective role of cannabidiol in brain disorders: a systematic review PT344 Fernanda Feuerharmel, MD; Jairo Vinícius Pinto, MD; To Compare P-glycoprotien Information of Márcia Kauer- an ’Anna, M , h ; Helena Tahnnhauser Psychotropics from Different Sources Barros, MD, PhD Kun-Po Chen, Shih-Ku Lin

PT338 PT345 Prediction of the human whole-brain The role of dopamine in social interactions transcriptome for hypothesis generation and Nace Mikus*, Michael Naef, Anke Linssen, Luke Clark, drug development Ulrich Müller, Trevor W Robbins, Christoph Eisenegger, Gryglewski G, Seiger R, James GM, Godbersen GM, Claus Lamm Komorowski A, Michenthaler P, Hahn A, Kasper S,

Lanzenberger R PT346 PT339 Long-term haloperidol changes in the striatum, prefrontal cortex and hippocampus of mice – a Oxytocin reactiveness to an emotional challenge proteomics perspective paradigm and relations to social-cognitive Cátia Santa, Joana F. Coelho, Diogo Bessa-Neto, Sandra I. functions in healthy volunteers Anjo, Graça Baltazar, Michael J. Dunn, David R. Cotter, Luckhaus C, Kampka N, Frommann N, Henning U Bruno Manadas

PT340 PT347 Genome-wide association study identifies Metabolic status of patients with chronic genetic polymorphisms associated with the schizophrenia under antipsychotic treatment analgesic effect of fentanyl in the preoperative Uzbekov Marat*, Ivanova Svetlana, Smirnova Ludmila, cold pressor-induced pain test Bokhan Nikolai, Semke Arkadi, Shikhov Sergej, Brilliantova Daisuke Nishizawa, Kaori Takahashi, Kaori Yoshida, Varvara Shinya Kasai, Junko Hasegawa, Kyoko Nakayama, Yuko Ebata, Yoshihiko Koukita, Ken-ichi Fukuda, Tatsuya Ichinohe, Kazutaka Ikeda PT348 Dynamics of metabolic changes in first-episode drug-naive schizophrenic patients under PT341 antipsychotic pharmacotherapy Novel Modulators of Serotonin, Dopamine, and Marat Uzbekov, Natalia Smolina, Varvara Brilliantova, Mu Opiate Receptors for Substance Use Tatjana Syrejshchikova, Gennadij Dobretsov , Sergej Disorders Pain and Mood Disorders Shikhov, Alexandr Shmukler Robert E. Davis, Peng Li, Wei Yao, Stephanie Cruz, Lei Zhang, Joseph P. Hendrick, Terry Martin, Allen Fienberg, PT349 Kimberly E. Vanover, Sharon Mates and Gretchen L. Snyder Developing a method for detection of

retrotransposon by next generation sequencing PT342 and its application to single brain cells Altered cerebellar microcircuit shapes emotional Miki Bundo, Junko Ueda-Hayashi, Masaki Nishioka, Emi memory via cerebellothalamic connectivity Kiyota, Kiyoto Kasai, Tadafumi Kato, Kazuya Iwamoto Sun-Ho Kwon, Jeong-Kyu Han, Sang-Jeong Kim, Sang-Kyu

Ye

60 Poster Abstracts

PT350 PT357 Molecular and genetic study of the discs, large Increased oxytocin gene expression levels in homolog 1 of Drosophila (DLG1) in patients with suicidal ideations schizophrenia Birgit Ludwig, Klemens Kienesberger, Laura Carlberg, Akihito Uezato, Naoki Yamamoto, Daisuke Jitoku, Emiko Patrick Swoboda, Alexandra Bernegger, Nestor D. Kapusta, Haramo, Eri Hiraaki, Yoshimi Iwayama, Masakazu Umino1, Martin Aigner, Helmuth Haslacher, Siegfried Kasper and Asami Umino, Akeo Kurumaji, Takeo Yoshikawa, Toru Alexandra Schosser Nishikawa PT358 PT351 Risk factors associated with non-suicidal self- Quantifying dopamine receptor availability in injuring behaviour and previous suicide the retina of humans using [11C]-(+)-PHNO attempts in a sample of affective disorder Fernando Caravaggio, PhD., Jun Ku Chung, B.Sc., Phillip patients 3 Gerretsen, M.D., PhD, Ariel Graff-Guerrero , M.D., PhD. Marleen M. M. Mitschek, Birgit Ludwig, Klemens PT352 Kienesberger, Laura Carlberg, Patrick Swoboda, Nestor D. Glutamatergic Neurometabolite Levels in Kapusta, Martin Aigner, Siegfried Kasper and Alexandra Patients with Treatment-resistant Schizophrenia: Schosser a Cross-sectional 3T Proton MRS study Yusuke Iwata, Shinichiro Nakajima, Eric Plitman, Jun Ku PT359 Chung, Fernando Caravaggio, Julia Kim, Philip Gerretsen, Specific alterations in epigenetic blood Sofia Chavez, Gary Remington, Ariel Graff-Guerrero biomarkers to predict suicide attempts B.Vire, N.Salvetat, S.Pointet, F.Chimienti, P.Courtet, PT353 D.Weissmann Frontostriatal functional connectivity and its relationship with striatal dopamine capacity in PTL360 schizophrenia ‘Hot and cold’ cognition in users of novel Seoyoung Kim, M.D., Euitae Kim, M.D., Ph.D. psychoactive substances George Savulich, Bob Stephenson, Owen Bowden-Jones, PT354 Annette B. Brühl, Karen D. Ersche, Trevor W. Robbins and Cognitive Clustering in Schizophrenia Patients, Barbara J. Sahakian their First-Degree Relatives and Healthy Subjects is Associated with Anterior Cingulate PTL361 Cortex Volume Escitalopram in Adult Seperation Anxiety Kazutaka Ohi, Takamitsu Shimada, Kiyotaka Nemoto, Disorder Yuzuru Kataoka, Toshiki Yasuyama, Kohei Kimura, Hiroaki Oguz Karamustafalioglu Okubo, Takashi Uehara, and Yasuhiro Kawasaki PTL362 PT355 Non-verbal Memory impairment in Korean Amphetamine-induced dopamine release and obsessive-compulsive disorder patients with sensitization are regulated by the prefrontal checking type compulsions cortex: A [11C]-(+)-PHNO PET study in healthy Min-Seong Koo, Chan Hyung Kim subjects and patients with schizophrenia Willeit Matthäus, Weidenauer Ana, Sauerzopf Ulrich, Bauer PTL363 Martin, Markus Mitterhauser, Bartova Lucie, Lanzenberger Deficit in the delayed visuospatial memory in Rupert, Pezawas Lukas, Kasper Siegfried, Wadsak ADHD children Wolfgang, Praschak- Rieder Nicole Sergey Kiselev

PT356 PTL364 Investigation of Mechanism of Increased Influence of body-oriented therapy on executive Appetite after Olanzapine by sLORETA during abilities in preschool children with ADHD Sleep Kiselev S., Parshakova A. Axel Steiger, Marcel Pawlowski, Yussuf Abshir-Ahmed, Pierre Beitinger

61 Poster Abstracts

PTL365 PTL372 An interaction between carbamazepine, Dynamics of cognitive functioning in patients fluvoxamine and clozapine in a patient with with major depressive disorder and anxiety- bipolar depression depressive disorders under the influence of Chen, Wei-Yuan antidepressant therapy Olena Khaustova, Azize Asanova PTL366 Use of benzodiazepines and hypnotics in PTL373 maintenance phase of patients with bipolar Optimized regimens of combined medications disorder in an outpatient setting for the treatment of major depressive disorder : Andrew L H Peh double-blind investigation Zoë Zuilhof, Sandhaya Norris, Claude Blondeau, Pierre PTL367 Tessier, Pierre Blier Valproic Acid-Induced Hyperammonemic Encephalopathy and Coma: A Case Report PTL374 Marleen M. M. Mitschek, Thomas Vanicek, Birgit Ludwig, Decrease in choline and N-acetyl aspartate levels Angela Naderi-Heiden, Richard Frey, Siegfried Kasper, in dorsolateral prefrontal cortex at the Nicole Praschak-Rieder beginning of recovery phase are markers of increased risk of depressive episode recurrence PTL368 under maintenance therapy – a proton magnetic Mindfulness training during pregnancy has resonance spectroscopy stud positive effect on neurocognitive development Henigs erg N, Kalem er , Šara H, Ra oš M, Ra oš M, of children Ozre ić , Er eljić-Tur , Hra ač , Bajs-Janović M, Ra B Sergey Kiselev∗, Inna Volik PTL375 PTL369 Complex tic movements as a manifestation of Development and Validation of a Clinical psychotic depression: a case report Calculator to Predict Acute-Phase Mafalda Corvacho, Duarte Palma, Catarina Félix, Joana Antidepressant Outcomes Using Early Changes Macedo Cunha, João Borba Martins in Irritability and Depression Severity: Findings from CO-MED and SAMS Trials PTL376 Manish Jha, Abu Minhajuddin, Charles South, Augustus Therapy of mental disorders in elderly patients John Rush, Madhukar Trivedi with multimorbidity Olena Khaustova, Igor Kalugin, Olena Osuchovska PTL370 Pre-treatment S100B Selectively Predicts PTL377 Response to SSRI Monotherapy Vs. Folie à deux: if you do not search for it, you will Antidepressant Combinations: Clinical never find it Implications of Blood Brain Barrier Dysfunction Mafalda Corvacho, Duarte Palma, Sílvia Batista, Joana Manish Jha, Abu Minhajuddin, Bharathi Gadad, Madhukar Macedo Cunha, Catarina Félix, João Borba Martins Trivedi PTL378 PTL371 Mindfulness training can reduce prenatal Association of Th2-Cell Mediated Immune maternal stress Response with Suicide Behavior in Adolescents Sergey Kiselev, Inna Volik and Young adults

Manish Jha, Madhukar Trivedi, Tracy Greer, Charles South, PTL379 Bharathi Gadad, Jennifer Hughes, Taryn Mayes A study of delirium: its course and outcome in a tertiary care teaching hospital Gulbahar Singh Sidhu, Deepali Gul

62 Poster Abstracts

PTL381 PTL388 The subtle line between belief and psychosis Risky co-operative behavior in Schizophrenia: A (and its underlying ethical dilemma): a case neuroeconomics examination report Deepa Purushothaman, Naren P Rao, Ganesan

Mafalda Corvacho, Duarte Palma, Catarina Félix, Joana Venkatasubramanian, Shivarama Varambally, Bhargavi

Macedo Cunha, João Borba Martins Nagendra, Vijaya Kumar

PTL382 PTL389 Altered white matter diffusivity of the cingulum Preliminary Evidence of a Suicidal Ideation- angular bundle in PTSD Specific Neural Signature of Synaptic Loss and Christopher L. Averill, B.S., Lynnette A. Averill, Ph.D., Dysconnectivity in Posttraumatic Stress Disorder Kristen M. Wrocklage, Ph.D., J. Cobb Scott, Ph.D., Teddy J. Lynnette A. Averill, Christopher L. Averill, Kristen M. Akiki, M.D., Brian Schweinsburg, Ph.D. Steven M. Wrocklage, Cobb J. Scott, Brian Schweinsburg, Steven M. Southwick, M.D., John H. Krystal, M.D, Chadi G. Abdallah, Southwick, John H. Krystal, Chadi G. Abdallah M.D. PTL390 PTL383 A retrospective study of suicide reporting in Psychiatric Symptoms and Responses in Indian Newspaper: Are WHO Guidelines Students in the High School Exposed to the followed? Sewol Ferry Disaster Gulbahar Singh Sidhu, Deepali Gul Jong Kil Oh, Bhang Soo-Young PTL391 PTL384 Suicide attempt during postpartum in Psychiatry Diagnostic approach to the mild traumatic brain Emergency Room injury verification in patients with PTSD Freddy Vasquez, Ysela Nicolas, Sylvia Falconi, Alicia Villar Olena Khaustova, Olena Smashna PTL392 PTL385 BDNF Gene is a Determinant of methadone dose Robust anti-suicidal and antidepressant effects on Heroin Dependence in Han Chinese of S-ketamine in post-psychotic depression: A Shang-chien Huang, Bing-Wen Soong, Cathy Shen-Jang case report Fann, Hsiang-Ping Huang, Hsiang-Hsiung Huang Lucie Bartova, Konstantinos Papageorgiou, Ivan Milenkovic, Markus Dold, Ana Weidenauer, Matthäus PTL393

Willeit, Dietmar Winkler, Siegfried Kasper Spread via real or virtual paths? Exploring seven

illicit drugs’ probable transmission based on the PTL386 poundage of drug seizing Heritability and Familiality of Psychopathologic Yu-Hsuan Lin, Bo-Yu Wong, Yuan-Chien Pan Dimensions in the Korean Families With Schizophrenia PTL394 Young-In Chung, Byung Dae Lee, Je Min Park, Young Min Parental involvement in the child’s activities can Lee, Eunsoo Moon, Kang Yoon Lee, Hee Jeong Jeong, Soo contribute to cognitive development of preterm Yeon Kim infants

Sergey Kiselev, Maria Lavrova, Ekaterina Suleymanova, PTL387 Olga Lvova, Inna Tuktareva Focus on apathy in schizophrenia: a review of non-pharmacological interventions and PTL395 pharmacological approaches Psychological trauma suffered by the people of Emmanuel Mulin, Olivier Lairez, Marc Brunet, Laurence Kashmir through the eyes of cinema: a repraissal Quintard, Nathalie Bordone Gulbahar Singh Sidhu, Deepali Gul

PTL396 Chronic unpredictable stress induces adaptation in inducible nitric oxide (iNos) knockout mice Fernandes, G.G., Campos, A.C.*

63 Poster Abstracts

PTL397 PTL405 Maternal Nicotine's Effects on Learning and Combination of an epigenetic modulator and a Memory in Adolescent Mice transcription regulator of a differentially- Celina Mojica, Ph.D., Yu Bai, Shahrdad Lotfipour, Ph.D. methylated pathway reverses PTSD in a rat model: A novel approach to PTSD treatment. PTL398 Gal Warhaftig, Noa Zifman, Chaya Mushka Sokolik,

Vildagliptin prevents insulin resistance induced Renaud Massart, Orshay Gabay, Moshe Szyf and Gal Yadid Cognitive Impairments in rat Siamak Reyhani-Rad, Kianoosh Dadashzadeh, Javad PTL406 Mahmoudi, Saeed Sadigh-Eteghad, Reza Badalzade D-neuron hypothesis: A new clue for central nervous system medicinal chemistry PTL400 Keiko Ikemoto Comparison of antipsychotic action of positive allosteric modulators of muscarinic M1, M4 and PTL407 M5 receptors Is TAAR1 prospective target receptor for Cieślik, M Woźnia , A il , JM Wierońs a, narcolepsy? Keiko Ikemoto PTL401 Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine Manabu Takaki, Masafumi Kodama, Yutaka Mizuki, Hiroki Kawai, Bunta Yoshimura, Makiko Kishimoto, Shinji Sakamoto, Yuko Okahisa, Norihito Yamada

PTL402 Nicotine Gateway Effects Enhance Adolescent Alcohol Intake and Preference in Mice Anjelica Cardenas, Yuexi Yin, Sally Liu, Shahrdad Lotfipour

PTL403 Altered rostromedial tegmental activation and behavioural response to chronic ethanol exposure in a preclinical model of depression- addiction comorbidity Joshua Dean Conway, Nageeb Hasan, Tristian Nicholas Critch, Gerryt Bruins, Stefan James, Francis Rodriguez Bambico

PTL404 The antidepressant-like behavioural and neuroplastic effects of stress controllability training are mediated by cortical endocannabinoid-CB1 receptor signaling Nageeb Hasan Rifat, Victoria Elizabeth Mackey, Courtney Clarke, Jordan Osmond, Sarah Bugden, Shannon Waye, Joshua Dean Conway, Francis Rodriguez Bambico

64 Congress Information

Congress Venue Austria Center Vienna IAKW - AG International Headquarters and Conference Center Vienna, AG Bruno Kreisky - Platz 1 A - 1220 Vienna

Host Organisation CINP Central Office Nasmyth Building, 2nd Floor 60 Nasmyth Avenue East Kilbride Glasgow G75 0QR Scotland, UK

Professional Conference Organiser Northern Networking Events Nasmyth Building, 2nd Floor 60 Nasmyth Avenue East Kilbride Glasgow G75 0QR Scotland, UK

Registration Desk All congress materials and documentation are available at the Registration Desk located on Level 0 (Entrance Level).

OPENING HOURS Saturday 16th June 2018 08.00 – 18.00 Sunday 17th June 2018 08.00 – 18.00 Monday 18th June 2018 08.00 – 18.00 Tuesday 19th June 2018 08.00 – 16.00

REGISTRATION FEES

ON-SITE REGISTRATION AND PAYMENT CINP Member 820 EUR Non Member 1,040 EUR Young Scientist* 440 EUR Delegate from Developing Countries** 260 EUR Student*** 160 EUR Accompanying Person 200 EUR

65 Congress Information

*Applicants must be under 35 years of age and a copy of passport or other government-issues ID must be submitted when registering.

** Developing Countries: To be eligible for this rate you must reside in one of the countries as classified by the World Bank. The valid list is published here: http://cinp.org/vienna/developing-countries/

***Students must be under 35 years of age who are currently enrolled in a registered course of study, including undergraduate or postgraduate study. Students must submit a copy of a valid Student ID

Registration fee for members, non-members, young scientists, delegates from developing countries and students includes:  Admission to all scientific sessions  Admission to Opening Ceremony  Admission to Welcome Reception  Admission to poster exhibition and technical exhibition  Congress materials (delegate bag, final programme)

Registration fee for accompanying persons includes:  Admission to Opening Ceremony  Admission to Welcome Reception  City Tour

On-site Registration Participants who wish to register on-site are advised to arrive early. On-site registration will be processed on a first-come, first-served basis. Priority will be given to pre-registered delegates. Depending on the number of onsite registered delegates, availability of congress bags may be limited.

66 Congress Information

Name Badges Delegates are requested to wear their name badges at all times during the congress. The colours of the name badges have the following significance:

All Delegates: Black Congress Staff (CINP Central Office): Green Exhibitor: Green Speakers & Chairs: Red Accompanying Person: Yellow

Congress Language The official language of the 31st CINP World Congress of Neuropsychopharmacology is English. No simultaneous translation will be provided.

Certificates of Attendance/ CME Certificates The CINP 31st World Congress has been granted 25 CME credits for full three day attendance by the European Accreditation Council for Continuing Medical Education (EACCME). CME certificates and certificates of attendance will be available online. Further information on how to obtain your certificate will be sent out to all registered participants in due course.

Abstract Book All abstracts will be published online via the CINP website.

To access the abstracts online, please visit: http://cinp.org/vienna/abstracts/

CINP 2018 Mobile App Get the CINP 2018 App for your smartphone now and experience the Congress at your fingertips!

Quickly navigate the most up-to-date congress schedule, and create a personalised Congress timetable for yourself by favouriting speakers and symposia. The app contains speaker biographies, learning objectives as well as links to social media and the main CINP site so you are always kept up to date on Congress news!

The App is free and can be downloaded on all smartphone and tablet devices for the Vienna World Congress.

Search ‘CINP 2018’ in your app store or click here to download.

Wireless Lan/ Internet Wifi will be available free of charge from Saturday 16th June until Tuesday 19th June. The wifi will be an open network and no password is required.

67 Congress Information

Speaker Registration Speakers are asked to report to the faculty desk located beside the main registration desk on Level 0.

The speaker preview room is on Level 0, Room 0.49 where speakers can test and upload their presentations before their session.

Poster Exhibition There are 3 poster sessions during the conference. In each session, there will be up to 150 posters Posters will be changed daily and are on display for the entire day.

The presenting author of the poster is encouraged to remain beside the poster during the poster session from 11.30 – 13.00, and give a short oral presentation to participants. Poster display area is located in the Galerie area of Level 1.

Presentation Schedule Poster Session Schedule Poster Session 1 11:30-13:00, Sunday 17th June 2018 Poster Session 2 11:30-13:00, Monday 18th June 2018 Poster Session 3 11:30-13:00, Tuesday 19th June 2018

Mounting and Dismantling Schedule Poster Session Mounting Dismantling Poster Session 1 08:30-11:30, Sun 17th June 17:30-18:30, Sun 17th June Poster Session 2 07:30-11:30, Mon 18th June 17:30-18:30, Mon 18th June Poster Session 3 07:30-11:30, Tues 19th June 16:00-17:00, Tues 19th June

Please be informed that secretariat will not be responsible for all remaining posters after dismantling time.

High-qualified poster submissions have been chosen as Rafaelsen Award posters. These posters will be presented during the entire three days of the Congress in a dedicated area.

In addition, late breaking posters (LB) will be displayed on Tuesday 19th June.

The poster exhibition is open to all registered delegates. Interested participants can meet the authors for discussions of their poster during the poster session from 11.30 – 13.00 each day.

Poster Awards Clinical, translational, and basic neuroscience research awards are given. Those presenting the best posters receive a certificate. These awards serve to encourage scientists who are actively involved in clinical and preclinical research. The final selection of Poster Awards will be made on the basis of the study’s scientific excellence during the congress. The awards will be handed out during the closing ceremony on Tuesday 19th June.

68 Congress Information

Poster Printing Service For poster presenters who wish to have their poster printed, you can do so by clicking here. This can be booked in advance of the Congress or there is also an on-site service. Posters can be collected on Level 1 in the Galerie area of Austria Center at a designated booth. The opening hours for the booth are:

Saturday 16th June 2018: 12.30 – 16.00 Sunday 17th June 2018: 08.00 – 16.00 Monday 18th June 2018: 08.00 – 16.00 Tuesday 19th June 2018: 08.00 – 11.30

Please note that poster printing is done through a third party, CTI Meeting Technology, so any queries regarding this service should be sent to them directly. You will also be asked to create a NEW login if ordering a poster print online, as this service is not run through the CINP website.

69 Congress Information

Technical Exhibition The 31st CINP World Congress 2018 will be accompanied by a technical exhibition taking place in Exhibition Hall on Level 0 of the Austria Centre.

See pages 73-74 for the list of CINP 2018 exhibitors and the floor plan.

Coffee bars and catering stations for snack lunches will be set up in direct vicinity of the exhibition area and also within the poster area on Level 1.

Opening Hours Sunday, 17th June 2018 09:00 – 17:00 Monday,18th June 2018 09:00 – 17:00 Tuesday, 19th June 2018 09:00 – 17:00

Programme Changes The organisers cannot assume liability for any changes in the congress programme due to external or unforeseen circumstances.

Recording Cameras, video cameras or audio recording devices are not permitted in the session rooms. Any recording of sessions is strictly forbidden.

Restaurants Most restaurants in the city centre are open daily. Hot food is generally offered from 11.00 am - 2.00 pm and from 6.00 pm - 10.00 pm. Many restaurants also serve hot food throughout the day. Some restaurants, often outside the city centre, are closed on one day each week, sometimes on Sundays as well.

Emergency First Aid In case of emergency please address the staff at the registration desk on Level 0. The staff will be on hand to assist.

70 Congress Information

How to Get There From Vienna International Airport to the Austria Centre Vienna International Airport is located in Schwechat 18km south east of central Vienna. Direct access to the airport is provided by inexpensive, convenient and easy-to-use public transportation system. The City Airport Train (CAT) travels between Vienna International Airport and Wien-Mitte, station every thirty minutes from early morning to late at night, the CAT only takes 16 minutes. Comfortable seats, plenty of legroom, free magazines and newspapers, news repoets on video screens, free high- speed Wi-fi as well as power outlets and USB ports are included as well.The airport limousine bus is also available.

Airport taxi  Fixed price of €36 for a maximum of 4 passengers  You must specify an airport tax when making a booking, otherwise additional costs will be charged (€13) for the taxi to return to Vienna.  The fixed price is valid ONLY for direct trips from an address in Vienna to the airport.  Group fares on request

Taxi Taxis are reliable and relatively cheap by Western European standards. City journeys are metered; the minimum charge is roughly €3.80 from 6am to 11pm Monday to Saturday and €4.30 any other time, plus a per kilometre fee of €1.42. A telephone reservation costs an additional €2.80. A tip of 10% is expected. Taxis are easily found at train stations and taxi stands all over the city. Most taxis accept common credit and debit cards but passengers should check before they travel. The day fare is charged from 6am to 11pm, the night fare is charged from 11pm to 6am and on Sundays and public holidays.

Public Transportation Vienna has a well-developed public transport network. Buses, trains, trams and underground lines will take you almost anywhere in the city in no time at all. Vienna public transport Wiener Linien operates five underground lines, 29 tram and 127 bus lines, of which 24 are night lines. Night lines only operate between 0.30 am and 5 am. On weekends and public holidays the Vienna underground remains at the service of its passengers all night.

The city of Vienna accounts for one full zone or core zone (Kernzone or "Zone 100"). A single ticket is valid for travelling one way in one zone. You may change to different lines in the course, but you may not interrupt your journey. Single tickets can be purchased at a price of EUR 2.20.

Validated tickets can be used for all public transport in the core zone. Tickets are available at ticket machines at most underground stations or at points of advance sale. Tobacconists also sell tickets. You may also purchase a ticket on board the bus or tram at an increased rate of EUR 2.30 per ticket. Apart from single tickets there are passes for longer periods of time. Passes are available for 24 hours and 72 hours, or as weekly, monthly or annual passes.

71 Congress Information

Bus The night buses operate daily from 12.30am to 5am in 30-minute cycles. On the weekends, the schedule is adapted to the continuous subway operation.

Underground The underground trains (U-Bahn) run from about 5:00 a.m. in the morning to about midnight (trams and buses normally stop running earlier). You can find detailed information in the schedules for the individual lines at www.wienerlinien.at.

Vienna's subway lines operate 24 hours a day on Friday night, Saturday night and on the nights before holidays. The trains run at 15-minute intervals. You can use the night subway and the night buses with all tickets from the Vienna Lines and of course with the Vienna City Card. The subway system is efficient, clean, safe and very easy. Do note, however that it can be crowded at peak times. Lines are categorized both by numbers and colors and can be referred to by either.

72 Congress Information

Credit Cards Major credit cards including Visa, American Express, Diners Club, Master Card and JCB are broadly accepted in most shops, hotels, department stores and restaurants. Credit card surcharges for uses in overseas may be incurred.

Currency The currency in Vienna is the Euro. As of 29th May 2018 , USD 1 = 0.87 Euro. Foreign currencies are conveniently exchangeable at airports, major hotels, bank branches and foreign exchange booths.

Electricity Electricity supply in Vienna is 230 volts with outlets having two round holes. Same types are used broadly in Europe and many other countries.

Language The official language in Vienna is German, however, English, is commonly used.

Climate June enjoys an average temperature of 18°C. This makes it the third-warmest month of the whole year, after the two peak summer months of July and August. Towards the end of June at night, the temperature drops to an average low of 15°C and in the afternoon, an average high of 24°

73 Exhibition Floorplan

74 Sponsor & Exhibitor Guide

Brainsway Janssen Pharmaceutical BrainsWay is engaged in the research, development Janssen Pharmaceutical Companies of Johnson & and marketing of BrainsWay Therapy, a non-invasive Johnson are dedicated to addressing and solving the treatment of brain-disorders. Based on a unique most important unmet medical needs of our time, technology, it can reach deeply and broadly into the including oncology (e.g. multiple myeloma and brain and produce nerve stimulation. The treatment prostate cancer), immunology (e.g. psoriasis), has reimbursement covering 90% of the US neuroscience (e.g. schizophrenia, depression, population and is FDA cleared for the treatment of dementia and pain), infectious disease (e.g. MDD, and CE marked for MDD, OCD, Smoking HIV/AIDS, hepatitis C and tuberculosis) and Cessation, PTSD and more. cardiovascular and metabolic diseases (e.g. diabetes). Driven by our commitment to patients, we develop Cambridge Cognition sustainable, integrated healthcare solutions by Cambridge Cognition is a neuroscience digital health working side-by-side with healthcare stakeholders, company developing products and technologies to based on partnerships of trust and transparency. enhance research of the brain and measure cognitive More information can be found on health and wellbeing in patients worldwide. Our http://www.janssen.com/emea/. software is the recognised gold standard digital Follow us on www.twitter.com/janssenEMEA for our measure of cognitive biomarkers – tracking latest news. improvement and decline of brain health in research, drug development and healthcare. Karger Publishers Karger Publishers in Basel, Switzerland, is a globally European College of active medical and scientific publishing company. Independent and family-run in the fourth generation Neuropsychopharmacology (ECNP) by Vice Chairwoman & Publisher Gabriella Karger ECNP is Europe’s leading independent forum for the and Chairman Thomas Karger, the company is science of CNS treatments. dedicated to serving the information needs of the

scientific community with publications of high- The ECNP Congress showcases the world’s best quality content, covering all fields of medical science. disease-oriented brain research, annually attracting The publication program comprises 50 new books between 4,000 and 6,000 neuroscientists, per year and 105 peer-reviewed journals with a psychiatrists, neurologists and psychologists. growing number of open-access publications. Karger

content is published predominantly in English, with a ECNP’s wide range of scientific and educational strong focus on basic and clinical research, and is in activities, programmes and events make it the largest general available online. non-institutional supporter of applied and S. Karger AG consists of the publishing company translational neuroscience research and education in Karger Publishers (est. 1890) and the International Europe. Subscription Agency Karger Libri (est. 1960).

European Psychiatric Assocation (EPA) With active individual members in as many as 88 H. Lundbeck A/S countries and 42 National Psychiatric Association Lundbeck – improved treatment and a better life for (NPA) Members who represent more than 80,000 people living with psychiatric and neurological European psychiatrists, the disorders. European Psychiatric Association is the main A global pharmaceutical company specialised in association representing psychiatry in Europe. The psychiatric and neurological disorders. EPA’s activities address the interests of psychiatrists For more than 70 years, we have been at the in academia, research and practice throughout all forefront of research in neuroscience with focus on stages of career development. The EPA deals with depression, schizophrenia, Parkinson's disease and psychiatry and its related disciplines, and focuses on Alzheimer's disease. the improvement of care for the mentally ill as well as on the development of professional excellence. www.lundbeck.com

75 Sponsor & Exhibitor Guide

NAPICU Wisepress Ltd. NAPICU is a rapidly expanding organisation 15 Lyon Road committed to developing and promoting the Merton psychiatric intensive care speciality. London NAPICU aims to improve service user experience, SW19 2RL outcome and promote staff support and Tel +44 (0) 208 715 1812 development with PICUs/LSUs by: . Improving mechanisms for the delivery of World Congress of Psychiatric Genetics psychiatric intensive and low secure care (WCPG) . Auditing effectiveness Join us at the World Congress from the 11th – 15th . Promoting research, education, practice October in Glasgow, Scotland as the field of development Psychiatric Genetics enjoys a period of rapid The association uses a number of tools and discovery. Clinical psychiatry is moving toward a methods to meet these aims, including Quarterly future where basic science discoveries are translated Meetings, website, and the Annual Conference. in-to genuine improvements in person-centered NAPICU publish their own Journal: Journal of care. The 2018 WCPG ‘Bench, Brain, and Bedside’ will Psychiatric Intensive Care feature a wide-ranging program of speakers and One of NAPICU’s strengths lies in the fact that it is a sessions that will appeal to scientists and clinicians truly multidisciplinary clinician led organisation. alike, while also engaging with the public. www.napicu.org.uk More information is available on-line: WCPG2018.org Oxford University Press (OUP) Oxford University Press is the proud publisher of Registration is Now Open the International Journal of Neuropsychopharmacology (IJNP), the official journal World Federation of Biological Psychiatry of the CINP. The central focus of the journal is on (WFSBP) research that advances understanding of existing The 14th World Congress of Biological Psychiatry will and new neuropsychopharmacological agents take place from 2 - 6 June 2019 in Vancouver, including their mode of action and clinical Canada. application or provides insights into the biological basis of psychiatric disorders and thereby advances The theme of the WFSBP Congress 2019 is their pharmacological treatment. IJNP is fully Open “Neuroscience Discoveries and Translation to Access, and ranked in the top 25% of Clinical Clinical Practice” and was chosen to address two Neurology journals (according to Journal Citation major challenges plaguing the field of mental health Reports®). OUP publishes some of the world's i.e. slow progress in new discoveries and barriers to leading neuroscience books, journals, and online evidence based application of new discoveries in day resources. to day clinical practice to improve patient care.

Wisepress The congress will be structured to include a Wisepress.com, Europe’s leading conference neuroscience discovery track and a clinical track. bookseller, has a complete range of books and Within each track, plenaries, round table debates, journals relevant to the themes of the meeting. workshops, symposia and short oral presentation Books can be purchased at the stand or, if you would sessions will address cutting edge topics. Priority will rather not carry them, posted to you – Wisepress will be given to symposia and workshop proposals that deliver worldwide. In addition to attending 200 report on new methods and tools in biological conferences per year, Wisepress has a psychiatry and psychopharmacology and their comprehensive medical and scientific bookshop translational aspects. online with great offers.

www.wisepress.com

76 Sponsor & Exhibitor Guide

World Psychiatric Assocation (WPA) 18th WPA World Congress of Psychiatry 2018

Join us in Mexico City, Mexico, 27-30 September 2018 to discuss how psychiatry can impact some of the most important social challenges facing communities across the globe. Hear from world experts and share in research and learnings that can be applied across borders for local benefit. Now, more than ever, it is essential for the psychiatric community to stand firm for mental health. Early Registration Deadline: 10 July, 2018

More information at www.wcp-congress.com

77 Sponsors and Exhibitors

Satellite Symposia Timetable

Sunday 17th June 2018 Hall E (Auditorium) Hall F1 Hall M Satellite Symposia 1 Satellite Symposia 2 Lundbeck - Schizophrenia Janssen - Depression Chair: Wolfgang Chair: Siegfried Kasper, Austria Fleischhacker, Austria 13.00- Treating depression today and 14.30 The place of long-acting tomorrow injectables in severe mental health disorders - bipolar disorder and schizophrenia Satellite Symposia 3 AsCNP/ Sumitomo Dainippon - Schizophrenia Chair: Wolfgang 18.00- Fleischhaker, Austria 19.30

Schizophrenia Today: Review of pharmacology, metabolics and cognition across the lifespan Monday 18th June 2018 Satellite Symposia 4 Satellite Symposia 5 Lundbeck - Depression AsCNP/Sumitomo Dainippon Chair: Philip Gorwood, France Chair: Siegfried Kasper, Austria 13.00- 14.30 Why do we need new treatments Neuropsychopharmacology to the for major depressive disorder next generation: New wave from and schizophrenia? Asia

78 Sponsors and Exhibitors

Thank you to our CINP 2018 Sponsors and Partners

79 Sponsors and Exhibitors

Thank you to our CINP 2018 Sponsors and Partners

80 Index

Programme Book Index Author Last Author First Page Number Abdallah, Chadi 63 Abdollahian, Ebrahim 38 Abela, Andrew 56 Abshir-Ahmed, Yussuf 61 Adachi, Naoto 37 Adamjee, Thofique 35,37 Adebiyi, Olubunmi 55 Adham, Nika 52 Adiletta, Antonio 45 Ago, Yukio 50 Aguilar-Valles, Argel 53 Ahn, Ju-Yeon 42 Aigner, Martin 61 Aizawa, Fuka 56 Akamatsu, Wado 51 Akansel, Veysel 43 Akiki, Teddy 63 Albani, Diego 47 Albuquerque, Margarida 39,44,46,59 Alic, Ivan 58 Alken, Giesbert 57 Allahverdiyeva, Nigar 49 Allers, Kelly 53 Alonso, Carlos 37 Aluisio, Leah 40 Anand, Ravi 45 Ananth, Mala 37 Ando, Shuntaro 49 Andrashko, Veronika 40 Andri, Andri 43 Androvicová, Renáta 42 Anjo, Sandra I. 60 Arai, Heii 55 Arai, Makoto 51 Arai, Naohiro 47 Arban, Roberto 53 Ardlan, M 54 Arnaut, Debora 35 Asai, Yuka 37,45 Asano, Keisuke 45 Asano, Shinya 59 Asanova, Azize 62 Asanuma, Masato 49,52 Ascoli, Bruna Maria 52

81 Index

Asgharnejad, Mahnaz 39 Asin, Karen 39,53 Atake, Kiyokazu 41 Aung, Hane 42 Averill, Christopher 63 Averill, Lynnette 63 Awasaki, Yasuyuki 54 Azeura, Masako 49 Baba, Hiroko 48 Babic, Ilijana 57 Bach, Patrick 35 Bäckman, Lars 56 Badalzade, Reza 64 Bae, Dong Sik 50 Bae, Kyung-Yeol 42 Baginska, Monika 54 Bahk, Won-Myong 37,40,43 Bai, Ya-Mei 37,38,40,41 Bai, Yu 64 Bajs Janovic, Maja 62 Balan, Shabeesh 33,51 Balanzá-Martinez, Vicent 37 Baldez, Daniel Prates 37 Baldinger-Melich, Pia 41,59 Baltazar, Graça 60 Bambico, Francis 64 Banaszkiewicz, Izabela 56 Bansal, Yashika 54,57 Barahona-Corrêa, Bernardo 38 Baroni, Stefano 58 Barros, Helena 60 Barsalou, Heather 53 Bartlett, Elizabeth 37 Bartova, Lucie 35,39,41,42,43,48,59,60,61,63 Batista, Sílvia 62 Bauer, Martin 43,48,60,61 Baumgartner, Markus R. 35 Bay-Richter, Cecilie 58 Beck, Anne 35 Becker, Benjamin 52 Beckmann, Christian 27 Beitinger, Pierre 61 Bellini, Bianca 35 Bellivier, Frank 23 Benattayallah, Abdelmalek 33 Bensing, Sophie 49

82 Index

Bercik, Premsyl 31 Berger, Stefanie 53 Bergman, Hagai 29 Berk, Michael 9,33,46 Bernegger, Alexandra 61 Berroterán-Infante, Neydher 41 Bertozzi, Giuliana 58 Bessa-Neto, Diogo 60 Bessho, Kazue 48 Bhandari, Ranjana 52 Bharath, Rose 48 Bhat, Musadiq Ahmad 50 Bi, Xiaoying 55 Biala, Grazyna 56 Biederman, Joseph 24 Binder, Elisabeth 4,12,17,25 Bisby, James 33 Bito, Rina 44 Blank, Thomas 41,59 Blazhenko, Alexandra 56 Blier, Pierre 8,18,26,29,52,62 Blondeau, Claude 62 Blumberg, Hilary 23 Bodén, Robert 39,53,54 Boedhoe, Premika 26 Boehm, Vincent 56 Boiko, Anastasiia 49 Bokhan, Nikolay 42,49,60 Bonassi, Stefano 47 Borba Martins, João 62,63 Bordone, Nathalie 63 Borg, Jackie 21 Borgwardt, Stefan 43 Borroto-Escuela, Dasiel 53 Bortolasci, Chiara 13,33 Bosker, Fokko J. 59 Bowden-Jones, Owen 61 Bradd, Danielle 57 Braganza, Nicole 36 Brandl, Eva 47 Brandt, Lena 39,53 Brandt, Simon D 56 Brenner, Philip 39,53 Brilliantova, Varvara 60 Bristot, Giovana 52 Brown, Lisa 36,52

83 Index

Brugger, Stefan 46 Brühl, Annette 30,61 Bruins, Gerryt 64 Brunet, Marc 63 Brunovský , Martin 40,42 Buchtova, Marcela 57 Bugden, Sarah 64 Bundo, Miki 58,60 Burr, Robert 40,41 Bychkov, E.R. 52 Caetano Silva, Ricardo 38 Cagnan, Hayriye 25 Cai, Wen Ting 51 Calabrò, Marco 39 Calzavara, Mariana 50 Campos, Alline 63 Canas Simião, Hugo 38 Caravaggio, Fernando 61 Cardenas, Anjelica 64 Carlberg, Laura 61 Carmine Belin, Andrea 56 Carpenter, Linda 22,25 Carsillo, Mary 53 Castilla-Ortega, Estela 51 Cattane, Nadia 60 Cattaneo, Anna 31,60 Cengiz, Zeliha 43 Chako, Dona 48 Chamberlain, Samuel 27,28,35 Chan, Wing 35 Chandragiri, Sanjay 45 Chandrasekaran, Prem Kumar 38 Chang, Cheng-Chen 45 Chang, Chih-Hua 56 Chang, Hui Hua 58 Chang, Hu-Ming 35 Chang, Jane 36 Chang, Jhin Goo 38 Chang, Jung-Chen 36 Chang, Kiki 37 Chang, Wei Hung 58 Chang, Wen-Han 37,40 Chang, Yue-Cune 46 Chang, Yu-San 35 Chao, Yan 44 Chaturvedi, Swati 54

84 Index

Chaudhry, Zara 45 Chavez, Sofia 61 Cheema, Sheraz 36 Chen, Andrew C.H. 36 Chen, F 54 Chen, Gang 41,59 Chen, Jun 40 Chen, Kun-Po 60 Chen, Mu-Hong 37,38,40,41 Chen, Pao-Huan 37 Chen, Po-See 58 Chen, Po-Wei 46 Chen, Tien-Yu 38 Chen, Wei-Yuan 62 Cheng, Chih-Ming 37,41 Cheng, Yingchih 38 Cheng, Zhongshan 51 Cherapkin, Egor 51 Chimienti, Fabrice 61 Chiou, Jeng-Yuan 45 Chiou, Lih-Chu 57 Chiu, Helen FK 38 Chiu, Nan-Ying 45 Cho, Bo Ram 51 Cho, Kang Ik K 47 Choi, Hee-Yeon 43,55 Choi, Jae-Sue 52 Chorazka, Katarzyna 54 Chou, Dylan 50 Choudhury, Tanzeem 42 Chu, Che-Sheng 38 Chung, Jun Ku 38,61 Chung, Kuo-Hsuan 37 Chung, Young-Chul 38 Chung, Young-In 63 Cicvaric, Ana 53,56 Cieslik, Paulina 64 Cihnioglu, Refik 38 Cintra, Pedro 59 Cipriani, Andrea 27 Claassen-Weitz, Shantelle 34 Clark, Luke 60 Clarke, Courtney Leigh 64 Coelho, Joana F. 60 Comai, Stefano 32,53 Connor, Timothy 33

85 Index

Conway, Joshua Dean 64 Cook, James 57 Cooper, Kimberly 39 Corponi, Filippo 47 Correll, Christoph 26,36,47 Corsi-Zuelli, Fabiana 49,58 Corvacho, Mafalda 62,63 Costa, Miguel 44,59 Cotter, David 60 Courtet, Philippe 61 Cowan, Caitlin 30 Crisafulli, Concetta 39 Critch, Tristian Nicholas 64 Crowley, Tamsyn 33 Cruz, Stephanie 60 Cryan, John 21 Cucchiaro, Josephine 46,47 Cui, Donghong 46 Cunningham, Janet 57 Curran, Val 33 Dadashzadeh, Kianoosh 64 Dafnas, Konstantinos 37 Dalton, Caroline 42 Daly, Ella 39,40 Danda, Hynek 51 Darghal, Mohamedi 39 Davis, Lea 26 Davis, Robert 47,60 de Chazeron, Ingrid 48 De Gregorio, Danilo 28,53,56 de Guevara-Miranda, David Ladrón 51 de Moura, Nuno 38 Dean, Brian 8,26,28,33,51,54,57,58 Dechairo, Bryan 36 Del-Ben, Cristina Marta 42,49,58 Delorenzo, Christine 37 Deng, Ling 37,47 Denys, Damiaan 29 Derci, Neide 50 Desnick, Robert 53 Devasthali, Gayatri 36 Dey, Avyarthana 48 Diaz Heijtz, Rochellys 31 Díaz-Cabiale, Zaida 51,53 DiBernardo, Allitia 39,53 Dijkstra, Francis 43

86 Index

Dipasquale, O. 43 Dizdar, Nil 56 Dmitrienko, Alex 47 Do, Kim 30 Dobretsov, Gennadij 60 Dodds, Chris 33 Dold, Markus 35,39,42,63 Dolder, Patrick 43 Döckinger, Erika, 59 Dorner-Ciossek, Cornelia 53,54 Dorninger, Lucia 42 Douzenis, Athanassios 37,38 Downar Jonathan 20 Drago, Filippo 57 Drazanova, Eva 57 Drevets, Wayne 39,40 Dröge, Melloney J. 59 Duarte, Tiago 45 Ducci, Giuseppe 47 Dunlop, Katharine 20,22 Dunn, Michael J. 60 Dunner, David 40,41 Duque, Ricardo 44 Dürler, Patricia 56 Ebata, Yuko 60 Ebrahimzadeh, Mohammad 52 Eckert, Anne 41 Einenkel, Karolin E. 41 Eisenegger, Christoph 60 Ekman, Agneta 56 El Mansari, Mostafa 52 El Rahimy, Youssef 53 Emeterio, Cristina 59 Endo, Aki 46 Endo, Kousuke 53 Enns, Justine 53,56 Enomoto, Takeshi 58 Erabi, Hisayuki 41 Erfurth, Andreas 8,23,49 Eriksson, Elias 8,17,25,27,39,52 Ernst, Margot 53,57 Erritzoe, David 31 Ersche, Karen 26,61 Esaki, Kayoko 33,51 Esteves-Sousa, Daniel 39 Estivill-Torrús, Guillermo 51

87 Index

Etkin, Amit 5,18,29 Fabbri, Chiara 47 Fachim, Helene 42,49,58 Facucho-Oliveira, João 39 Falconi, Sylvia 49,63 Falkai, Peter 9,22,26 Fanelli, Giuseppe 58 Fang, Chiu-Ping 36 Fang, Yiru 40 Fann, Cathy Shen-Jang 63 Farde, Lars 40 Fardell Sandberg, Camilla 56 Farkas, Bence 52 Fedorenko, Olga 49 Félix, Catarina 62,63 Ferentinos, Panos 37,38 Fereshetyan, Katarine 44 Fernandes, Gabriel 63 Ferreira, André 45 Feuerharmel, Fernanda 60 Fienberg, Allen 60 Fineberg, Naomi 5,26,28,32 Fleischhacker, Wolfgang 29,31,46,78 Fletcher, Paul 56 Flores-Burgess, Antonio 51,53 Forrest, Emma 45 Foster, Karen 39 Frank, Ellen 21,32,42 Franke, Barbara 21,22 Frazer, Alan 8,27 Freeman, Tom 33 Frey, Richard 8,29,41,42,62 Fries, Gabriel 13,34 Frommann, Nicole 60 Frustaci, Alessandra 47 Fugger, Gernot 41,42 Fuji, Yasuo 46 Fujimoto, Michiko 48 Fujino, Haruo 48 Fujita, Kazuki 38 Fujita, Masayo 51 Fujita, Yasutaka 46,47 Fujita, Yousuke 53 Fukuda, Ken-ichi 60 Fukumoto, Maki 44 Fukunaga, Kohji 52

88 Index

Fukushima, Taisuke 49 Furukori, Hanako 40 Furukori, Norio 37 Fuxe, Kjell 10,51,53 Gabay, Orshay 64 Gadad, Bharathi 62 Gafarov, Valery 58 Gafarova, Almira 58 Gago, Belén 51,53 Gago, Joaquim 39,46 Gagulin, Igor 58 García, Lara 51,59 García-Durán, Laura 51 Gardner-Lubbe, Sugnet 34 Ge, Bin 51 Géa, Luiza Paul 52 Gean, Po-Wu 56 Gelernter, Joel 21,51 Genç, Abdullah 43 George, Mark 20,22 Gerretsen, Philip 61 Gibbons, Andrew 54,58 Gil-Rodríguez, Sara 51 Glass, Steven 47 Glenthoej, Birte 5,18,30,32 Gobbi, Gabriella 26,28,53,56 Godbersen, Godber Mathis 50,59.60 Godinho, Filipe 45 Gogos, Andrea 54,57 Goh, Pollyanna 58 Goldman, Robert 37,47 Goldstein, Rita 26 Gomes, Felipe 13 Gomes-Pereira, Sérgio 39 Goncalves, Vanessa 47 Gorbovskaya, Ilona 37 Gordon, Josh 3,4,19,20,28 Görtz, Philipp 57 Goto, Saeri 44 Goto, Yukiori 52,55 Gough, Gillian 58 Gounaridis, Ai 46 Gournellis, Rossetos 38 Grace, Anthony 9,27,33 Graff-Guerrero, Ariel 38,42,61 Graham, Stephen 45

89 Index

Grant, Jon 28,35 Gray, Laura 33 Greber-Platzer, Susanne 53 Greengard, Paul 33 Greer, Tracy 62 Gromova, Elena 58 Grünblatt, Edna 43 Gründer, Gerhard 33 Gryglewski, Gregor 36,41,50,59,60 Gul, Deepali 62,63 Guru, Sameer Ahmad 50 Güven, Dilek 43 Haber, Suzanne 29 Hacker, Marcus 8,50,59 Haddar, Meriem 51,53 Hageman, Ida 58 Hägg, David 39,53 Hagi, Katsuhiko 36 Hagihara, Hideo 40 Hagino, Yoko 51,52 Hagiwara, Tetsuya 45 Hagsäter, Sven Melker 52 Hahn, Andreas 29,30,41,50,59,60, Hainfellner, Johannes 53 Hajkova, Katerina 56 Halldin, Christer 22 Han, Bai 38,39,52,53 Han, Changsu 39,42 Han, Doug Hyun 43 Han, Jeong-Kyu 60 Han, Kyu-Man 42 Handschuh, Patricia Anna 59 Hanihara, Tokiji 43 Happ, Denise 58 Hara, Hideaki 50,51 Hara, Hiroe 54 Hara, Kumiko 53 Harada, Yoshihiko 37,45 Haramo, Emiko 61 Hardy, John 58 Harkany, Tibor 5,8,18,23,32 Hartenbach, Markus 50 Hartman, Richard 45 Harutyunayn, Aida 44 Harvey, Philip D 47 Hasan Rifat, Nageeb 64

90 Index

Hasegawa, Junko 50,60 Hashimoto, Hitoshi 50 Hashimoto, Kenji 8,23,53 Hashimoto, Mamoru 58 Hashimoto, Ryota 48 Hashimoto, Yasuhiko 48 Haslacher, Helmuth 61 Hattori, Kotaro 59 Haubensak, Wulf E. 56 Hawaidah, 47

Hayashi, Hiroaki 49 Hayata, Atsuko 50 He, Feng 51 He, Shen 46 Heilker, Ralf 54 Heinz, Andreas 35 Hendrick, Joseph 60 Hengerer, Bastian 54 Hennig, Juergen 59 Henning, Uwe 57,60 Hidese, Shinsuke 59 Hienert, Marius 59 Hieronymus, Fredrik 39,52 Higuchi, Makoto 59 Hiraaki, Eri 61 Hirabayashi, Yoshio 51 Hirano, Jinichi 42,47 Hiremath, Chaitra 48 Hiroi, Noboru 4,8,9,17,28 Hirsiger, Sarah 35 Ho, Yu-Cheng 50 Hoener, Marius C 56 Hoermann, Gregor 42 Hoesel, Bastian 56 Höflich, Anna 41 Höftberger, Romana 49 Hogarth, Samuel 57 Hokama, Choryo 43,49 Holder, Richard 40 Holmberg, Björn 56 Holy, Marion 56 Honda, Hideo 38 Hong, Chen-Jee 41 Hong, Ji Sun 43 Hong, Wu 40 Hongo, Shiho 49

91 Index

Hoogman, Martine 21 Hope, Bruce 26 Hopkins, Christopher 43 Hopper, Shaun 57 Horácek, Jirí 40 Hori, Hiroaki 59 Horikawa, Naoki 41 Horikoshi, Sho 45 Hosseini, Azam 38 Hough, David 39,40 Hovatta, Iiris 31 Howes, Oliver 9,21,46 Hsieh, Haui-Te 38 Hsieh, Kuanying 35 Hsieh, Ming-Chun 50 Hsieh, Ming-Hong 45 Hsu, Jay 46 Hsu, Ju-Wei 38 Huang, Chuan 37 Huang, Hsiang-Hsiung 45,63 Huang, Hsiang-Ping 63 Huang, Kei-Lin 38 Huang, Mao-Hsuan 41 Huang, Ming-Chyi 35 Huang, Min-Wei 36 Huang, San-Yuan 38 Huang, Shang-chien 63 Huang, Shou-Hung 37 Huang, Tianming 44 Huang, Wei-Jan 57 Huang, Xu-Feng 57 Huang, Yu-Chen 38 Huang, Yu-Jhen 46 Huergo, Covadonga 59 Hughes, Jennifer 62 Humberg, Thomas 53 Hung, Chia Chun 27 Hur, Ja-Youn 42 Hurd, Yasmin 8,23 Hway Ann, Anne Yee 27 Ichikawa, Naho 42,50 Ichinohe, Tatsuya 60 Ichinose, Mizue 40,45 Ichise, Masanori 59 Ide, Soichiro 53 Igarashi, Shun 37

92 Index

Igata, Natsuki 41 Igata, Ryohei 41 Iguchi, Yumiko 57 Ihara, Masafumi 25 Iida, Hiroki 44 Iizawa, Mifumi 43 Ikai, Saeko 48 Ikari, Ayako 57 Ikeda, Akio 54 Ikeda, Kazuhito 58 Ikeda, Kazutaka 8,28,50,51,52,60 Ikegame, Tempei 58 Ikekubo, Yuiko 53 Ikemoto, Keiko 64 Imamura, Yuki 44 In Hee, Shim 50 Inada, Hitoshi 50 Inada, Ken 43,49,58 Inagawa, Takuma 47 Inamdar, Amir 39 Inazu, Masato 53 Inoue, Shintaro 50 Inoue, Yuichi 49 Inuzuka, Shin 45 Ionescu, Irina 53 Ishigooka, Jun 43,49,58 Ishii, Nobuyoshi 49 Ishikawa, Fuminori 39 Ishioka, Masamichi 40 Isobe, Masanori 35 Ito, Hidefumi 54 Ito, Masanobu 55 Ito, Masashi 40,45 Itokawa, Masanari 51 Ivanova, Svetlana 42,49,59,60 Iwamoto, Kazuya 58,60 Iwanami, Akira 39 Iwasaki, Yoko 47 Iwata, Nakao 41,58 Iwata, Yusuke 61 Iwayama, Yoshimi 33,51,61 Jacob, Arpitha 48 Jacobsen Teixeira, Manoel 35 Jaehne, Emily 57 Jain, Sanjeev 36 Jalón, Maria Marta 59

93 Index

Jambunathan, Stephen Thevanathan 38 James, Gregory M. 36,41,59,60 James, Stefan 64 Jäntsch, Kathrin 56 Javitt, Daniel 30 Jeon, Sang Won 42 Jeon, So-Yeon 52 Jeong, Hee Jeong 63 Jeong, Hyun Ghang 47 Jha, Manish 13,33,62 Jhon, Min 46 Jimenez Naranjo, Carlos 57 Jinnin, Ran 41 Jitoku, Daisuke 61 Samia Regiane Joca, 42,58 Lourenço Jones, Carrie 24 Jong Kil, Oh 63 Joyce, Eileen 24,29,37,40 Ju, Po-Chung 45 Jung, Wi Hoon 48 Jurasek, Bronislav 56 Just, David 57 Kadriu, Bashkim 29,58 Kahn, René 29 Kaiya, Hisanobu 36,44 Kakeda, Shingo 41 Kaku, Tomohiro 54 Kalcher, Klaudius 59 Kalelioglu, Tevfik 38 Kalugin, Igor 62 Kamo, Toshihiko 50 Kampka, Nina 60 Kan, Shihi 52 Kane, John 46 Kaneda, Ayako 40 Kaneda, Yasuhiro 39 Kanehisa, Masayuki 49 Kaneko, Haruka 40,45 Kang, Hee-Ju 42 Kang, Won Sub 47 Kanno-Nozaki, Keiko 45 Kapczinski, Flavio 37 Kapusta, Nestor 61 Karamustafalioglu, Nesrin 38,43 Karamustafalioglu, Oguz 43,61

94 Index

Kasai, Kiyoto 58,60 Kasai, Shinya 51,60 Kashii, Hirofumi 52 4,6,8,16,19,22,24,28,35,36,39,40,41,42,43 Kasper, Siegfried ,48,50,59,60,61,62,63,78 Kataoka, Yuzuru 48,61 Kato, Masaki 37 Kato, Tadafumi 58,60 Kato, Takahiro A. 41 Katsuki, Asuka 41 Katsumoto, Eiichi 37 Kauer-Sant’Anna, Márcia 37,52,60 Kautzky, Alexander 42,59 Kawai, Hideaki 39 Kawai, Hiroki 38,64 Kawano, Masahiko 43,49,58 Kawano, Miho 43 Kawano, Takaaki 43,49,58 Kawasaki, Naoko 36 Kawasaki, Yasuhiro 48,61 Kendrick, Keith M. 52 Kennedy, James 36,47 Kennedy, Sidney 9,42 Kessler, Ronald 51 Khaustova, Olena 62,63 Khokhlov, P.P. 52 Khurana, Paramjeet 35 Kidnapillai, Srisaiyini 33 Kiefer, Falk 35 Kienesberger, Klemens 61 Kiguchi, Norikazu 46 Kijima, Harui 50 Kikutchi, Tetsuro 28 Kim, Alexandr 51 Kim, Chan-Hyung 48 Kim, Daeho 44 Kim, Doh Kwan 49 Kim, Dongju 44 Kim, Eui-Jung 55 Kim, Euitae 48,61 Kim, Eun Jin 42 Kim, Hee Jin 43 Kim, Jae-Min 42,46 Kim, Jeong-Hoon 51 Kim, Ji Yeon 42 Kim, Jong Woo 47

95 Index

Kim, Julia 61 Kim, Jung Jin 47 Kim, Ju-Wan 46 Kim, Minah 47 Kim, Moon Doo 37,40,43 Kim, Na-Hyun 52 Kim, Sang-Jeong 60 Kim, Seok Hyeon 44 Kim, Seong-Youn 43 Kim, Seon-Young 46 Kim, Seoyoung 48,61 Kim Seung-Hyun 47 Kim, Soo Yeon 63 Kim, Sun Mi 43 Kim, Sung-Wan 42,46 Kim, Wha Young 51 Kim, Woo Sung 48 Kimura, Haruhide 54 Kimura, Kohei 48,61 Kimura, Ryuichi 50 Kimura, Yasuyuki 59 Kinboshi, Masato 54 Kinjo, Tomoya 55 Kirino, So 46 Kiselev, Sergey 61,62,63 Kishi, Taro 41 Kishimoto, Makiko 38,64 Kishino, Yuri 36 Kishioka, Shiroh 56 Kiss, Béla 52 Kitahata, Ryosuke 42 Kitaichi, Kiyoyuki 44 Kitamura, Yoshihisa 49,52 Kitoh, Hiroko 48 Kiyota, Emi 60 Klirova, Monika 40 Klöbl, Manfred 40,50,59 Klostermann, Martin 42 Kobayashi, Ayumi 53 Kobayashi, Daichi 56 Kobayashi, Kazuto 51 Kobayashi, Miyuki 54 Kobayashi, Tetsuo 50 Kobayashi, Toshiyuki 52 Kodama, Masafumi 64 Koizumi, Teruki 39

96 Index

Kok Kendirlioglu, Burcu 38 Komatsu, Chika 44 Komorowski, Arkadiusz 41,59,60 Kong, Eryan 53 Kono, Hiroyuki 50 Konoike, Naho 58 Koo, Min-Seong 61 Korogi, Yukunori 41 Kosemoto, Hajime 44 Koshimizu, Hisatsugu 59 Kosugi, Yohei 54 Kosyakova, Galina 56 Kotani, Manato 58 Koukita, Yoshihiko 60 Kowalska, Marta 54 Koyama, Yutaka 56 Kranz, Georg 8,20,22,36,41,59 Kranzler, Henry 51 Kraus, Christoph 59 Kreiner, Gregorz 54 Krueger, Frank 48 Kruk-Slomka, Marta 56 Krymov, Eldar 58 Krystal, John 5,6,8,16,19,21,25,27,30,63 Kubo, Kaoruhiko 42,46 Kubota, Manabu 59 Kubota, Yukihisa 37 Kuchar, Martin 56 Ku-Chung, Jun 38 Kudo, Shuhei 40 Kuhad, Anurag 52,54,57 Kulich, Pavel 57 Kulkarni, Karishma 36 Kumagai, Fumiaki 46 Kumar, Puneet 55,57 Kumar, Vijaya 63 Kundakovic, Marija 31 Kuno, Haruhiko 54 Kunte, Mugdha 48 Kunugi, Akiyoshi 54 Kunugi, Hiroshi 40,59 Kuo, Hsiang-Wei 36 Kupfer, David 42 Kurosawa, Keiko 49 Kurose, Shin 46 Kurumaji, Akeo 61

97 Index

Kusmierczyk, Justyna 54 Kussmaul, Lothar 53,54 Kusui, Yuka 51 Kuwabara, Hidenori 48 Kuwata, Aki 48 Kuypers, Kim 31 Kwak, Myung Ji 51 Kwon, Jun-Soo 8,29,47,48 Kwon, Sunho 60 Kwon, Young Joon 37,40,43 Ladrón de Guevara- David 51 Miranda, Lai, Cheng-Yuan 50 Lai, Terence 56 Lairez, Olivier 63 Lalovic, Aleksandra 42 Lam, Linda 36 Lamm, Claus 60 Lancelot Alberto, Rodrigo 35 Landi, Stefano 47 Lane, Hsien-Yuan 30,46 Lane, Rosanne 39,40 Lang, Julia 49 Lange-Asschenfeldt, Christian 57 Lansink, Carien 26 Lanzenberger, Rupert 8,19,27,36,41,43,48,50,59,60,61 Large, Charles 31 Lau, Khai Ying 35 Laviolette, Steven 23 Lavrova, Maria 63 Lawn, Will 13,33 Lebedev, Andrey 52,56 Lee, Byung Dae 63 Lee, Chau-shoun 36 Lee, Frankie 56 Lee, Hochang Benjamin 25 Lee, Hsin-Jung 57 Lee, Hyewon 49 Lee, Hyunji 44 Lee, Junhee 28,47 Lee, Kang Yoon 63 Lee, Kang-Soo 52 Lee, Kang-Uk 52 Lee, Pin-Tse 37,52 Lee, Shin-Hsiung 36 Lee, Shyh-Chyang 36

98 Index

Lee, Tae Young 47 Lee, Young Min 63 Lee, Young Sik 43 Lee, Young-A 52,55 Leigh-Pemberton, Richard 43 Lenczowski, Marzena 49 Levey, Daniel 51 Lhotková, Eva 51 Li, Chen 38,52,53 Li, Cheng-Ta 37,40,41 Li, Chia-Wei 35 Li, Gang 39 Li, Hejun 38,52,53 Li, Jialin 52 Li, Jianying 38,39,52,53 Li, Peng 60 Li, Wenjing 39 Li, Xin-Min 55 Liang, Chih-Sung 38 Librenza-Garcia, Diego 37 Liebenberg, Nico 54 Liebermann, Jeffrey 47 Liechti, Matthias 43,44,56 Lim, Pilar 39,40 Lim, Se Won 42 Lim, Weon-Jeong 43,55 Lim, Wonshin 43,55 Lin, Chieh-hsin 46 Lin, Ching-Hua 46 Lin, Shih-Ku 9,28,46,60 Lin, Tzer-Bin 50 Lin, Wei-Chen 40,41 Lin, Yezhe 46 Lin, Yu-Hsuan 63 Lindholm-Carlström, Eva 57 Linscott, Richard 57 Linssen, Anke 60 Lisal, Sonny T. 47 Lisinski, Alexander 39 Liu, Chia-Chen 36 Liu, Fang 56 Liu, Hsing-Cheng 38 Liu, Kezhan 38,52,53 Liu, Ren-Shyan 41 Liu, Sally 64 Liu, Shu-Chi 36

99 Index

Liu, Tung-Hsia 36 Liu, Xiaohua 40 Liu, Yu Chia 58 Liu, Yu-Li 35,36 Llorca, Pierre-Michel 48 Loebel, Antony 36,37,40,46,47 Loonen, Anton J.M. 49,59 Lopez-Canul, Martha 53,56 Losenkov, Innokentiy 42 Lotfipour, Shahrdad 64 Loureiro, Camila 42,49,58 Louzada-Junior, Paulo 42,49,58 Lowry, John 57 Lu, Wei hong 37 Luckhaus, Christian 60 Ludwig, Birgit 61,62 Luethi, Dino 56 Lum, Jeremy S. 53,57 Lundberg, Johan 40 Luo, Yan li 44 Luykx, Jurjen 21 Luzi, Livio 32 Lvova, Olga 63 Macedo Cunha, Joana 62,63 Maciukiewicz, Malgorzata 47 Mackey, Victoria Elizabeth 64 Maekawa, Motoko 33 Mahardika, Agustine 47 Mahmoudi, Javad 64 Maier, Julian 56 Mak, Arthur 36 Malik, Yaseen 54 Malmerfelt, Anna 57 Maltezos, Stefanos 50 Manadas, Bruno 60 Månberg, Anna 57 Manchia, Mirko 32 Mandelli, Laura 39 Manji, Husseini 39,40 Manthis, Joan 43 Manzoni, Olivier 23 Mao, Yongcai 37 Marazziti, Donatella 58 Marcolin, Marco Antonio 35 Marcus, Monica 57 Mariani, N 60

100 Index

Marin, Alina 58 Martin, Terry 60 Martinez, Diana 32 Martins, Daniel 43 Martins, Paulo 45 Maruki, Tsutomu 38,42 Maruki, Yuichi 38,42 Masaki, Mina 44 Massart, Renaud 64 Masuda, Yoshikazu 42,50 Mates, Sharon 47,60 Matsukawa, Takehisa 49 Matsumoto, Kenji 41 Matsumoto, Madoka 41 Matsunaga, Takamasa 41 Matsuo, Kazuya 52 Matsuoka, Yutaka 49 Matsushita, Sachio 51 Matsuzaki, Shinsuke 56 Matthews, Mark 42 Matumoto, Satomi 36 Maximov, Vladimir 58 Mayer, Felix P 56 Mayes, Taryn 62 Mazibuko, Ndaba 43,50 Mazzucco, Christine 39 McCarthy, Michael J. 32 McCutcheon, Robert 46 McLaughlyn, Ryan 56 McPherson, Kate 54 Medeiros, Leonardo Simão 37 Medhi, Bikash 57 Mehmet Cem, Ilnem 38 Melkersson, Kristina 49 Meltzer, Herbert 10,47 Mendlewicz, Julien 10,39,42 Mendonça, Luis 39 Merriman, Tony 57 Meyer, Bernhard 41,59 Meyer-Lindenberg, Andreas 3,16,21 Micale, Vincenzo 30 Michenthaler, Paul 60 Michopoulos, Ioannis 37,38 Miki, Akihisa 49 Mikulan, Ezequiel 42 Mikus, Nace 60

101 Index

Milenkovic, Ivan 63 Millard, Samuel 53 Miller, Andrew 33 Millón, Carmelo 51,53 Mimura, Masaru 38,39,42,45,46,47,48,51 Min, Ji Young 44 Min, Kyung Joon 37,43 Minami, Fusaka 36,39,44 Minhajuddin, Abu 33,62 Misawa, Fuminari 46 Mishima, Kazuo 49 Mishina, Masayoshi 53 Miskowiak, Kamilla 29,30 Mitchener, Ludivo 33 Marleen Margret Mitschek, 61,62 Mignon Mitterhauser, Markus 8,36,50,59,61 Mitterhauser, Wolfgang 41,59 Miura, Itaru 40,45 Miura, Takamasa 48 Miyakawa, Tsuyoshi 40,59 Miyamoto, Yoshiaki 51,52,53 Miyazaki, Ikuko 49,52 Miyazaki, Takahiro 38 Mizoguchi, Takahiro 51 Mizuki, Yutaka 64 Mizuno, Yuya 46 Moaddel, Ruin 58 Möller, Hans Jürgen 9,10,22,30 Mohareri, Fatemeh 38 Mojica, Celina 64 Molero, Patricio 39 Molz, Barbara 53 Mondelli, Valeria 36,49 Monje, Francisco J. 53,56 Montgomery, Stuart 10,39,42 Montreerarat, Yuwarat 42 Moon, Eunsoo 63 Moreno-Fernández, Román Darío 51 Morgan, Celia 33 Mori, Asako 41 Morilak, David 22,23 Morishita, Seiya 51 Morrison, Randall 40 Moser, Bernhard 56 Moser, Ewald 41,59

102 Index

Moulton, Calum 43 Mouri, Akihiro 57 Mucci, Federico 58 Mukai, Takahiro 54 Mulin, Emmanuel 63 Müller, Daniel 36,47 Müller, Felix 43 Müller, Heidi 54 Müller, Ulrich 60 Muniz, Bianca 50 Munoz, Douglas 58 Murakami, Hiroko 52 Muralidharan, Kesavan 36 Muramatsu, Shin-ichi 51,53 Muraoka, Hiroyuki 49,58 Murata, Yui 58 Murphy, Nicholas 48 Murray, Aoife 58 Musazzi, Laura 32,54 Musina, Ludmila 59 Myung, Woojae 49 Nabeshima, Toshitaka 9,57 Naderi-Heiden, Angela 62 Naef, Michael 60 Nagahama, Yasufumi 49 Nagai, Nobuhiro 46 Nagakura, Tomoki 53 Nagamine, Takahiko 46 Nagao, Yuki 54 Nagaoka, Maki 48 Nagendra, Bhargavi 48,63 Naito, Nanami 52 Nakagami, Taku 40 Nakagawa, Atsuo 37 Nakagawa, Shin 53 Nakajima, Shinichiro 38,42,51,61 Nakako, Tomokazu 58 Nakamoto, Kazuo 56 Nakamura, Katsuki 58 Nakamura, Kazuhiko 40 Nakamura, Masaru 46 Nakamura, Shinji 54 Nakamura, Shinsuke 51 Nakamura, Tomohisa 48 Nakamura, Tomoyuki 41 Nakamura, Yuka 52

103 Index

Nakano, Tatsunori 43 Nakatsu, Keigo 47 Nakayama, Kyoko 60 Nakazawa, Takanobu 50 Nalepa, Irena 54 Narita, Zui 47 Narváez, José Ángel 51,53 Narváez, Manuel 53 Näslund, Jakob 39,52 Naudé, Petrus 13,34 Navarro, María Cecilia 37 Nemeroff, Charles 9,25 Nemoto, Kiyotaka 61 Neto, Daniel 46 Netter, Petra 59 Neves, António 44 Newcomer, John W. 46 Newcorn, Jeffrey 24 Newell, Kelly A. 53 Nichols, Benjamin J. 53 Nicol, Mark 34 Nicolas, Ysela 49,63 Nics, Lukas 43,48 Nilsson, Peter 57 Nilsson, Staffan 39 Nishida, Atsushi 49 Nishikawa, Toru 61 Nishimura, Katsuji 43,49,58 Nishina, Maika 44 Nishioka, Masaki 60 Nishito, Yasumasa 52 Nishizawa, Daisuke 50,60 Nissbrandt, Hans 56 Nitta, Atsumi 51,52,53 Nizetic, Dean 58 Noda, Takamasa 47 Noda, Yoshihiro 38,42 Nogawa, Shun 59 Noguchi, Kyouko 44 Noike, Hiroshi 52,58 Norris, Sandhaya 62 Nosaka, Tadashi 36 Novak, Tomas 40 Nozaki, Keiko 40 Nuñez, Yaira 51 Nutt, David 25

104 Index

Nyengaard Jens 54 O'Brien, John 9,25 Ochoa-Sanchez, Rafael 56 Ochs-Ross, Rachel 39 Odlaug, Brian 28 Ogawa, Tania Marie 35 Ogden, R. Todd 37 Ogihara, Tomomi 37,43,45 Ogyu, Kamiyu 42 O'Hare, Kirstie 57 Ohi, Kazutaka 48,61 Ohira, Yuki 49 Ohka, Seii 50 Ohnishi, Tetsuo 33,51 Ohno, Yukihiro 54,57 Ohuchi, Kazuki 51 Okada, Ayumi 49 Okada, Go 41,42,50 Okada, Yasunori 50 Okahisa, Yuko 38,64 Okamoto, Yasumasa 41,42,50 Okano, Hideyuki 51 Okubo, Hiroaki 48,61 Okuhata, Shiho 50 Oqendo, Maria A 3,16,24 Osada, Ryota 37,45 Osborne, Ashleigh L. 57 Oshibuchi, Hidehiro 43,49,58 Osmanova, Diana 42,49 Osmond, Jordan 64 Østergaard, Søren Dinesen 58 Osuchovska, Olena 62 Osumi, Noriko 50 Otabi, Hikari 40 Otsuki, Kanami 49 Oya, Dai 43 Ozawa, Chisa 39,46 Özer, Ömer Akil 43 Padberg Frank 20 Pae, Chiun 39 Pagonas, Spyridon 37 Paik, Jong Woo 40,47 Pálenícek, Tomáš 51,56 Paliwal, Jyoti 52 Palma, Duarte 62,63 Paloyelis, Yannis 43,50

105 Index

Pan, Xiandi 44 Pan, Yuan-Chien 63 Panizzutti, Bruna 33 Panov, Dmitriy 58 Papadopoulou, Marianna 38 Papageorgiou, Konstantinos 22,42,63 Pariante, Carmine 36,60 Pariwatcharakul, Pornjira 42 Park, Je Min 63 Park, Jeong Ha 43 Park, So-Hyun 43 Parkin, Georgia 58 Parsey, Ramin 37 Parshakova, Aleksandra 61 Passos, Ives Cavalcante 37 Patel, Rooshi 45 Paulzen, Michael 33 Pavey, Geoffrey 57 Pavón, Francisco J. 51 Pawlowski, Marcel 61 Peh, Andrew L H 62 Pekarik, Vladimir 57 Pelayo-Teran, Jose Maria 49 Peng, Daihui 40 Peng, Hsien-Yu 50 Peng, Yanmin 46 Pereira, Sérgio 39,44 Perrone, Alessia 57 Pessariello, Catherine 36 Pettersson, Robert 52 Pezawas, Lukas 8,41,48,59,61 Pfaff, Sarah 48,50 Pfaffenseller, Bianca 52 Philippe, Cecile 48,59,60 Phillips, Angela 40,41 Phillips, Jennifer 29 Pichler, Verena 41,60 Pifl, Christian 56 Pikalov, Andrei 36,37,40,46,47 Pinterová, Nikola 51 Pinto, Jairo Vinícius 37,52,60 Plitman, Eric 42,61 Pointet, Stephanie 61 Pokorny, Thomas 56 Polimanti, Renato 51 Polizzotto, Nicola 48

106 Index

Pollak, Daniela D. 8,26,53,56 Popoli, Maurizio 23,31,54 Popova, Vanina 39 Porcelli, Stefano 39 Porichi, Evgenia 37 Posa, Luca 53,56 Potier, Marie-Claude 58 Pozhidaev, Ivan 42,49 Prahar, Ishwar 54 Praschak-Rieder, Nicole 8,25,43,48,59,60,61,62 Prats, Laura 37 Preller, Katrin 28,56 Provenzano, Julian 41,59 Puri, Vinod 50 Purty, Abhishek 36 Purushothaman, Deepa 63 Qi, Liqin 39 Quednow, Boris 35 Quintard, Laurence 63 Rabbani, Habib A. 49 Rabl, Ulrich 41,42,59 Rafferty, Megan 48 Rainer, Rupprecht 35 Ramakrishnan, Nithya 48 Ramos, Aline 50 Ran, Caroline 56 Rao, Jinrui 46 Rao, Naren P 9,48,63 Rasenick, Mark 23,24 Rashid, Mamunur 54 Rashid, Mir 50 Ratta-apha, Woraphat 27 Redden, Sarah A. 35 Reddy, YC Janardhan 36 Reed, Murray 50 Reif, Andreas 21,22 Reis, Dóris 38 Reisinger, Sonali N. 53 Reither, Harald 56 Remington, Gary 61 Rene, Seiger 59 Reuter, Martin 59 Reutfors, Johan 39,53 Reyahni Rad, Siamak 64 Reynolds, Gavin 42 Rezendes, David 43

107 Index

Riba, Jordi 31 Ribases, Marta 22 Ribeiro Scholz, Jaqueline 35 Ricken, Gerda 53 Rietschel, Marcella 35 Rischka, Lucas 41,50 Riva, MA 60 Robbins, Trevor 8,11,23,60,61 Rodríguez de Fonseca, Fernando 51 Roh, Daeyoung 48 Ronovsky, Marianne 56 Rosa, Adriane Ribeiro 37 Rosell-Valle, Cristina 51 Rosenstock, Tatiana 50 Rossi-Menezes, Paulo 49,58 Rovelet-Lecrux, Anne 58 Rowland, Laura M 47 Ruda-Kucerova, Jana 30,57 Ruhe, Henricus 30 Rujescu, Dan 26,36,59 Rush, Augustus John 62 Sachs, Gabriele 8,28,49 Sadigh Eteghad, Saeed 64 Sahakian, Barbara 6,8,18,19,21,25,30,61 Saika, Fumihiro 56 Saillard, Jelena 47 Saito, Kenji 59 Saito, Toshikazu 8,18,22,27,32 Saito, Yuta 46 Sakamoto, Shinji 38,64 Sakamoto, Teruo 49 Sakuma, Mutsuki 46 Sakurai, Hitoshi 46,47 Salum, Giovanni 13,33 Salvetat, Nicolas 61 Sanacora, Gerard 29,39,40 Sanigorski, Andrew 33 Santa, Cátia 60 Santín, Luís 51,53 Saroj, Priyanka 57 Sasaki, Tsukasa 58 Sasayama, Daimei 37,38,45,54,59 Satlin, Andrew 47 Sato, Atsushi 52 Sato, Goro 46,47 Sato, Naomi 50

108 Index

Sato, Yasushi 40 Sauerzopf, Ulrich 30,43,48,59,60,61 Savulich, George 61 Sawa, Akira 8,9,30 Sawada, Kyosuke 38,39 Sawamura, Rie 58 Sawanobori, Yosuke 39 Saxena, Alpana 50 Schatzberg, Alan 41,54,59 Scheidegger, Milan 29 Schilbach, Leonhard 56 Schmid, Johannes A. 56 Schmid, Yasmin 44 Scholze, Petra 53 Schooler, Nina 46 Schoretsanitis, Georgios 13,33 Schosser, Alexandra 32,61 Schuler, Michael 54 Schulze, Thomas G. 32 Schuschnig, Uwe 50 Schwarcz, Robert 31 Schweinsburg, Brian 63 Scott, J. Cobb 63 Scotton, Ellen 52 Seiger, Rene 36,59,60 Seiriki, Kaoru 50 Seki, Chie 59 Seki, Tomoe 53 Semke, Arkady 49 Semke, Arkari 60 Sendo, Toshiaki 49,52 Seo, Ji-Seon 13,33 Serikawa, Tadao 57 Serra, Giulia 24 Serrano, Antonia 51 Serretti, Alessandro 9,39,42,47,58 Setoyama, Daiki 41 Setoyama, Shiori 47 Shabanov, Petr 52 Shalyapin, Pavel 56 Shelton, Richard C. 39 Shen, Guang Fan 48 Shi, Yuan 46 Shibasaki, Chiyo 41,42,50 Shikhov, Sergej 60 Shim, Sehoon 38,41

109 Index

Shimada, Hitoshi 59 Shimada, Takamitsu 48,61 Shimamoto, Chie 13,33,51 Shimazawa, Masamitsu 50,51 Shimazu, Tomokazu 38,42 Shimizu, Saki 54,57 Shimoda, Masayuki 50 Shin, Cheolmin 42 Shin, Il-Seon 42,46 Shin, Young Chul 42 Shinagawa, Shunichiro 38 Shinotoh, Hitoshi 59 Shintani, Norihito 50 Shintani, Yusuke 50 Shiotsuki, Ippei 49 Shirasaka, Tomohiro 27 Shmukler, Alexandr 60 Shoji, Hirotaka 40 Shuhama, Rosana 49,58 Šíchová, Klára 51 Siebenga, Pieter 43 Sieghart, Werner 57 Sigurdardottir, Helen 36,59 Silberbauer, Leo 41 Silva, Hugo 44 Simião, Hugo 38 Simões do Couto, Frederico 45 Simutkin, German 42 Singewald, Nicolas 31 Singh, Raghunath 54,57 Singh, Sandeep 54 Singh Khurana, Paramjeet 35 Singh Sidhu, Gulbahar 62,63 Sitte, Harald H. 8,23,53,56 Skoupy, Radim 57 Slaby, Alex 45 Smashna, Olena 63 Smirnova, Ludmila 60 Smith, Gwenn 9,25 Smolina, Natalia 60 Smoller, Jordan 51 Soares, Claudio 42 Soares, Jair 34 Soda, Midori 44 Söderkvist, Peter 56 Soga, Tomoko 54

110 Index

Sogabe, Satoshi 54 Sogo, Katsumasa 44 Soh, Keng Chuan 35 Sokolik, Chaya 64 Solowij, Nadia 57 Sommerdahl, Nadia Bendixen 58 Sonenberg, Nahum 53 Song, In Chan 47 Song, Rui 37 Soong, Bing-Wen 63 Soo-Young, Bhang 63 Sotres-Bayon, Francisco 23 Souery, Daniel 39,42 Sousa, Daniel 39,44,59 South, Charles 62 Southwick, Steven 63 Sozen, Sule 38 Spies, Marie 27,36 Spínola, Carla 46,59 Spolding, Briana 33 Spurny, Benjamin 59 Stamenkovic, Mara 59 Starcuk, Zenon 57 Stark, Tibor 57 State, Matthew 25 Stattmann, Miranda 53 Štefková, Kristýna 51 Steiger, Axel 61 Stein, Dan 9,26 Stein, Murray 21,51 Steinkellner, Thomas 53 Stephenson, Bob 61 Stickeler, Elmar 33 Strydom, Andre 58 Sturla, Antonella 51 Su, Kuan-Pin 36,42 Su, Ping 56 Su, Tsung-Ping 37,52 Su, Tung-Ping 37,38,40,41 Su, Yousong 40,46 Sudheimer, Keith 54 Sueyoshi, Kazuki 47 Sugahara, Takafumi 57 Sugawara, Hiroko 43,58 Sugawara, Norio 40 Sugimura, Haruhiko 50

111 Index

Sugiyama, Nobuhiro 54 Sugiyama, Yoko 44 Suh, Ho-Suk 52 Suhara, Tetsuya 22,59 Suiama, Mayra 50 Sulaiman, Ahmad Hatim 40 Sulcova, Alexandra 9,30,57 Suleymanova, Ekaterina 63 Sumi, Kazuyuki 52,53 Sumi, Mamta 50 Sumiyoshi, Chika 48 Sumiyoshi, Tomiki 47 Sumiyoshi, Yusuke 52 Sun, Lei 43 Sun, Xia 37 Sunder-Plassmann, Raute 42 Suyama, Haruna 36 Suzuki, Atsushi 54 Suzuki, Motohisa 54 Suzuki, Noriko 54 Suzuki, Takefumi 29,39,45,46,47,48,51 Suzuki, Toshihito 55 Svensson, Torgny 57 Swoboda, Patrick 61 Syamsuddin, Saidah 47 Sydow, Olof 56 Sykora, David 56 Syrejshchikova, Tatjana 56 Szyf, Moshe 64 Tabira, Takeshi 50 Tada, Haruka 54 Tada, Mitsuhiro 48 Tadama, Hiroshi 39 Tajima, Yasukazu 54 Takado, Yuhei 59 Takagaki, Koki 41 Takahashi, Kaori 60 Takahashi, Kazuhito 43 Takahashi, Kie 47 Takahashi, Shoko 59 Takahashi, Yukiteru 47 Takahata, Keisuke 46,59 Takaki, Manabu 38,64 Takamatsu, Yukio 52 Takamura, Masahiro 41,42,50 Takashio, Osamu 39

112 Index

Takazawa, Chiemi 49 Takemoto, Atsushi 58 Takeuchi, Hiroyoshi 46 Tamminga, Carol 8,24,26,29,31 Tanabe, Haruka 37,45 Tanaka, Maiko 54 Tanaka, Masuo 27 Tanaka, Miho 52 Tani, Hideaki 46,48 Tanioka, Fumihiko 50 Tanra, Andi Jayalangkara 9,47 Tarumi, Ryosuke 42 Tasker, R. Andrew 58 Tatsumi, Shingo 49 Tauscher, Johannes 22 Telese, Francesca 23 Tensho, Masami 48 Terao, Takeshi 49 Tessier, Pierre 62 Thakur, Vandana 55,57 Thase, Michael E. 39 Tiger, Mikael 40 Tillman S 54 Tissen, Ilia 52 Titulaer, Joep 57 Tiwari, Arun 36,47 Tocco, Michael 37,40,46,47 Tokudome, Kentaro 57 Tokunaga, Masaki 59 Tokuyama, Shogo 56 Tomita, Masaru 41 Tomita, Tetsu 40 Tournikioti, Kalliopi 38 Toyoda, Atsushi 40 Toyoshima, Manabu 51 Treccani, Giulia 54 Treven, Marco 57 Trindade, Teresa 38 Trivedi, Madhukar 33,39,62 Tsai, Ching-Hong 35 Tsai, Hung-Ming 36 Tsai, Joyce 37 Tsai, Shang-Ying 37 Tseng, Huai-Hsuan 58 Tseng, Ping-Tao 38 Tsuchimine, Shoko 40

113 Index

Tsugawa, Sakiko 38,42 Tsujii, Takashi 42 Tsukamoto, Katsura 44 Tsunoda, Kenichi 48 Tsuruga, Koji 40 Tsutumi, Takahiro 49 Tu, Pei-Chi 38,40,41 Tuktareva, Inna 63 Turck, Christoph 59 Turecki, Gustavo 8,25 Tylš, Filip 42 Tzortsou, Sofia 38 Uchida, Hiroyuki 26,29,39,42,45,46,47,48,51 Uchida, Naoshige 28 Uchida, Shusaku 53 Uchida, Takahito 42,47 Uchimura, Naohisa 41 Uchino, Hiroyuki 53 Uchino, Shigeo 52 Udawela, Madhara 57,58 Ueda-Hayashi, Junko 60 Uehara, Takashi 48,61 Uematsu, Ken 41 Ueno, Fumihiko 51 Uezato, Akihito 61 Üke Uzun, Saniye 43 Umino, Asami 61 Umino, Masakazu 61 Unalan Ozpercin, Pelin 38 Uno, Hiromitsu 39 Uno, Junji 47 Uno, Kyosuke 51,53 Ursano, Robert 51 Uzawa, Masahiro 43 Uzbekov, Marat 59,60 van den Buuse, Maarten 57 van Gerven, Joop 43 van Vliet, Bernard J. 59 Vanicek, Thomas 21,36,41,50,59,62 Vanover, Kimberly 57,60 Varambally, Shivarama 48,63 Vaskovicova, Nadezda 57 Vasquez, Freddy 49,63 Venigalla, Hema 45 Venkatasubramanian, Ganesan 9,48,63 Vieta, Eduard 9,20,22,23,39,47

114 Index

Viktorinová, Michaela 42 Villar, Alicia 63 Vire, Berengere 61 Vizeli, Patrick 44 Voevoda, Mikhail 58 Volders, Haukeline H. 59 Volik, Inna 62 Vollenweider, Franz X. 56 Vollstadt-Klein, Sabine 35 von Moltke, Lisa 43 Vonmoos, Matthias 35 Vyalova, Natalya 42 Vyssoki, Benjamin 41,54 Wada, Masataka 38 Wade, Ben 33 Wadsak, Wolfgang 8,36,41,43,48,50,59,60,61 Wahajuddin, M 54 Wajs, Ewa 40 Walder, Ken 33 Walker, Christopher 48 Wallon, David 58 Walss-Bass, Consuelo 34 Walter, Henrik 35 Wang, Chih-Jen 35 Wang, Feng 52 Wang, Jong-Yi 45 Wang, Juihui 55 Wang, Sheng-Chang 36 Wang, Yong 37,40 Wang, Yu 37 Wang, Yu-Hsun 45 Wang, Yun 40 Warhaftig, Gal 64 Washizuka, Shinsuke 38,43,45 Watanabe, Keita 41 Watanabe, Kenya 40,45 Watanabe, Koichi 49 Watanabe, Koichiro 37 Watanabe, Yoichiro 37 Watanabe, Yoshifumi 53 Waye, Shannon 64 Wegener, Gregers 54,58 Wei, Zhenyu 52 Weidenauer, Ana 24,43,48,59,60,61,63 Weingart, Michal 47 Weissmann, Dinah 61

115 Index

Wen, Yang-Cheng 50 Weston-Green, Katrina 53,57 Wijtenburg, Andrea S 47 Wilffert, Bob 49,59 Willeit, Matthäus 8,26,43,48,59,60,61,63 Williams, Lana 46 Williams, Nolan 20 Williams, S. 43,50 Winkler, Dietmar 8,25,63 Winstanley, Catharine 23 Womack, Danica 48 Wong, Bo-Yu 63 Wong, Estee 38 Woo, Young Sup 37,40,43 Wozniak, Janet 24 Wrocklage, Kristen 63 Wu, Changwei 35 Wu, Fan 52,53 Wu, Hui-Ju 40 Wu, Zhiguo 40 Xu, Jingjie 46 Xu, Lin 39 Xue, Li li 37 Yabe, Hirooki 40,45 Yabuki, Yasushi 52 Yada, Hiroki 47 Yadid, Gal 64 Yagi, Gohei 39 Yako, Shingo 38 Yamada, Hidetaka 50 Yamada, Hiroki 39 Yamada, Makiko 58 Yamada, Mari 39 Yamada, Norihito 38 Yamada, Ryuji 54 Yamagata, Bun 38 Yamagata, Hirotaka 53 Yamaguchi, Masaki 38 Yamamori, Hidenaga 48 Yamamoto, Naoki 61 Yamamoto, Shinnosuke 40,45 Yamanaka, Tusuyoshi 53 Yamashita, Hakuei 38,42 Yamawaki, Shigeto 8,17,22,28,41,42,50 Yamazawa, Ryoko 47 Yan, Zhen 33

116 Index

Yanagi, Tomoyuki 48 Yang, Bang-Hung 41 Yang, Jae-Won 53 Yang, Jiaye 56 Yang, Shu-Yu 46 Yang, Xi 52 Yang, Yen Kuang 43 Yao, Wei 60 Yasuda, Makiko 53 Yasuda, Yuka 48 Yasui-Furukori, Norio 40,46 Yasuyama, Toshiki 48,61 Yatham, Lakshmi 22,28 Ye, Chen yu 37 Ye, Sang-Kyu 60 Yeh, Ta-Chuan 38 Yenkoyan, Konstantin 44 Yep, Rachel 58 Yi, Jung Seo 47 Yin, Yuexi 64 Yokota, Akihiro 54 Yokoyama, Kazuhito 49 Yokoyama, Satoshi 41,42,50 Yoon, Bo-Hyun 37,40,47 Yoon, Jin-Sang 42,46 Yoon, Youngwoo B 47 Yoshida, Hiroyuki 50 Yoshida, Kaori 60 Yoshida, Kazunari 39,47 Yoshikawa, Takeo 33,51,61 Yoshimura, Bunta 64 Yoshimura, Reiji 37,41 Yoshino, Atsuo 41,42,50 Yoshino, Yuta 50 Yoshio, Takashi 48 Yoshizaki, Kaichi 50 Young, Allan 8,23,40 Yuan, Cheng mei 37 Yuan, Peixiong 58 Yuksel Oksuz, Ozge 38 Zach, Peter 42 Zai, Clement 36,47 Zai, Gwyneth 12,36 Zalim, Qais 45 Zambon, Alice 56 Zanderigo, Francesca 37

117 Index

Zangen, Abraham 32 Zapico-Merayo, Yolanda 49 Zar, Heather 34 Zarate, Jr, Carlos 58 Zelaya, Fernando 43,50 Zelek-Molik, Agnieszka 54 Zettergren, Anna 56 Zhang, Bo 39 Zhang, Chen 40 Zhang, Lei 60 Zhang, Xinyi 46 Zhang, Yanbo 55 Zhang, Yun 39 Zhao, Shuyue 52 Zhou, Qian 40 Zhou, Rubai 46 Zhu, Cuizhen 46 Zhu, Xiyu 33 Zifman, Noa 64 Zohar, Joseph 20,21,26,32,39,42 Zuberi, Mariyam 50 Zuiker, Rob 43 Zuilhof, Zoë 62 Zunta-Soares, Giovana 34

118